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Abstract
A series of fourteen new nickel Schiff base complexes was synthesised by a two-step
procedure.

Initially

2,4,6-trihydroxybenzaldehyde

was

reacted

with

1-(2-

chloroethyl)piperidine hydrochloride, 4-(2-chloroethyl)morpholine hydrochloride or
1-(3-chloropropyl)piperidine hydrochloride in the presence of K2CO3 to afford three
organic precursor compounds featuring different pendant groups. These compounds
were then successfully reacted with different diamines in the presence of Ni(II) to
form a series of nickel Schiff base complexes featuring four pendant groups. All new
organic compounds and nickel complexes were characterised using 1D and 2D
nuclear magnetic resonance (NMR) spectroscopic methods, elemental microanalysis
and electrospray ionisation mass spectrometry (ESI-MS). The solid-state structures
of four nickel complexes were determined by single crystal X-ray crystallography
and revealed that the coordination geometry around the nickel ion was square planar
in each case.
The ability of the nickel complexes to bind to the double stranded DNA molecule
D2, the tetramolecular G-quadruplex Q4, the unimolecular G-quadruplex Q1 in its
parallel, anti-parallel and hybrid topologies, the parallel unimolecular G-quadruplex
c-KIT1, and the fluorescently labelled unimolecular G-quadruplex F21T, was
investigated using ESI-MS and circular dichroism (CD) spectroscopy, Fluorescence
Indicator Displacement (FID) assays, Fluorescence Resonance Energy Transfer
(FRET) melting assays and molecular docking.
The results of these studies enabled the effect of varying the diamine moiety and the
pendant groups on DNA binding properties to be explored. It was found that
changing the diamine moiety whilst retaining the same pendant groups often had a
ii

significant effect on binding affinity towards different DNA molecules. For example,
changing the diamine moiety from phenylenediamine in (53) and (54) to the meso1,2-diphenylethylenediamine moiety in (65) and (66), respectively, resulted in the
binding preference changing to favour G-quadruplex DNA over double stranded
DNA. In addition, nickel complexes with propylpiperidine pendant groups generally
exhibited stronger interactions with a variety of different DNA molecules than
analogues containing the same diamine moiety but one of the other two types of
pendant groups. For example, complex (61), which possessed propylpiperidine
pendant groups, exhibited a much greater ability than either (59) or (60) to form noncovalent adducts with Q4, Q1 and D2 in ESI-MS experiments. This is despite (61)
having the same diamine moiety and is a result of the latter two nickel complexes
having ethylpiperidine and ethylmorpholine pendant groups, respectively. Circular
dichroism studies showed that parallel c-KIT1 was the only G-quadruplex whose CD
spectrum was significantly affected by (61). This result suggests this nickel complex
may bind to parallel c-KIT1 with some selectivity over other types of Gquadruplexes.
Complexes (53), (56) and (65) and their analogues with only two pendant groups
were evaluated for their cytotoxicity against V79 lung cancer cells using MTT
assays. The results obtained suggested introduction of two additional pendant groups
does not in general appear to confer additional cytotoxicity onto this class of nickel
complexes.
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Chapter 1

Introduction

1.1 Deoxyribonucleic acid (DNA)
Deoxyribonucleic acid (DNA) is a polymeric biomolecule that is found in most
lifeforms. It is a major component of chromosomes and responsible for storing,
transmitting and processing cellular genetic information. DNA is composed of many
repeating units called nucleotides. Each nucleotide consists of the sugar deoxyribose,
a phosphate group, and a nitrogenous base which can be one of the two pyrimidines
cytosine (C) and thymine (T), or one of the purines adenine (A) or guanine (G)
(Figure 1.1). Within each nucleotide, the nitrogenous base is linked to the
deoxyribose sugar unit through an N-glycosidic bond with the 1ʹ-carbon, while the
phosphate group is linked to deoxyribose through a phosphoester bond. A single
DNA strand is formed when nucleotides are linked together in their 5ʹ and 3ʹ
positions via phosphodiester bonds.
A double stranded DNA (dsDNA) structure occurs when base pairs in two pieces of
single stranded DNA (ssDNA) are held together by hydrogen bonds between
complementary pyrimidine and purine bases. The dsDNA structure is further
stabilised by base stacking interactions which consist of van der Waals, electrostatic
and hydrophobic interactions between the purine and pyrimidine bases.1
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Figure 1.1: A portion of the structure of dsDNA, illustrating Watson-Crick base
pairing between complementary bases on the two DNA strands.
The structure of the most common form of DNA (B-DNA) was first determined by
Watson and Crick in 1953.2 The crystal structure of B-DNA revealed that it is
composed of two right-handed anti-parallel strands that are held together by specific
hydrogen bonding interactions. The base pairs formed are known as Watson-Crick
base pairs and are highly specific in that A always pairs with T via two hydrogen
bonds while G only ever pairs with C via three hydrogen bonds (Figure 1.1). The
preservation of the above base pairs is a fundamental aspect of the DNA replication
process as this facilitates synthesis of complementary strands with high fidelity. In BDNA the nitrogenous bases are stacked perpendicular to the helical axis, with ~10
base pairs per helical turn, resulting in the formation of two grooves known as the
major and minor grooves.3 The width of the major and minor grooves is an important
factor involved in determining how drug molecules may interact with DNA.
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Most DNA present in cells is found in the classic double-helix B-DNA form.
However, there are other less common structures that dsDNA can adopt under certain
conditions. For example, in low humidity environments dsDNA can adopt the righthanded A-form structure with ~11 base pairs per helical turn.3 In A-DNA, the
nitrogenous bases are displaced from the helical axis and ejected into the minor
groove. In addition, in environments with high salt concentrations dsDNA can adopt
the left-handed double helical Z-DNA structure with ~11 base pairs per helical turn.
In contrast to the A- and B- forms of DNA the Z-DNA structure is wider, more
compact and has a deeper minor groove.3 The latter results from the displacement of
the base pairs from the helical axis of Z-DNA. Another distinctive feature of the
structure of Z-DNA is alternating purine–pyrimidine sequences (e.g. GC) with anti
and syn conformations of the alternating glycosidic bonds. This conformation gives
rise to the wrinkled appearance of the sugar-phosphate backbone in Z-DNA.
Alternative hydrogen bonding arrangements between DNA bases also exist which
expand the ways in which DNA can fold to form additional secondary structures
such as triplexes and guanine quadruplexes (G-quadruplexes).

1.2 G-quadruplex DNA
G-quadruplexes are less common secondary DNA structures that are formed from
guanine-rich DNA sequences. These sequences are found in different locations of the
genome, including the extended 3ʹ-overhang region consisting of ssDNA that is
located at the end of chromosomes in regions known as telomeres. Although the
formation of guanine tetrads (G-tetrads) were first reported in 1910, their
characterisation was not accomplished until 1962.4,5 G-tetrads are the basic structural
feature of a G-quadruplex. Each G-tetrad is a square planar array of four guanine
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bases held together by eight Hoogsteen hydrogen bonds (Figure 1.2 (a)). In a Gquadruplex at least four G-tetrads are stacked on top of each other and held together
by π-π base stacking interactions (Figure 1.2 (b)). The central channel of each Gtetrad is stabilised by the presence of monovalent cations (e.g. K+, Na+ or NH4+).6,7
The latter coordinate to the electronegative oxygen atoms of the guanine carbonyl
groups and minimise the repulsive effects that would otherwise arise from their
proximity to each other.8 The ability of the above cations to stabilise G-quadruplex
structures was found to vary according to the following sequence K+ > Na+ >
NH4+.7,9-11 They have been shown to intercalate between adjacent G-quartets joined
together by the sugar phosphate backbone of the DNA strands (Figure 1.2 (b)).

Figure 1.2: Schematic representation of a G-quadruplex structure: (a) four guanines
self-associate into a planar G-tetrad with a central cavity occupied by a monovalent
cation (green sphere) coordinated to oxygen atoms. (b) G-quadruplex structure
formed as a result of π-π stacking of G-tetrads.
G-quadruplex DNA structures can exhibit various topologies depending on a number
of factors. These include the nucleobase sequence(s) of the strand(s) they are formed
from, whether they are intra- or intermolecular, the number of DNA strands
associated with the structure (one, two or four), strand orientation (parallel, antiparallel or hybrid), and the type of loops connecting the DNA strands (lateral,
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diagonal or strand reversal).8,12 For example, unimolecular G-quadruplexes formed
from a single DNA strand can fold into a parallel conformation with external
(propeller) loops (Figure 1.3 (a)) or into an anti-parallel conformation with either
lateral (edgewise) loops (Figure 1.3 (b)) or a mixture of lateral and diagonal (hybrid)
loops (Figure 1.3 (c)). Bimolecular G-quadruplexes are formed from two DNA
strands and can fold into a parallel conformation with external loops connecting the
adjacent strands or into an anti-parallel conformation with either lateral loops or
diagonal loops connecting the adjacent strands (Figure 1.3 (d) and (e)).
Tetramolecular G-quadruplexes are formed from four DNA strands which can orient
themselves in either parallel (Figure 1.3 (f)) or anti-parallel positions with respect to
each other, resulting in different intermolecular structures.
The exact topology exhibited by a G-quadruplex can vary depending on the sequence
of nucleotides and the surrounding environment.13 For example, the human telomeric
sequence d[AGGG(TTAGGG)3] forms anti-parallel and parallel G-quadruplex
structures in buffers containing Na+ and K+ ions, respectively.14,15 In contrast, the
following sequence, which differs slightly from that present in human telomeres,
d[GGG(TTAGGG)3T], forms an intramolecular anti-parallel G-quadruplex in buffers
containing potassium ions.16 A number of different DNA sequences containing
human telomeric repeats have also been found to form different G-quadruplex
structures under different ionic conditions.17
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Figure 1.3: Schematic illustration of different G-quadruplex conformations: (a)
unimolecular parallel with external loops; (b) unimolecular anti-parallel (chair type)
with lateral loops; (c) unimolecular anti-parallel (basket type) with a mix of lateral
and diagonal loops; (d) bimolecular anti-parallel with external loops; (e) bimolecular
anti-parallel with lateral loops; and (f) tetramolecular parallel. Loops are coloured
red. Arrows refer to strand orientation. Adapted from various references.17-21
Many of the G-quadruplex DNA topologies discussed above have been found to be
stable under physiological conditions, suggesting they may have potential roles in
biological activities.22 Therefore, in recent years, considerable attention has focused
on the detection and characterisation of G-quadruplex structures in living cells in
order to understand their formation and biological functions.
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1.3 Biological aspects of G-quadruplex DNA
The formation of G-quadruplex structures in human cells was clearly demonstrated
by the Balasubramanian group through the use of fluorescently labelled structurespecific antibodies (BG4).23 These revealed the presence of G-quadruplex structures
in both telomeric and non-telomeric regions of chromosomes (Figure 1.4). Similar
results were subsequently obtained by other research groups using different Gquadruplex specific antibodies (IgG 1H6 and scFv D1).24,25

Figure 1.4: Immunofluorescence microscopy analysis of BG4 antibody on
chromosomes isolated from HeLa cervical cancer cells. Chromosomes are stained
with DAPI DNA dye (blue). (a), (b) and (c) show discrete BG4 foci (red) within the
non-telomeric regions, (d) and (e) show discrete BG4 foci (red) at the telomeres.
Reprinted by permission from Springer Nature, Giulia Biffi et al, Nature Chemistry.
2013, Vol 5 (3), p 182-186.23 Copyright 2013.
According to an in vitro sequencing study, over 700,000 DNA sequences in the
human genome are capable of forming G-quadruplexes.26 Most of these were found
in telomeres and promoter regions such as c-MYC, BCL-2, c-KIT, KRAS, and
VEGF.27-38 The predominance of potential G-quadruplex forming sequences in these
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regions has led to suggestions they may play a role in several key biological
processes including DNA replication, transcription and translation, as well as
telomere maintenance and genomic regulatory processes.

9,22,39,40

It has also been

speculated that the formation of G-quadruplex DNA structures may be connected to
the onset of certain human diseases including different types of cancer.41-43 Such
studies have provided impetus for the development of G-quadruplex binding and
stabilising agents as a new class of therapeutic drugs.

1.3.1 The formation of G-quadruplexes from the human telomeric
sequence
G-quadruplex formation in many organisms was first observed in telomeric
regions.44 Telomeres are DNA-protein complexes found at the ends of chromosomes
that provide protection from genetic instability arising from events which involve
merging with neighbouring chromosomes. Human telomeric DNA is composed of a
noncoding region of duplex TTAGGG repeats, and a 3′ single-strand overhang
region that is also composed of multiple repeats of the same guanine-rich base
sequence. This 3′ single-strand overhang is a product of an inherent issue (“end
replication problem”) that arises during the DNA replication process occurring
during cell division. During replication dsDNA is first unwound by the DNA
helicase enzyme.18 This results in leading and lagging ssDNA strands that run in
opposite directions (5′ to 3′ and 3′ to 5′ direction, respectively) (Figure 1.5 (a)) and
provides an opportunity for G-quadruplex structures to be formed. It has been
theorised that the presence of folded G-quadruplex structures may prevent a ssDNA
strand from being able to function as a template for replication.39 A number of
helicases which are known to unwind G-quadruplex structures are found in telomeres
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in vitro, strongly suggesting that G-quadruplex formation may naturally occur in
telomeres in living cells.22,45-47
(a)

(b)

(c)

Figure 1.5: (a) Schematic illustration of the DNA replication process highlighting the
“end-replication problem”. Polymerase ε in eukaryotes replicates the leading strand
while polymerase α synthesises discontinuous DNA fragments known as Okazaki
fragments along the lagging strand; (b) Incomplete replication of the lagging strand
occurs as DNA primase is unable to synthesise the final required primer sequence,
and (c) Complete replication of the leading strand. Adapted from various
references.48,49
DNA replication is performed by a DNA polymerase enzyme (DNA pol α-primase
complex) following binding of an RNA primer to the target ssDNA strand. The
polymerase works only in the 5′ to 3′ direction along the template DNA strand.
Therefore, the leading strand is able to be replicated by the polymerase enzyme in a
continuous fashion by closely following the helicase with only one molecule of RNA
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primer required to initiate the process. In contrast, the lagging strand is replicated
discontinuously in small segments with a series of RNA primers being required to
initiate each of the individual DNA synthesis events. This produces a series of
discontinuous DNA segments called Okazaki fragments.50 After synthesis is
completed the RNA primers are removed and the gaps in the DNA sequence are
filled by a DNA ligase enzyme. A problem arises since the RNA primase in linear
chromosomes is unable to synthesise the final primer at the 3′ end of the template
DNA strand. This prevents the complete replication of the lagging strand, leaving the
DNA with a 3′ single stranded overhang (Figure 1.5 (b)). This failure to completely
reproduce a copy of the template strand is called the “end replication problem”.51 As
a result, the length of telomeric DNA progressively decreases after each round of
DNA replication.48 Eventually it reaches a critical length, after which a DNA damage
response is activated and the cell enters a senescent state, and eventually undergoes
apoptosis.52,53
To protect the telomere from being recognized as damaged DNA, the 3′ single-strand
overhang forms a telomeric loop (T-loop) and generates a local displacement loop
(D-loop) by folding back to the double stranded region (Figure 1.6 (a)).54,55 T-loop
formation is mediated by a protein complex called shelterin which consists of six
proteins (Figure 1.6 (b)).55 The shelterin complex caps telomeric DNA through the
binding of Telomeric Repeat-binding Factor 1 and 2 (TRF1 and TRF2) to the
TTAGGG sequences present in dsDNA56 and the binding of the Protection of
Telomeres 1 protein (POT1) to these sequences in the ssDNA regions.57 TRF1Interacting Nuclear factor 2 (TIN2) binds to TIN2-interacting protein 1 (TPP1) and
holds TRF1, TRF2 and POT1 together in the complex (Figure 1.6 (b)). Finally,
Repressor Activator Protein 1 (RAP1) also binds to TRF2 in order to form the fully
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protected telomere. In addition to end capping of the telomere, T-loops also regulate
activity of the enzyme telomerase by inhibiting access to the telomere terminus.
Therefore, the T-loops have to be unfolded first before telomere extension mediated
by telomerase can occur.

Figure 1.6: (a) Schematic illustration of the structure of a telomere showing the Tloop, D-loop and shelterin; and (b) structure of the shelterin complex involving six
different proteins (TRF1, TRF2, TIN2, TPP1, POT1 and RAP1).
1.3.1.1 Telomerase and cancer
Apoptosis is an essential process required to prevent uncontrolled cell division in
somatic cells. In contrast, stem cells and germ cells express the enzyme telomerase to
maintain telomere length and high proliferation capacities.58,59 The same occurs with
many types of cancer cells which show high levels of telomerase activity.59
Telomerase is a ribonucleoprotein enzyme that was first discovered in 1984 and
normally exhibits minimal activity in somatic cells.49,52,60 The enzyme is comprised
of the catalytic enzyme unit which is called Telomerase Reverse Transcriptase
(TERT), and a telomerase RNA component known as TERC. Telomerase serves to
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maintain the length of telomeric DNA in human cells by adding the G-rich six-base
nucleotide sequence TTAGGG onto the 3′-end of the telomeric single stranded DNA
overhang.52,60 The TERC is produced by RNA polymerase II, and used as the
template for the telomeric DNA synthesis process.
Over-expression of telomerase provides a mechanism by which cancer cells can
avoid the apoptotic process by which all cells normally eventually die. However, it
has been suggested that folding of the G-rich single stranded overhang region present
in telomeres into G-quadruplex structures may result in inhibition of telomerase
activity, thereby providing a mechanism of targeting cancer progression.61-65 As a
result there has been an increasing amount of research recently directed toward
understanding the formation and stabilisation of G-quadruplexes.64-68 This
understanding has made it possible to design small molecules with features that
enable them to bind effectively to and stabilise G-quadruplexes, sometimes in a
highly selective fashion with respect to the more common B-DNA found throughout
cells. Therefore, the development of small-molecule ligands which can bind to Gquadruplexes has become a recent focus of many studies aimed at developing new
strategies for cancer therapy.43,69

1.4 DNA G-quadruplex binding ligands
The main property sought in novel G-quadruplex ligands is the ability to show a high
degree of binding selectivity in favour of these novel secondary DNA structures
comparing to dsDNA. It has been reported that the main structural features a ligand
must possess in order to exhibit this behaviour are a large planar aromatic system
which allows π-stacking interactions with G-tetrads, and positively charged
substituents that enable favourable electrostatic binding with the negatively charged
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phosphate backbone of a G-quadruplex.70 Furthermore, the presence of flexible sidechains with specific functional groups that endow the ligand with the ability to
participate in selective interactions with the grooves and/or loops of G-quadruplexes
has also been shown to be advantageous.71,72
The past two decades has seen a remarkable growth in the number of different
classes of G-quadruplex binding ligands, with now more than 1000 having been
reported in the G-Quadruplex Ligands Database.73 Most of these have been
examined for their ability to bind to and stabilise telomeric G-quadruplex DNA,
however only a small number have had their cytotoxicity towards cancer cells
explored.74-77 Some examples of notable G-quadruplex binding ligands will be
discussed in the following sections.

1.4.1 Organic G-quadruplex ligands
The compound BRACO-19 (1) is one of the most studied organic molecules known
to have a high affinity towards G-quadruplexes, and is composed of a central planar
aromatic core that enables π–π stacking interactions with G-quartets and three side
chains functionalized with tertiary amine moieties (Figure 1.7).78 The results of a
Fluorescence Resonance Energy Transfer (FRET) melting assay revealed that
addition of (1) resulted in a 25.9 °C increase in melting temperature for the
unimolecular G-quadruplex F21T.79 In contrast only an 11.2 °C increase in melting
temperature was observed when the experiment was performed using a control
duplex DNA sequence. In addition, (1) exhibited selectivity for G-quadruplex DNA
over dsDNA in Surface Plasmon Resonance (SPR) experiments, which afforded
affinity constants (Ka) of 31.0 × 106 M-1 for the human telomeric G-quadruplex
(hTel) and 0.5 × 106 M-1 for duplex DNA.80
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Figure 1.7: Crystal structure of the complex formed between (1) and two molecules
of bimolecular human telomeric G-quadruplex DNA (PDB ID: 3CE5). Each
quadruplex contains three stacked G-tetrads with the BRACO-19 molecule stacking
directly onto the 3′ end quartet. Adapted with permission from Journal of the
American Chemical Society, 2008, Vol.130 (21), p. 6722-6724.78 Copyright 2008
American Chemical Society.
Results obtained from a sulphorhodamine B (SRB) short-term cytotoxicity assay
performed using (1) afforded values of IC50 of 2.4 and 2.5 μM for MCF7 breast
cancer cells and A549 lung cancer cells, respectively. In contrast the IC50 obtained
with the normal human lung fibroblast cell lines IMR90 and WI-38 were 10.7 and >
25 μM, respectively.81 These results demonstrate that (1) exhibits a degree of
cytotoxicity towards some cancer cell lines. BRACO-19 has also been shown to
inhibit telomerase activity by decreasing hTERT expression, and to cause telomere
shortening by destabilizing the shelterin complex in DU145 prostate cancer cells,
UXF1138L human uterus cancer cells and U87 human brain cancer cells.82-84 Despite
these promising initial results, the very poor membrane permeability, low levels of
cellular uptake and instability at physiological pH exhibited by (1) have to date
inhibited its further development for clinical use.85
The tetra-cationic porphyrin TMPyP4 (meso-tetra(N-methyl-4-pyridyl)porphine) (2)
is another widely used ligand to study the binding properties of G-quadruplexes due
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to its ability to stabilise such structures.86,87 Compound (2) has a structure featuring
four cationic functional groups attached to a central porphyrin core. Hurley and coworkers reported for the first time that (2) binds to a human telomeric G-quadruplex
with high affinity.61 It has also been demonstrated that (2) efficiently inhibits
telomerase (IC50 = 6.5 ± 1.4 μM) and downregulates the expression of oncogenes
like c-MYC, VEGF and KRAS.61,88 This property may be in part responsible for the
inhibition of proliferation of various cancer cell lines treated with (2).89-92 In other
studies (2) showed a diverse range of binding modes with G-quadruplexes including
intercalation between adjacent G-tetrads, stacking onto external G-quartets and
interacting directly with TTA sequences that form the loops connecting G-tetrads.
An example of the latter binding mode that was revealed by X-ray diffraction studies
is shown in Figure 1.8.93,94

Figure 1.8: Crystal structure of the complex formed between (2) and a bimolecular
human telomeric G-quadruplex (PDB ID: 2HRI). TMPyP4 binds by stacking onto
the TTA nucleotides, as part of the external loop or at the 5′ region of the stacked
quadruplex, without direct interaction with the G-tetrads. The crystal structure
reprinted with permission from Biochemistry, 2007, Vol 46 (9), p. 2390-2397.94
Copyright 2007 American Chemical Society.
It has been reported that (2) loses its ability to inhibit telomerase when also in the
presence of high concentrations of dsDNA, and causes cytotoxicity to normal cells
under these conditions.95-97 The ability to bind to dsDNA has been proposed to be a
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result of the positive charges present on (2).98 The above results suggest that
modifications to the structure of (2) are required in order to enhance its binding
selectivity in favour of G-quadruplex DNA over dsDNA, and thereby reduce its
toxicity to healthy cells. One method for achieving this objective is based on
recognition that the central aromatic core of (2) is not large enough to engage in
strong π–π stacking interactions with G-quartets and prevent interaction with
dsDNA. It is therefore not surprising that there have been several aromatic
compounds containing larger aromatic systems which have been reported to bind to
G-quadruplexes. These include telomestatin (3), 5,10,15,20-[tetra-(N-methyl-3pyridyl)]-26-28-diselenasapphyrin chloride (Se2SAP (4)) and MM41 (5).

Telomestatin is a neutral molecule originally isolated from Streptomyces annulatus
and later synthesised in the laboratory.99 The tremendous propensity for (3) to bind to
G-quadruplexes is reflected in its ability to induce their formation in the absence of
monovalent cations.100,101 It has also been reported that (3) binds selectively to
intramolecular anti-parallel telomeric G-quadruplexes over dsDNA due to its cyclic
shape and absence of an overall charge.100,101 Further indirect evidence in support of
the ability of (3) to bind to G-quadruplexes is provided by the results of a TRAP
assay which showed that it was approximately 1000-fold more effective than TPyP4
at inhibiting telomerase (IC50 = 5nM).99,100 Treatment of several cancer cell lines
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with (3) was shown to cause dissociation of TRF2 and POT1 from telomeres leading
to telomere dysfunction and apoptosis.102-106 Despite the promising results described
above, a disadvantage of (3) as a drug lead is its poor solubility in water, which may
limit its pharmacological effects in vivo.107 In addition, it is difficult to obtain from
the natural source or synthesise in the laboratory.
Another example of a multi-heterocyclic compound which exhibits notable Gquadruplex binding ability is (4).108 This compound was synthesised by Hurley and
co-workers, who reported that it was able to convert the parallel c-MYC Gquadruplex and the anti-parallel telomeric G-quadruplex into hybrid structures.101,108
In addition, SPR experiments revealed that (4) binds with a high degree of selectivity
(50-fold) in favour of a c-MYC G-quadruplex over dsDNA.108 The ligand was also
shown to exhibit greater selectivity for G-quadruplexes over dsDNA than TMPyP4,
and to suppress VEGF transcription in different cancer cell lines.108,109 Unfortunately
(4) shares one of the same disadvantages as a drug lead as tolemestatin, which is a
very low-yielding method of preparation.
The G-quadruplex DNA stabilising compound (5) was first prepared by Neidle and
co-workers.110 They also reported the solid-state structure of the complex formed
between (5) and an intramolecular human telomeric DNA G-quadruplex (Figure 1.9).
The chemical structure of (5) is similar to that of (1) in that it has a central aromatic
core with multiple attached pendant groups. It was reported that (5) binds strongly to
G-quadruplexes present in telomeres and the promoter regions of KRAS and BCL-2.
These binding events resulted in down-regulation of expression of these cancer genes
and eventually apoptosis.110,111 In addition, (5) has displayed notable cytotoxicity
towards several pancreatic cancer cell lines, as well as against the MIA PaCa-2
pancreatic cancer xenograft model (IC50 =10 nM), resulting in an ∼80% reduction in
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tumour volume.111 Despite these results, (5) does not inhibit telomerase activity at
concentrations that would be expected to result in inhibition of cancer cell growth. 110
This suggests that the compound may have a complex mode of action. Despite this, it
is worth highlighting that the basic structure of (5), consisting of a central aromatic
core capable of participating in -stacking interactions with a G-tetrad, and several
pendant groups, is one that results in notable levels of G-quadruplex binding.

Figure 1.9: Crystal structure of the complex formed between (5) and an
intramolecular human telomeric DNA G-quadruplex (PDB ID: 3UYH). Two
asymmetric units are shown with two stacked intramolecular G-quadruplexes with
MM41 (purple) bound to external 3′ G-quartet surfaces. Reprinted with permission
from Journal of Medicinal Chemistry, 2013, 56 (7), p. 2959-2974.110 Copyright 2013
American Chemical Society.

1.4.2 Metal complexes as G-quadruplex binding agents
Metal complexes have recently attracted growing interest as G-quadruplex binding
agents in part due to their structures, relative ease of synthesis in many cases, and in
some instances, demonstrated cytotoxicity towards cancer cells.112-117 Owing to the
strong affinity displayed by many of these complexes, it has been possible to
determine some of the most important structural features for efficient binding of
metal complexes to G-quadruplexes.113 These include having an overall positive
charge, coordinated ligands which feature an extended aromatic system, and the
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metal positioned in such a way that upon binding to a G-quadruplex it becomes
located above the ionic central channel of the latter to improve π-stacking
interactions between the ligands and the G-quartet.
One of the earliest classes of metal complexes reported to act as G-quadruplex
binding agents are metalloporphyrins such as (6) – (8). This includes complexes
produced by inserting metal atoms including Ni(II), Mn(III), Zn(II) and Cu(II) into
the centre cavity of (2). Each of the resulting complexes showed the ability to bind to
and stabilise G-quadruplexes as revealed by binding studies conducted using SPR,
and in vitro telomerase inhibition assays.118 In addition, [Zn(TMPyP4)]2+ (6)
demonstrated the ability to induce the formation of a parallel G-quadruplex DNA
topology from a ssDNA molecule, whilst the corresponding manganese complex (7)
showed an ability similar to the free ligand (2) to inhibit telomerase, but also
exhibited an ~10-fold binding preference for G-quadruplex DNA over dsDNA.118
This suggests that inserting the manganese ion into the centre cavity of (2)
significantly improved DNA binding selectivity.

Meunier and co-workers reported that the Mn(III) porphyrin complex (8) binds
selectively with, and stabilises, a G-quadruplex formed from the sequence
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((GGGTTA)4), by end-stacking on the terminal G-quartets.119 Complex (8) was also
shown to inhibit telomerase, and in SPR experiments exhibited a 10000-fold greater
degree of binding in favour of G-quadruplex DNA over dsDNA, compared to (2).120
This shows that incorporating the manganese ion into (2) and replacing its mesomethylpyridinium groups by four flexible, bulkier cationic pendant groups resulted in
greater G-quadruplex binding affinity and selectivity.
Teulade-Fichou and co-workers have explored the G-quadruplex binding properties
of a range of metal complexes of derivatised terpyridine ligands. For example, the
Pt(II) and Cu(II) complexes (9) and (10) exhibited a high degree of affinity as well as
selectivity for G-quadruplex DNA.121 These complexes were also revealed by FRET
melting assays to show a greater ability to stabilise G-quadruplex DNA compared to
the corresponding free ligands.121 The same research group also investigated the
DNA binding abilities of another group of metal complexes including (11) – (13).122
This study once again confirmed the important effects the metal cation can have on
DNA binding, since the corresponding free ligand showed little or no ability to do so
in a FRET melting assay. Of the complexes investigated the Pd(II) derivative (13)
exhibited the greatest ability to stabilise human telomeric G-quadruplex DNA. The
results of Electrospray Ionisation Mass Spectrometry (ESI-MS) and UV/Vis
spectrophotometric experiments suggested that the greater stabilisation ability of the
Pd(II) derivative may attributed to its faster coordination rate (within a minute
timescale) to the G-quadruplex DNA molecule compared to the other metal
complexes.
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Takenaka and co-workers reported that the zinc complex (14) exhibited enhanced
affinity

towards

the

telomeric

sequences

[TAGGG(TTAGGG)3]

and

[AGGG(TTAGGG)3] in the presence of K+ ions in comparison to the corresponding
free ligand.123 Both the free ligand and the metal complex showed notable levels of
telomerase inhibition in results obtained by performing TRAP assays.

Modified phenanthroline ligands and their metal complexes have also received
attention for their ability to bind to G-quadruplexes. For example, Reed and coworkers used FRET assays to investigate the ability of (15) – (17) to stabilise a Gquadruplex formed by the sequence (5′-FAM-d(GGG[TTAGGG]3)-TAMRA-3′).112
The platinum(II) complex with the piperidine pendant group (17) was found to
induce a higher degree of stabilisation of a telomeric G-quadruplex than the
corresponding free ligand (16). This suggests that the metal plays an important role
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in increasing the strength of the interaction with the DNA. In addition, the results of
FRET assays indicated that (17) exhibits more than a 40-fold selectivity factor in
favour of binding to G-quadruplex DNA over dsDNA.

This study also showed that the free ligand with the piperidine pendant group (16)
exhibited a greater ability to stabilise a telomeric G-quadruplex than (15), which has
an identical structure except for the absence of the pendant group. This highlights the
role that piperidine substituents, particularly once protonated, can play in enhancing
the strength of interactions with G-quadruplexes. The researchers also used TRAP
assays to explore the effects of each of the compounds on telomerase activity and
found that (17) is a more potent enzyme inhibitor than either (15) or (16). This study,
along with a number of those discussed above, highlight the favourable impacts
introducing a metal centre and pendant groups can have upon binding affinity and
selectivity towards G-quadruplexes.

1.4.3 Metal Schiff base complexes
One of the most widely studied classes of G-quadruplex binding metal complexes are
those containing Schiff base ligands.112,124,125 A pivotal study in this area was that
conducted by Reed and co-workers, who reported on the telomerase inhibition and
G-quadruplex binding properties of the square planar nickel(II) complexes (18) and
(19).
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The above complexes were shown to induce telomerase inhibition with telEC50 values
of ~ 0.1 μM.124 The results obtained from qualitative molecular modelling studies
suggested the salphen (salicylidene phenylenediamine) ligands in these complexes
would be able to interact with the terminal G-quartet of a G-quadruplex via π-π
stacking interactions, providing a possible explanation for enzyme inhibition
(Figure 1.10). In addition, electrostatic interactions between the positively charged
piperidine substituents and functional groups located in the grooves of the DNA were
revealed, which may also enhance the overall interaction.124

Figure 1.10: (a) top view and (b) side view of the molecular docking of (18) with a
human parallel intramolecular G-quadruplex formed from four repeats of telomeric
DNA (PDB ID: 1KF1).124
Later work from the same research group investigated the effects of changing the
ligand framework and identity of the metal centre on G-quadruplex DNA binding
properties of a number of salen (salicylidene ethylenediamine) and salphen metal
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complexes including (20) – (23).125 The results of FRET assays revealed the square
planar nickel(II) salphen complex (20) and copper(II) salphen complex (21) showed
a significant ability to stabilise human telomeric DNA, and binding selectivity in
favour of a G-quadruplex DNA over dsDNA. In contrast, the distorted square
pyramidal complexes (22) and (23) exhibited a much lower ability to raise the
melting temperature, Tm, (∆Tm = 1.4 and 10.5 °C, respectively) compared to (20) and
(21) (∆Tm = 22.9 and 21.5 °C, respectively).125 This is consistent with the view that a
complex with a square planar geometry is able to participate in stronger π−π stacking
interactions with a G-quartet, whereas those with a disordered square pyramidal
geometry are inhibited from doing so to different extents owing to sterically
undesirable interactions involving axial hydroxido or oxido ligands.

Whilst the G-quadruplex DNA binding properties of a number of different metal
Schiff base complexes have now been explored, there have been very few
investigations into their cytotoxicity to date. A notable contribution are studies
conducted by Ansari and co-workers using complexes such as (24) – (31).126,127 In
the first of their studies, these researchers used MTT assays to examine the
cytotoxicity of a series of manganese complexes of salen and derivatised salen
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ligands.126 This study showed that the Mn(III) complexes were cytotoxic towards,
and able to induce apoptosis in malignant MCF7 breast cancer cells, but were nontoxic towards the non-malignant cell line (MCF10). Increasing the number of
aromatic rings in the complexes, by replacing the ethylenediamine moiety of (24)
with either ortho-phenylenediamine or 2,3-diaminonaphthalene to give (25) and (26),
respectively resulted in slight increases in anticancer activity (IC50 values of 20, 15
and 11 μM for (24), (25) and (26), respectively).126

The IC50 values obtained for (27) – (29) were also found to vary from ~ 20 – 40 μM,
showing that changing the position of substituents on the periphery of the Schiff base
ligand can have an effect on cytotoxicity. It is notable that the degree of cytotoxicity
and selectivity exhibited by these Mn(III) complexes towards MCF7 cells was very
similar to that shown by cisplatin, highlighting the potential of these complexes as
anticancer agents. In a subsequent study conducted by the same group it was shown
that (30) and (31) could induce apoptosis in cultured human cancer cells, with a high
degree of selectivity toward MCF7 breast cancer cells (IC50 = 26 and 12 μM,
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respectively) and CCL228 colon cancer cells (IC50 = 22 and 12 μM, respectively)
compared to non-malignant MCF10 breast cancer cells (IC50 = 31 and 38 μM,
respectively).127
The effects of changing the metal ion or the number of aromatic rings present in a
Schiff base ligand on G-quadruplex binding was also examined by Terenzi and coworkers, using complexes (32) – (36).128 Each of the complexes featured two
positively charged pendant groups located para with respect to the phenolic oxygen
atoms. This is in contrast to where such substituents are normally located which is
meta to the phenol. It was reported that each of the three metal complexes (32) – (34)
exhibited selectivity by binding with higher affinity to a telomeric G-quadruplex
compared to dsDNA, with (32) showing the greatest ability to stabilise the former, as
evaluated by UV visible absorption spectrophotometry. The latter complex was also
shown by Circular Dichroism (CD) spectroscopy to induce the formation of a Gquadruplex structure from ssDNA molecules containing the human telomeric
sequence in the presence and absence of K+ cations (Figure 1.11). This further
exemplified the significant affinity of (32) for this type of DNA secondary structure.
The results obtained from Polymerase Chain Reaction (PCR) stop assays indicated
that (32) – (34) were cytotoxic towards HeLa and MCF-7 human cancer cell lines.
Complex (32) was found to be the most cytotoxic, hinting at a relationship with Gquadruplex binding ability.
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Figure 1.11: CD spectra of unfolded hTel [5′-(AGGGTT)3AGGG-3′] (3 μM) (red
line) and the corresponding G-quadruplexes folded in the presence of 100 μM K+
(black line) and 20 μM (32) (blue line). Reprinted with permission from RSC
Advances, 2014, 4 (63) p. 33245-33256.128 Copyright 2014 The Royal Society of
Chemistry.
In a subsequent study the ability of the salen type complexes (35) and (36) to
stabilise a G-quadruplex was compared to that of (32) using UV-Vis
spectrophotometry, CD spectroscopic and FRET techniques.129 It was reported that
removing the naphthalene moiety in (32) resulted in small decreases in affinity
toward G-quadruplex DNA, however selectivity in binding with respect to dsDNA
was significantly enhanced. For example, in the case of (35) no binding to dsDNA
was detected via the FRET assay. It was also noted that (35) exhibited selectivity in
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its binding to different G-quadruplex topologies, with a preference for interacting
with c-KIT1 over both h-TERT and BCL2. Complex (35) showed a greater binding
affinity towards G-quadruplex DNA than (36), again highlighting the effect of
varying the metal centre noted previously. This may be result of the near perfect
square planar geometry of (35) seen in the solid-state structure of the complex, which
is in contrast to the distorted coordination environment present around the copper ion
in the solid-state structure of (36). Complex (35) was found to exhibit cytotoxicity
towards MCF-7 breast cancer cells in the presence of lipofectamine in an MTT assay
(IC50 = 29 μM). The cytotoxicity of (36) was comparable to but less pronounced than
that exhibited by (35).
The above results illustrate that, in general nickel complexes of Schiff base ligands
are better G-quadruplex binding agents than either their copper or zinc analogues,
owing to their typically more rigorous square planar geometries.125,128-131 As a result
it is not surprising that in recent years further research looking to develop salen and
salphen complexes that function as anticancer agents as a result of their ability to
bind to G-quadruplexes and inhibit telomerase have focussed on this metal.132-135
Introducing electron withdrawing substituents such as fluorine atoms or a
carboxymethyl group, as in complexes (37) and (38) was found to decrease their
ability to stabilise G-quadruplex structures.132 It was therefore surprising that (39),
which contains a sulfonic acid group at the same position as the carboxymethyl
present in (38), decreased binding selectivity but resulted in a greater ability to
stabilise the DNA. In addition, in an attempt to enhance the G-quadruplex DNA
binding affinity of the metal complex, a third ethylpiperidine substituent was added
to a nickel(II) salphen complex, resulting in preparation of (40). FRET assays

28

revealed that (40) exhibited a high degree of binding affinity but low selectivity
towards a human telomeric G-quadruplex.132

The effect of changing the number and position of dimethyimidazole pendant groups
attached to a series of nickel(II) salphen complexes on their G-quadruplex DNA
binding properties has also been investigated using complexes (41) – (44).134 The
results obtained from a TRAP-G4 assay revealed that all the complexes examined
could reduce telomerase activity in vitro, with (44) proving to be the most potent
enzyme inhibitor (IC50 = 70 nM). Comparison of these results with those obtained
from a standard TRAP assay utilising dsDNA showed (44) also exhibits a high
degree of binding selectivity towards G-quadruplex DNA over dsDNA.
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Changing the size and position of aromatic moieties present in nickel Schiff base
complexes has also been shown to have a significant effect on their binding
interactions with both G-quadruplex and dsDNA.135,136 For example, results obtained
from binding studies performed using ESI-MS or by examining the effect of the
complexes on DNA melting temperature suggested (18) and (45) exhibited the ability
to bind to both G-quadruplex and dsDNA. In contrast, (46) exhibited a much lower
affinity towards the same dsDNA molecule than (18) but still showed the ability to
significantly interact with a tetramolecular G-quadruplex, as illustrated by its
propensity to form non-covalent adducts with the nucleic acid molecule that
produced ions detectable by ESI-MS (Figure 1.12 (a)). The lack of ability to bind to
dsDNA exhibited by (46) was attributed to the orientation of the two aromatic rings
derived from the meso-1,2-diphenylethylenediamine moiety in a non-coplanar
fashion with the rest of the Schiff base ligand. This was proposed to result in
significant hindrance to intercalative interactions with the dsDNA base pairs. These
results suggest that incorporating the meso-1,2-diphenylethylenediamine moiety may
be a general approach to engendering metal Schiff base complexes with DNA
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binding selectivity in favour of G-quadruplexes. In contrast, (18), which features one
aromatic ring in the top of the Schiff base ligand coplanar with those in the rest of the
molecule, showed significant binding to both G-quadruplex and dsDNA (Figure 1.12
(b)). Affinity towards dsDNA was even more pronounced in the case of (45),
presumably as a result of a greater ability to participate in intercalative interactions
owing to the presence of the three coplanar aromatic groups in the top of the ligand
structure. This same structural feature may have, however, limited the ability of (45)
to bind to G-quadruplex DNA by hindering interactions with the loops of the latter
molecules.

Figure 1.12: Relative abundances of ions in ESI mass spectra of solutions containing
either a 3:1 or 6:1 ratio of nickel Schiff base complexes and dsDNA (D2),
unimolecular G-quadruplex DNA (Q1) or tetramolecular G-quadruplex DNA (Q4):
(a) solutions containing (46) and (b) solutions containing (18). Reproduced with
permission from Royal Society of Chemistry, Kimberley Davis et al, Dalton
Transactions. 2015, 44, 3136-3150.135
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More recently, Pham and co-workers showed that the number of pendant groups
attached to nickel Schiff base complexes can have a significant effect on their
binding interactions with DNA.137 These workers performed binding studies with
several different types of DNA, including multiple topologies of G-quadruplexes,
using ESI-MS and several other methods. Each of the nickel complexes studied
featured four aromatic rings distributed around the Schiff base ligand and varied only
in the number of attached pendant groups. Selected examples of the complexes
investigated included (47) – (49). The results obtained from DNA binding studies
indicated that (47) and (48) which have one and two pendant groups, respectively,
exhibit a low degree of affinity towards both G-quadruplexes and dsDNA. Molecular
docking studies performed using a G-quadruplex DNA structure and these nickel
complexes revealed unfavourable stacking interactions in which the nickel ions were
displaced away from above the centre of the G-tetrads, and the upper aromatic ring
systems were positioned orthogonal to the G-tetrad. As a result, not all of the
aromatic ring systems in these complexes were able to participate in effective πstacking interactions.

In contrast (49), which features four pendant groups, exhibited a significant ability to
bind to both intermolecular and intramolecular parallel G-quadruplexes in
spectroscopic binding studies, as well as comparatively low affinity towards dsDNA.
For example, results obtained from FRET assays showed that (47) and (48) slightly
increased the melting temperature (Tm) of a unimolecular G-quadruplex by 8.5 and
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13 °C respectively, whereas under the same conditions addition of (49) resulted in an
increase in Tm of 31.4 °C.
The above results were supported by those obtained from molecular docking studies
performed using (48) and (49) (Figure 1.13). This showed that (49) was able to bind
effectively to the parallel, unimolecular G-quadruplex 22AG (PDB: 1KF1) via πstacking interactions which resulted in the nickel ion being located directly above the
centre of the G-tetrad (Figure 1.13 (a)). In contrast, the nickel ion of (48) was not
located centrally over the G-quartet (Figure 1.13 (b)).

Figure 1.13: Molecular docking of nickel complexes: (a) (49) and (b) (48) with a
human parallel intramolecular quadruplex formed from four repeats of telomeric
DNA (PDB ID: 1KF1). Reproduced with permission from Royal Society of
Chemistry, Son Pham et al, Dalton Transactions. 2020, 49, 4843-4860.137
Furthermore, each of the four aromatic rings of (49) were able to position themselves
parallel to the surface of the G-tetrad, thereby maximising the effectiveness of stacking interactions with the latter. In contrast, two of the aromatic rings of (48)
were almost orthogonal to the metal ion coordination plane, and not able to
participate in π–π interactions with the G-quartet. Furthermore, the pendant groups of
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(49) were positioned so as to facilitate favourable binding interactions with the loops
and grooves of the G-quadruplex.

1.5 Methods of Preparing Metal Schiff Base Complexes
Schiff bases are compounds that have the general formula RHC=N-R′, where R is an
alkyl or aryl group and R′ is an aryl group. They are also known as imines, and
commonly synthesised by the condensation of a primary amine with a carbonyl
compound. Many Schiff bases feature NO or N2O2 donor atom sets suitable for
binding to metal ions.138 Coordination of metal ions to Schiff bases is generally
readily accomplished simply by heating the ligands with an appropriate metal salt for
brief periods, which is one of the reasons why they are attractive candidates as
potential drugs.124,125,132,134,139 For example, (18) may be synthesised by following the
synthetic procedure outlined in Figure 1.14.124

Figure 1.14: Synthetic scheme for the synthesis of (18).
Many other synthetic strategies have been reported for the preparation of Schiff
bases and their metal complexes. These may be useful when the direct method of
preparing the complexes proves surprisingly difficult, and include solid–solid
synthesis, ultrasound irradiation, microwave assisted synthesis and mechanochemical
synthesis.140-143 In the following section the latter approach will be described and
some recent examples of its application described.
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1.5.1 Mechanochemical synthesis by ball milling
Mechanochemical (MC) synthesis involves the chemical activation of solid reactants
through mechanical action such as ball milling or grinding.141,144-147 In some cases a
small amount of solvent is included in the reaction mixture to facilitate the stirring
process. The latter method is known as liquid assisted grinding (LAG).148,149
Mechanochemical synthesis methods using grinding equipment have attracted
attention due to the advantages they can offer, which include greater yields, as well
as the ability to perform reactions at room temperature under solvent free conditions,
and with shorter reaction times. In addition, it has been shown that using MC
techniques can reduce the amount of undesired by-products obtained in reactions,
and thereby minimise the amount of purification that must be performed post
synthesis.150-152
Ball milling and grinding techniques are the most widespread mechanochemical
techniques utilised to apply mechanical forces in order to induce chemical reactions
to occur.143,153-155 Vibratory Ball Mills (VBM) are used for performing reactions on
the milligram to gram scale. The starting materials for the reaction to be performed
are placed inside the mill, which in the case of the project described in this thesis
contained stainless steel jars that are charged with stainless steel balls. (Figure 1.15)
The mill is then rapidly swung in a horizontal fashion back and forth with an
oscillating frequency of up to 30 Hz. The chemical reagents experience mechanical
stresses resulting from the friction and collisions that occur with the milling balls and
the inner surface of the jar. The stresses resulting from the action of the ball mill
results in the breaking of bonds and creation of new bonds to afford the desired
product.
35

Figure 1.15: Photographs of equipment used to perform mechanochemical synthesis
experiments described in this thesis: (a) Domel mill mix 20 synthesis apparatus; (b)
milling jars and (c) milling balls. Pictures reproduced from the Domel website.156
Ball milling techniques have been successfully applied to a variety of organic and
inorganic synthetic procedures, including amine condensation reactions and
formation of metal complexes.143,154 For example, the synthesis of salen and salphen
ligands, and of their corresponding transition metal complexes, by a ball milling
approach has been reported.143,154 James and co-workers reported that salen could be
successfully prepared from ethylenediamine and salicylaldehyde, using a liquid
assisted ball milling method and conditions outlined in Figure 1.16.143 The salen
formed by this approach was then used in further ball milling experiments to prepare
complexes with zinc, nickel and copper. For both the initial ligand preparation and
subsequent metal complexation reactions, ball milling was performed for 30 min at
25 Hz and resulted in pure complexes with yields ranging from 96 to 98%.
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Figure 1.16: Reaction conditions used by James and co-workers in ball milling
experiments to synthesise salen and some of its metal complexes.143
In addition, Cort and co-workers reported the LAG mechanochemical synthesis of a
series of salphen ligands and their zinc, nickel and palladium complexes
(Figure 1.17).154 The yields obtained from these reactions ranged from 60 to 68%.

Figure 1.17: Salphen ligands and corresponding metal complexes synthesised by
Cort and co-workers using a LAG ball milling approach.154
The results obtained from the above studies show that the mechanochemical
synthesis approach can be a simple and rapid alternative to solution-based methods
for preparing metal Schiff base complexes.
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1.6 Aims
A number of metal Schiff base complexes have been used in DNA binding studies
owing to their ease of preparation, their stability and because they possess structural
features which enhance binding affinity. In the case of nickel Schiff base complexes,
it has been shown that the number and position of aromatic groups, and the number
and chemical composition of the pendant groups can affect the binding affinity and
selectivity towards G-quadruplexes. These observations, including in particular the
notable binding affinity and selectivity exhibited by (49), together with the
significant anti-tumour activity exhibited by the organic compound (5), which also
features four pendant groups, suggest that it would be worthwhile to prepare and
study the DNA binding properties, and cytotoxicity, of a wider range of nickel
complexes containing four pendant groups.
Therefore, the main aim of this project was to prepare and characterise a range of
new nickel Schiff base complexes (50 – 67) featuring four pendant groups and
comprehensively explore their DNA binding properties using different spectroscopic
methods. Initial attempts to prepare these complexes were adapted from the literature
method illustrated in Figure 1.14.124 In addition, the utility of the ball milling method
for preparing the complexes was explored for selected examples.
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1.7 Outline of the thesis
This thesis is presented as the following chapters:
Chapter 1: This chapter reviews the literature concerning the structure of Gquadruplex DNA and its biological relevance, as well as different classes of both
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organic and inorganic G-quadruplex DNA binding agents including metal Schiff
base complexes and methods for synthesising the latter.
Chapter 2: This chapter provides detailed information about all the reagents and
materials used in experiments, procedures for performing characterisation
measurements on all new compounds, and methods for carrying out DNA binding
and cytotoxicity studies.
Chapter 3: This chapter provides details of the methods used to synthesise new
compounds, and characterisation data. The NMR spectra and ESI mass spectra of
selected compounds and complexes are discussed in detail, and the solid-state
structures of all compounds characterised using this method are also described.
Chapter 4: This chapter presents the results of binding experiments performed to
examine the effect of varying the head group of nickel Schiff base complexes on
their binding affinity and selectivity towards different types of DNA, including a
dsDNA molecule (D2), a parallel tetramolecular G-quadruplex (Q4) and different
topologies of a human telomeric unimolecular G-quadruplex (parallel Q1, antiparallel Q1 and hybrid Q1) as well as a second parallel unimolecular G-quadruplex
(c-KIT1).
Chapter 5: This chapter presents the results of binding experiments performed to
examine the effect of changing the pendant groups of nickel Schiff base complexes
on their binding affinity and selectivity towards the different types of DNA
mentioned above.
Chapter 6: This chapter presents final conclusions based on the work described in
the previous chapters as well as suggestions for future research.
Chapter 7: This chapter presents the list of references used throughout this thesis.
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Chapter 2

Materials and methods

2.1 Chemicals
All solvents and reagents used in this study were of the highest grade commercially
available. Milli-QTM water (Millipore, Molsheim, France) was used in all
experiments. 1-(2-chloroethyl)piperidine hydrochloride, 1-(3-chloropropyl)piperidine
hydrochloride, 1-(2-chloroethyl)morpholine hydrochloride, anhydrous magnesium
sulfate,

1,2-phenylenediamine,

1,2-ethylenediamine,

1,2-meso-

diphenylethylenediamine, 1,3-diaminopropane, 1,2-diaminopropane, nickel acetate
tetrahydrate, CDCl3, (CD3)2SO (DMSO-d6), high purity DMSO (≥ 99.5%), cesium
iodide (Fluka brand), sodium dodecyl sulfate (SDS) and thiazolyl blue tetrazolium
bromide (MTT), were all purchased from Sigma-Aldrich (Castle Hill, Australia). All
oligonucleotides were also obtained from Sigma-Aldrich.
Potassium carbonate (K2CO3), dimethylformamide (DMF), dichloromethane (DCM),
dimethylsulfoxide (DMSO), acetic acid, hydrochloric acid, methanol (MeOH),
anhydrous diethyl ether (Et2O), aluminium oxide used for column chromatographic
separations, as well as acetonitrile (ACN), ammonia and ammonium acetate
(NH4OAc) were all purchased from Ajax Finechem (Seven Hills, Australia).
Thiazole orange (TO) that was used in fluorescence indicator displacement (FID)
assays was purchased from Chemscene (New York, USA).
Conical centrifuge tubes (10, 50 mL) and phosphate buffered saline (PBS) tablets
(Oxoid brand) were obtained from Thermo Fisher Scientific (Waltham, USA). Fetal
bovine serum (FBS, French Bovogen, heat-inactivated), sterile Greiner 10 and 25 mL
pipettes, cell culture flasks (250 mL, 75 cm2 surface area) and 96 well plates for
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MTT assays were obtained from Interpath (Heidelberg West VIC, Australia).
Penicillin-streptomycin solution, trypsin (2.5%) and Dulbecco’s modified Eagle
medium (DMEM, low glucose, pyruvate) were obtained from Life Technologies
(Scoresby VIC, Australia).

2.2 Characterisation of nickel Schiff base complexes
2.2.1 Physical measurements
Elemental microanalysis determination for the elements carbon, hydrogen, nitrogen
and nickel were performed at the Campbell Microanalytical Laboratory at the
Department of Chemistry, University of Otago, New Zealand. NMR spectra of the
nickel complexes dissolved either in DMSO-d6 or CDCl3 were obtained using Bruker
400 or 500 MHz nuclear magnetic resonance (NMR) spectrometers at 25 °C. The
chemical shifts of the resonances observed in 1H and 13C NMR spectra were reported
in ppm (δ) relative to either tetramethylsilane (TMS) or the solvent peak as an
internal standard. In 1H NMR spectra, the signal from the small amount of CHCl3
present in CDCl3 solvent was reported at 7.26 ppm, while the signal from the small
amount of CD3SOCD2H present in DMSO-d6 was reported at 2.50 ppm. For

13

C

NMR spectra, the resonance from the CDCl3 solvent was set to 77.7 ppm, while that
from the DMSO-d6 solvent was assigned to 39.6 ppm. Hydrogen and carbon
resonances were fully assigned through the use of 2D experiments including
Correlation Spectroscopy (COSY), Nuclear Overhauser Effect Spectroscopy
(NOESY), Heteronuclear Single-Quantum Correlation (HSQC) and Heteronuclear
Multiple-Bond Correlation (HMBC) Spectroscopy.
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Electrospray ionisation (ESI) mass spectra of alkylated nickel Schiff base complexes
were obtained using a Thermo Finnigan linear trap quadrupole (LTQ) mass
spectrometer, using solutions prepared in H2O:MeOH (50:50). Solutions containing
metal complexes (20 μΜ) were injected into the instrument at a flow rate of 20
μL/min. Mass spectra of metal complexes were obtained in positive ion mode. The
parameters used to obtain the spectra are listed in Table 2.1.
Table 2.1: Instrument parameters used to obtain positive ion ESI mass spectra of
metal complexes
MS parameter
Capillary (V)
Cone voltage (V)
RF lens energy (V)
Source block temperature (°C)
Desolvation temperature (°C)
Desolvation gas flow (L/hour)
Collision energy (V)
Acquisition mass range (m/z
Multiplier

Setting
3500
10-80
60-80
60
140
300
2-10
200-1200
170-200

2.2.2 Crystallography
X-ray structural studies were performed by Dr Christopher Richardson of the School
of Chemistry and Molecular Bioscience, University of Wollongong, Australia. X-ray
diffraction measurements performed on complexes (18), (20), (34) and (38) were
carried out at 150 (10) K using a Rigaku XtaLAB Mini II HPC diffractometer with
MoKα radiation; λ = 0.71073 Å. Using Olex2,157 structures were solved with the
ShelXT158 structure solution program using Intrinsic Phasing and refined with the
ShelXL159 refinement package and Least Squares minimisation.
During refinement of crystallographic structures, hydrogen atoms bonded to C were
positioned geometrically and the water H atoms were based on peaks from a
difference electron density map and potential H-bonded contacts. The H atoms were
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initially refined with soft restraints on the bond lengths and angles to regularize their
geometry (C-H in the range 0.93 - 0.98 Å, O-H = 0.82 Å) and with the isotropic
displacement parameter Uiso(H) in the range 1.2 - 1.5 times the equivalent isotropic
displacement factor Ueq of the parent atom, after which the positions were refined
with riding constraints. The only exception to the above was for those H atoms
bonded to O which were allowed to refine freely.

2.3 Preparation of Oligonucleotide solutions
2.3.1 Purification of single stranded oligonucleotides
Single stranded oligonucleotides were purchased from Sigma-Aldrich (Castle Hill,
Australia), as freeze-dried ‘trityl-off’ derivatives. The base sequences of DNA
molecules which were used in this study are presented in Table 2.2. These
oligonucleotides were purified using High Performance Liquid Chromatography
(HPLC) by following previously reported procedures.160-162 Purified DNA solutions
were then freeze-dried using a Savant SpeedVac (Selby-Biolab, Australia) prior to
storage at -20 °C.
Table 2.2: Properties of DNA molecules used in this study.
Oligonucleotide sequence
5´- 3´
GCTGCCAAATACCTCC
GGAGGTATTTGGCAGC
(GCTGCCAAATACCTCC/GGAGGTATTTGGCAGC)
(TTGGGGGT)4
GGG(TTAGGG)3
GGG AGG GCG CTG GGAGGA GGG
a

DNA
label
D2A
D2B
D2
Q4
Q1
c-kit1

Mass
(Da)a
4786.2
4977.3
9763.5
9986.6
6653.4
6698.4

Calculated using the Oligonucleotides Properties Calculator.164

When required, freeze-dried samples were dissolved in 1000 μL of Milli-QTM water.
Diluted solutions (300× dilution factor) were prepared by adding 2 μL of one of the
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above DNA solutions to 598 μL of Milli-QTM water. In order to determine the
concentration of the final DNA solutions, the absorbance at 260 nm was measured,
and the molar absorption coefficients (ε) of the individual nitrogenous bases present
in the DNA sequence were used to obtain an overall value of ε for the
oligonucleotide itself. Values of ε for the purine and pyrimidine bases were obtained
using the Oligonucleotides Properties Calculator.163

2.3.2 Preparation of dsDNA (D2)
Solutions containing appropriate quantities of the single stranded DNA (ssDNA)
molecules D2A and D2B were mixed together in an Eppendorf tube and dried using
a Savant SpeedVac. The resulting pellet was then dissolved in an appropriate volume
of NH4OAc solution (100 mM, pH 7.4) to give a final dsDNA concentration of 1
mM. The DNA was then annealed by heating in a water bath at 61 °C (the melting
temperature of the DNA plus 10 °C) for 15 min,162 after which it was allowed to cool
slowly to room temperature overnight. Annealed DNA samples were kept in a
freezer at -20 °C prior to further use.

2.3.3 Preparation of parallel qDNA (Q1, c- KIT1 and Q4)
An appropriate quantity of solution containing a specific ssDNA (Q1, c- KIT1 or Q4)
was placed in an Eppendorf tube, dried using a Savant SpeedVac and then the
resulting pellet dissolved in sufficient NH4OAc buffer solution (150 mM, pH 7.4) to
give a final concentration of 1 mM. Solutions containing the ssDNA molecule Q1
were annealed by heating in a water bath at 95 °C for 15 min, and then slowly
cooling to room temperature at a rate of 5 °C/hour in order to obtain a parallel
topology.135,162 Solutions containing the ssDNA c- KIT1 were annealed by heating in
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a water bath at 50 °C for 5 min, and then slowly cooling to room temperature in
order to obtain the parallel topology. Solutions containing the ssDNA Q4 were
annealed by heating in a water bath at 90 °C for 15 min,137 after which they were
allowed to cool slowly to room temperature overnight to form a parallel topology.
Annealed DNA samples were kept in a freezer at -20 °C prior to further use.

2.3.4 Preparation of anti-parallel qDNA (Q1)
An appropriate quantity of solution containing the ssDNA Q1 was placed in an
Eppendorf tube, dried using a Savant SpeedVac and then the resulting pellet
dissolved in a sufficient volume of aqueous solution containing 100 mM NaCl, 15
mM NaH2PO4 and 15 mM Na2HPO4 (pH 7.4) to give a final concentration of 1 mM.
The DNA was then annealed by heating the solution in a water bath at 95 °C for 10
min and then cooling immediately on ice for 30 min, after which it was allowed to
come to room temperature.137,164 Annealed DNA samples were kept in a freezer at 20 °C prior to further use.

2.3.5 Preparation of hybrid-type qDNA (Q1)
An appropriate quantity of solution containing the ssDNA Q1 was placed in an
Eppendorf tube, dried using a Savant SpeedVac and the resulting pellet then
redissolved in a sufficient volume of aqueous solution containing 100 mM KCl, 15
mM KH2PO4 and 15 mM K2HPO4 (pH 7.4) to give a final concentration of 1 mM.
The DNA was then annealed by heating the solution in a water bath at 95 °C for 10
min and then cooling immediately on ice for 30 min, after which the solution was
allowed to come to room temperature.137,164 Annealed DNA samples were kept in a
freezer at -20 °C prior to further use.
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2.4 Preparation of metal complex stock solutions
Stock solutions of metal complexes were prepared at 1 mM concentration in the
same buffer used for preparation of the oligonucleotide to be used in binding
experiments. Since not all metal complexes were completely soluble in the buffer
solution alone, some methanol was added to achieve complete dissolution. Most
metal stock solutions had an initial concentration of 1 mM and were prepared using a
solvent consisting of 80:20 (v/v) buffer:MeOH, however, there were some
exceptions. For example, stock solutions of complexes (20) and (36) were prepared
using a solvent consisting of 30:70 (v/v) buffer:MeOH. In addition, in order to ensure
complete dissolution of complexes (7), (54), (19) and (20) a small amount of 100
mM HCl solution was required, and so a solvent consisting of 79:20:1 (v/v/v)
buffer:MeOH:HCl) was used.

2.5 ESI-MS Mass spectrometry experiments
Metal complex stock solutions (1mM), DNA stock solutions (1mM) and the same
buffer used for preparation of the DNA stock solution, were used to prepare reaction
mixtures containing different ratios of DNA (final concentration = 10 μM) and nickel
complex (final concentration = 10, 30, 60 and 90 μM). This gave mixtures with final
metal:DNA complex ratios of 1:1, 3:1, 6:1 and 9:1. The volumes of different reagent
solutions used to prepare these reaction mixtures are presented in Table 2.3.
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Table 2.3: Volumes of stock solutions used to prepare nickel/DNA samples for
analysis by ESI-MS.
Metal:DNA
complex ratio
1:1
3:1
6:1
9:1

Volume of DNA
(1 mM stock)
(μL)
1
1
1
1

Volume of metal
complex (1 mM
stock) (μL)
1
3
6
9

Volume of
buffer
(μL)
98
96
93
90

ESI-MS was used to investigate the binding of nickel complexes to dsDNA and
qDNA. A Waters Q-ToF UltimaTM ESI mass spectrometer (Manchester, UK) was
used to acquire mass spectra in negative ion mode. The instrument was calibrated
using a cesium iodide (CsI) solution (1 mg/mL), prior to acquiring the spectra of
samples containing DNA and nickel complexes. The samples were injected into the
mass spectrometer using a Harvard model 22 syringe pump (Natick, USA) at a
constant flow rate (10 μL/min). The parameters used to obtain the spectra for all
experiments are listed in Table 2.4.
Table 2.4: ESI-MS conditions used for the analysis of DNA/metal complex
solutions.
MS parameter
Capillary (kV)
Cone (V)
Source temperature (°C)
Desolvation temperature (°C)
Desolvation gas flow (L/hour)

Setting
2.10
40-50
25
80
100

2.6 Circular dichroism (CD) experiments
A Jasco J-810 spectropolarimeter and 0.1 cm path-length quartz cell was used to
obtain CD spectra of solutions different ratios of DNA molecules and nickel
complexes between 200 and 400 nm. The instrument parameters used to acquire
these spectra are listed in Table 2.5.
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Table 2.5: Instrument parameters used to acquire all CD spectra of nickel/ DNA
samples.
CD parameter
Sensitivity
Scanning speed
Response
Band width
Number of accumulations
Temperature

Setting
standard
100 nm/min
4s
1 nm
6
25 °C

In each case the CD spectrum was obtained first for 300 μL of solution containing
DNA (20 μM) alone. Aliquots of stock solutions (Error! Not a valid bookmark
self-reference.) containing both the same type of DNA (20 μM) and the required
nickel complex (0.6 mM) were then added to the initial DNA solution in order to
produce samples with DNA:metal complex ratios of 1:1, 3:1, 6:1 and 9:1. The
reaction mixtures were then mixed and allowed to stand for 3 min prior to
measurement of additional CD spectra.
Table 2.6: Volumes of DNA/metal complex stock solutions required for
preparation of samples for analysis by CD spectroscopy.
DNA: metal complex ratio
1:1
3:1
6:1
9:1

Volume of DNA/nickel complex stock
solution added (μL)
10.4
23.0
41.7
53.6

2.7 Fluorescence intercalator displacement (FID) assays
Initially, 25 μM solutions of parallel Q1 or Q4, or D2, were prepared by diluting 1
mM stock solutions of the required oligonucleotide. A 100 μM stock solution of
Thiazole Orange (TO) in DMSO was also prepared. The above stock solutions were
then used to prepare a working solution containing DNA (0.25 μM), TO (0.5 μM)
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and the appropriate buffer. Fluorescence spectra were first obtained for the working
solution containing DNA and TO only. Titration experiments were then performed
by addition of a stock solution containing DNA (0.25 μM), TO (0.5 μM) and metal
complex (100 μM) to the cuvette containing the initial working solution. During the
titration the DNA and TO were kept at a fixed concentration. The samples were
mixed and allowed to stand for 3 min prior to measurement of additional
fluorescence spectra, which was continued until there was no further significant
change in fluorescence intensity.
An Agilent Cary Eclipse fluorescence spectrophotometer and 1 cm path-length
quartz cell together with an excitation wavelength of 501 nm was used to obtain
fluorescence spectra between 515 and 750 nm.125,165 The instrument parameters used
to acquire these spectra are listed in in Table 2.7.
Table 2.7: Instrument parameters used to acquire FID spectra of nickel/ DNA/TO
samples.
FID parameter
Excitation wavelength
Emission wavelength
Excitation slit width
Emission slit width
Scan rate
Detector voltage
Temperature

Setting
501 nm
535 nm
5 nm
10 nm
120 nm/min
600 V
25 °C

The fluorescence intensities were measured at the emission wavelength (535 nm) of
TO. In order to determine the concentration of nickel complex that caused 50%
displacement of TO from the DNA (DC50), Stern–Volmer quenching plots were
created using Equation 2.1.137,165,166
Iₒ
I

= 1 + 𝑘𝑐………. (2.1)
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In this equation Io and I are the maximum fluorescence intensity of DNA/TO in the
absence and presence of nickel complex, respectively. In addition, c is the
concentration of nickel complex and k is the Stern-Volmer constant. When Io/I = 2, c
= DC50. Values of DC50 were calculated from lines of best fit. Experiments were
performed in triplicate in order to obtain an average value of DC50 and standard error
of the mean.

2.8 Fluorescence resonance energy transfer (FRET) assays.
Metal complex stock solutions (1 mM) were diluted using MilliQTM water to afford a
series of intermediate solutions with concentrations of 5, 10, 20 and 25 μM. The
FAM-TAMRA labelled oligonucleotide F21T (HPLC purified) was dissolved in
MilliQTM water to prepare a 100 μM stock solution. This solution was then diluted to
a concentration of 0.25 μM using a solution containing 12.5 mM lithium cacodylate
(pH 7.4) and 125 mM NaCl.135,162 The DNA solution was then annealed by heating
in a water bath at 95 °C for 5 min after which it was cooled immediately on ice for
30 min.
Fluorescence measurements were recorded using fluorescence capable 96-well plates
that were covered with adhesive films after solutions were added. The final volume
of the solution in each sample well was 25 μL, which consisted of 20 μL of 0.25 μM
stock oligonucleotide, and 5 μL of 5, 10, 20 or 25 μM metal complex stock solution.
This gave reaction mixtures in each sample well with a final concentration of 0.2 μM
oligonucleotide, and 0, 1, 2, 4, 5 or 10 μM nickel complex. Duplicates of each
reaction mixture with a specific nickel:DNA ratio were prepared on each plate. The
96-well plates were then sealed and centrifuged at 1000 rpm for 1 min at 25 °C.
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A Bio-Rad CFX96 Polymerase Chain Reaction (PCR) instrument was used to
monitor the fluorescence emission as the temperature was gradually increased from
25 to 95 °C at a ramping rate of 1 °C/min. An excitation range of 450 - 490 nm and
an emission range of 510 - 530 nm was used. Six filtered LEDs (light emitting
diodes) were used as the excitation source. The fluorescence data from at least three
separate plates were averaged and normalised between 0 and 1 using GraphPad
Prism 8. Values of the melting temperature (Tm) were then obtained by fitting the
data with a four-parameter equation.

2.9 DNA melting experiments
A Varian Cary 100 UV-Vis-NIR spectrophotometer with a 1 cm path-length quartz
cuvette and a filter size of 101 were used to monitor the absorbance of solutions
containing the dsDNA D2 at 260 nm as the temperature was gradually increased
from 25 to 90 °C at a ramping rate of 1 °C/min. This resulted in production of a
DNA melting curve, which was also obtained for solutions containing nickel
complex:D2 ratios of 0:1, 3:1 and 6:1. All solutions contained 1 μM DNA in 100
mM NH4OAc at pH 7.4. The cuvette containing the solution was covered to
minimise solvent evaporation. Solutions containing both DNA and nickel complex
were allowed to stand at room temperature for 10 min prior to measurement. The
melting temperatures (Tm) were calculated using Varian software that was supplied
with the instrument. Experiments were performed in triplicate in order to obtain
average values of Tm and standard errors. Melting curves were normalised using
GraphPad Prism 8.
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2.10 Molecular docking experiments
2.10.1 Preparing receptors (DNA molecules) for docking studies
The crystal structures of unimolecular parallel qDNA and dsDNA used in docking
studies were retrieved from the RCSB protein data bank. The base sequences and
PDB ID’s of the DNA molecules are provided in Table 2.8. In order to validate the
DNA structures, it was necessary to use the following Procheck online server:
https://swift.cmbi.umcn.nl/servers/html/prepdock.html. These structures were then
relaxed by minimizing their energy with the steepest descent algorithm (3000 steps)
by using the Accelrys DS visualizer 2.0 software together with the CHARMM22
force field.167-169 During this step water molecules were deleted from the DNA
molecule present in the PDB file. AutoDock Tools v1.5.6 (ADT)170 software was
used to generate PDBQT format files for each DNA molecule by adding partial
charges (Q), assigning atom types (T) and protonating the oligonucleotide in the
PDB file.
Table 2.8: Structures, base sequences and PDB ID’s of oligonucleotides used in
molecular docking studies
Structure
Unimolecular parallel Gquadruplex

PDB ID

Base sequence

1KF115

AGGG(TTA GGG)3

Duplex DNA

1KBD171

(5´- CTG GGG ACT TTC CAGG -3´)
/(5´- CCT GGA AAG TCC CCAG -3´)

2.10.2 Preparing the ligands (complexes) docking studies
All initial ligand geometries were designed using ChemDraw Professional v17.1
except for (53) and (65). For the latter nickel complexes their crystallographically
determined geometries were used without further optimisation. Structures derived
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using ChemDraw were converted to three-dimensional structures and hydrogen
atoms added by using OpenBabel v3.0.0.172 The resulting structures were then
subjected to an initial energy optimization by using Avogadro v1.2.0.173 These
optimisation procedures were performed using the Universal Force Field (UFF) and
four steps per update with the Steepest Descent algorithm, after which the Gaussian
input file was generated. Subsequently, the structures were fully optimized at the
B3LYP/6-31G(d,p) level of theory by using Density Functional Theory (DFT)
calculations within the Gaussian09 electronic structure program.129,174 The
calculations were run on the High Performance Cluster (National Computational
Infrastructure (NCI)) located at the Australian National University (ANU). The
Gaussian output files were generated in a log file format which was then converted to
PDB files by using OpenBabel software. In addition, the cif files corresponding to
the X-ray crystal structures of (53) and (65) were also converted to PDB file format
by using OpenBabel software. The latter were then converted to PDBQT file format
using ADT, which was employed to add partial charges (Q) and assign atom types
(T) to each atom in the ligand. ADT was also employed to allow flexibility in the
ligand by defining the rotatable bonds.

2.10.3 Molecular docking procedure
Blind molecular docking experiments were performed using AutoDock Vina
v1.1.2.175 The docking procedure used was reported previously.137 For each docking
experiment the DNA receptor was kept rigid while the nickel complex was allowed
to be flexible and featured rotatable bonds. The location of the docking site in three
dimensions (x, y, z) was determined by using VMD v1.9.3 (Visual Molecular
Dynamics software). The grid box which determines the search space was centred at
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the receptor, and selected to be 30 × 30 × 70 grid points spaced 0.375 Å apart. This
size was chosen as it is sufficiently large to ensure coverage of all active sites on the
receptor and to allow the nickel complex to freely rotate in order to get the most
stable docking structure.
The last step of the molecular docking procedure was to submit a configuration file
to AutoDock Vina v1.1.2.168,169,175 The configuration file contained all the required
docking parameters which includes the location and the size of the docking site in
three dimensions, the exhaustiveness, CPUs (central processing units), the required
number of binding modes and the names of the receptor and ligand PDBQT files.
Upon completion of a docking experiment two separate output files were generated.
The first was obtained in a log file format and contained the docking free binding
energies (given in kcal/mol) for all requested binding modes. The second output file
was in PDBQT format and contained information about the conformations of the
nickel complexes docked with the two different DNA molecules. These
configurations were visualized using PyMol v1.3,176

176

which was also used to

generate the artwork presented in this thesis.

2.11 Cell Culture
Chinese hamster lung cancer (V79) cells were obtained from Prof P. Lay (University
of Sydney) as frozen permanents. The cells were stored in liquid nitrogen in 2 mL of
solution containing 50% (v/v) DMEM growth medium, 40% FBS and 10% (v/v)
DMSO at a density of 4 × 106 cells per mL. When required cells were thawed from a
frozen permanent and grown in 25 cm2 cell culture flasks containing 25 mL complete
medium. The latter was comprised of low glucose DMEM growth medium
supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin.
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Culture flasks containing cells were incubated at 37 °C under an atmosphere of 5%
CO2 and 95% air in a Revco Ultima incubator (Twinsburg, USA). The cells were
sub-cultured twice a week by using phosphate buffered saline (PBS) (10 ml) for
washing the cells and 0.25% (w/v) trypsin in PBS (5 ml) for lifting the cells from the
surface of the flasks.

2.12 MTT Assays
2.12.1 Preparation of treatment solutions containing the nickel
complexes
Treatment solutions containing nickel complexes were prepared by first dissolving
the required amounts in order to obtain the highest concentrations possible in DMSO.
The resulting stock solutions were then serially diluted using DMSO to afford a
range of intermediate solutions with different concentrations. Each of these was then
diluted 50 times with incomplete medium (DMEM) to give the final nickel treatment
solutions. The final concentration of DMSO in the latter was 2% (v/v). Nickel
treatment solutions were prepared immediately prior to use.

2.12.2 MTT Assays procedure
The cytotoxicity of nickel complexes was assessed using the MTT assay.177 This
assay is used to measure the cellular toxicity of small molecules by quantifying the
extent of mitochondrial enzymatic reduction of the yellow compound 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to form the purple
formazan, (E,Z)-5-(4,5-dimethylthiazol-2-yl)-2,5-diphenylformazan (Figure 2.1).178
This cellular reduction reaction occurs in viable cells with functioning
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mitochondria.179 The amount of purple formazan produced is directly proportional to
the number of viable cells, and an IC50 value (concentration of complex which results
in only 50% of all treated cells remaining viable) can be determined from this data,
with smaller values of IC50 indicating the compound(s) is/are more cytotoxic.

Figure 2.1: Reduction of yellow MTT to form a purple formazan compound.
V79 cells (4 ×104 cells in 100 µL/well) were seeded into 96-well plates in complete
growth medium and incubated at 37 °C, 5% CO2 for 24 h prior to treatment to allow
the cells to adhere to the bottom of the wells. The cell medium was then removed by
aspiration and replaced with freshly prepared treatment solutions (100 µL) with a
range of concentrations, while incomplete DMEM medium (100 µL) was added to
the control well cells. The plates were then incubated at 37 °C, 5% CO2 for 24 h after
which MTT solution (20 µL, 5 mg/mL in PBS) was added to the wells and the plates
incubated at 37 °C, under an atmosphere of 5% CO2 for 4 h to allow for formazan
development. The resulting purple crystals were dissolved by adding a solution of
10% sodium dodecyl sulfate (SDS) in 0.01 M HCl (100 µL) to the wells and then the
plates were incubated at 37 °C, 5% CO2 overnight. The absorbance of the solutions
in the wells was then measured at 570 nm (formazan absorbance) and 630 nm
(background reading) by using a BMG LabTech Polarstar Omega microplate reader.
Concentration-response curves were produced using equation 2.2 to enable
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calculation of the percentage MTT conversion for each compound at each
concentration of nickel complex.
A570 -A630 (treated cells)
570 -A630 (untreated cells)

MTT conversion (%)= A

× 100

(2.2)

Experiments were performed in triplicate in order to obtain average values of IC50
and standard errors of the mean. Each plate contained 6 control wells and 6 wells for
each concentration of nickel complex. The calculated MTT conversion was plotted
against the treatment concentrations to enable determination of the IC50 value of each
compound.
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Chapter 3

Synthesis and characterisation of

nickel Schiff base complexes
3.1 Introduction
This chapter discusses the results obtained whilst developing methods for
synthesising a series of new nickel Schiff base complexes with different amines and
substituents attached to the aromatic rings. This includes discussion of NMR
spectroscopic characterisation data for representative compounds. Full spectroscopic
data and detailed synthetic procedures are also provided in this chapter, along with
ESI mass spectrometric and elemental analyses data. The solid-state structures of
some of the complexes, which were determined using X-ray crystallography, are also
analysed.

3.2 Discussion of synthetic methods
Binding selectivity in favour of G-quadruplex over dsDNA was the main feature
sought in the new nickel Schiff base complexes reported in this thesis. It was hoped
that the desired selectivity might be obtained through incorporating four pendant
groups into the structures of each of the complexes. These would enable additional
binding interactions with the loops and the grooves of G-quadruplex DNA structures,
whilst simultaneously inhibiting intercalation with dsDNA owing to steric hindrance.
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3.2.1 Synthesis of nickel complexes (adapted literature method)
Initial attempts to synthesise nickel Schiff base complexes with four pendant groups
were based on an adaptation of a widely used literature method.124 This adapted
procedure involved two steps and is illustrated in Figure 3.1 using the synthesis of
complexes (50) and (53) as an example. In the first step, 1,2-phenylenediamine was
reacted with 2,4,6-trihydroxybenzaldehyde in the presence of nickel acetate to afford
the precursor complex (50). In the second step the isolated precursor complex was
reacted with an excess of 1-(2-chloroethyl)piperidine in anhydrous solvent (DMF) in
the presence of a weak base (K2CO3).

Figure 3.1: Initial reaction scheme used for the solution-based synthesis of nickel
Schiff base complexes with four pendant groups.
Precursor complexes (51) and (52) were synthesized by analogous reactions
involving 1,2-phenylenediamine and either 2,3,4- or 2,4,5-trihydroxybenzaldehyde,
respectively. During the first synthetic step, prior to the addition of nickel acetate,
transparent solutions that were red or orange in colour were formed. Subsequent
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addition of nickel acetate resulted in formation of (50) and (51) as coloured
precipitates. In contrast, complex (52) did not form a precipitate and a different
isolation procedure had to be developed. This involved removal of the solvent by
evaporation, and suspension of the resulting solid in water after which (52) was
isolated via filtration. The three precursor complexes were purified by washing with
MeOH, diethyl ether and water, before being dried under vacuum then in an oven (80
˚C, 24 h).
Complexes (51) and (52) were obtained as insoluble solids and therefore could not be
characterised by NMR spectroscopy and ESI mass spectrometry. Their lack of
solubility is attributed to the formation of an extensive network of intermolecular
hydrogen bonds in the solid state owing to the presence of multiple hydroxyl groups.
In contrast, while (50) was insoluble in many common organic solvents such as
methanol, ethanol, and chloroform, it was soluble in both DMSO and DMF. The
successful formation of (50) was therefore able to be confirmed using NMR
spectroscopy and ESI mass spectrometry
The alkylation of complexes (51) and (52) according to the reaction scheme outlined
in Figure 3.1 could not conducted due to their insolubility. However, an alkylation
reaction was carried out using (50) in an attempt to obtain (53). This reaction was
performed using 8 equivalents of 1-(2-chloroethyl)piperidine over a period of 72
hours at 25 ˚C in DMF under N2, and afforded (53) in ~ 1% yield. Examination of
the product mixture using 1H NMR spectroscopy indicated that a significant amount
of the starting material had not reacted. In an attempt to improve the yield and purity
of (53) a range of different reaction conditions were trialled. These included
increasing the reaction temperature to 50 ˚C, as well as use of a longer reaction time
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(10 days) and larger excess of alkylating agent. However, despite the efforts
invested, no improvement in yield and purity were achieved.
The limited success achieved by performing the above reactions may be a result of
the presence of traces of water in the reaction mixtures. Complete removal of water
was very difficult since (50) is obtained as a hydrated complex. In the presence of
even traces of water, the K2CO3 used in the reaction mixture would have produced
significant quantities of hydroxide ions which could have reacted with the alkylating
agent before it had a chance to react with (50). Another possible explanation for the
very low yields of (53) in these reactions was that it may have decomposed as a
result of heating during the evaporation of the DMF solvent in order to isolate the
complex. However, when the procedure was repeated but with the DMF allowed to
evaporate slowly at room temperature over a period of 10 days, there was no
improvement in the purity or yield of the complex. Therefore, alternative pathways
were sought to synthesise the target complexes.

3.2.2 Synthesis of nickel complexes (synthesis by ball milling)
The first alternative approach that was explored was mechanochemical synthesis at
room temperature. Complexes (50), (51) and (52) were synthesised by dry milling a
mixture of 1 mmol of 1,2-phenylenediamine, 2 mmol of the appropriate aldehyde,
and 1.2 mmol of nickel acetate at 20 Hz for 2 h (Figure 3.2). The milling procedure
resulted in red clay-like products which probably still contained some water and
acetic acid. After being allowed to dry in air overnight, the products were able to be
collected by scraping off the walls of the milling jar. They were then washed with
cold MeOH and water to afford the final materials in yields ranging from 92 to 98%.
62

Complexes (51) and (52) obtained via the mechanochemical route were found to be
soluble in DMSO, in contrast to the products obtained via the solution methods. This
enabled their characterisation by NMR spectroscopy and ESI mass spectrometry.

Figure 3.2: Synthetic scheme for production of (50), (51) and (52) by
mechanochemical synthesis.
In view of the successful synthesis of the three precursor complexes (50), (51) and
(52) it was decided to see if the ball milling approach could be used to successfully
react each with 1-(2-chloroethyl)piperidine. An initial attempt to prepare (53) used 1
equivalent of (50), 4 equivalents of 1-(2-chloroethyl)piperidine hydrochloride and
4.5 equivalents of anhydrous K2CO3. After the reaction mixture was subjected to ball
milling at a frequency of 25 Hz for 1 h, and subsequent workup, an insoluble dark
solid was obtained which could not be characterised by either NMR spectroscopy or
ESI mass spectrometry. Altering reaction conditions including milling time,
operating frequency, quantities of reagents and introduction of a small amount of
DMF did not improve the reaction outcome. Since this method could not be
successfully applied to obtain (53) it was decided to not use it to attempt to
synthesise (54) and (55) from (51) and (52), respectively.
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3.2.3 Synthesis of nickel complexes (organic precursor method)
In view of the problems described above which were encountered during attempts to
prepare the target nickel complexes, a third approach employing a common organic
precursor was developed. This new procedure is outlined for one series of complexes
in Figure 3.3 and was developed by modifying a previously reported method.125 The
key step in the procedure is the initial selective di-alkylation of 2,4,6trihydroxybenzaldehyde at only one of the ortho as well as the para positions. It was
anticipated that only two hydroxyl groups would react, since the second ortho
hydroxyl group would be protected by a hydrogen bond with the carbonyl oxygen of
the aldehyde.
Initial attempts to alkylate 2,4,6-trihydroxybenzaldehyde were made using 1-(2chloroethyl)piperidine, and were performed in anhydrous acetone in the presence of
K2CO3. This reaction was performed under a variety of conditions in order to
optimise the yield and purity of the desired product, compound (68) (Table 3.1).
During initial attempts to synthesise (68) an excess of 1-(2-chloroethyl)piperidine
was used to minimise the chance of obtaining mono-alkylated compounds as byproducts. This led to the formation of a mixture of di- and trialkylated compounds.
Therefore, subsequent attempts used either less than or exactly the stoichiometric
amount of the alkylating agent. Unfortunately, this again resulted in a formation of a
mixture of di- and trialkylated compounds. As each of these initial reaction mixtures
used an excess of K2CO3, it was decided to then examine the effect of using smaller
quantities of the base. This change in reaction conditions enabled the selective dialkylation reaction to take place successfully. Furthermore, when the reaction
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temperature was increased from 25 ˚C to 40 ˚C the reaction time was able to be
shortened from 6 to 3 days and the yield increased from 20 to 32%.

Figure 3.3: Synthetic scheme for the synthesis of nickel Schiff base complexes (53),
(54) and (55) using alkylated organic precursor compounds.
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Table 3.1: Reaction conditions employed during attempts to prepare (68)
Equivalents
of
1-(2chloroethyl)piperidine

Equivalents
of
K2CO3

Yield
(%)

Time
(days)

Temperature
(°C)

Equivalents
of
benzaldehyde

6

25

1

2.5

3

22

6

25

1

2

3

31

6

25

1

1.5

3

26

6

25

1

2

2.5

20

3

40

1

2

2.5

32

Product
Mixture
di- and trialkylated
products
di- and trialkylated
products
di- and trialkylated
products
di-alkylated
product
only
di-alkylated
product
only

Compound (68) was soluble in water and a number of organic solvents including
DCM, CHCl3 and ethyl acetate. This facilitated its purification, by solvent extraction
first of all into CHCl3 and subsequently using ethyl acetate. Confirmation that (68)
had been successfully prepared was provided by elemental analysis, as well by ESI
mass spectrometry and NMR spectroscopy.
After the successful synthesis of (68), the same synthetic procedure was used with
only minor modifications to enable both (69) and (70) to be obtained. The changes
consisted of replacing 1-(2-chloroethyl)piperidine hydrochloride in the reaction
mixture with 4-(2-chloroethyl)morpholine hydrochloride in order to prepare (69),
and with 1-(3-chloropropyl)piperidine hydrochloride in order to synthesise (70). The
successful preparation of (69) and (70) was confirmed by elemental analysis, ESI
mass spectrometry and NMR spectroscopy.
Initial attempts to synthesise (53), (54) and (55) used the two-step procedure
illustrated in Figure 3.3. In the first step the free Schiff base ligand was synthesised
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by bringing to reflux two equivalents of (68), (69) or (70) and one equivalent of 1,2phenylenediamine in ethanol for 1h. The solvent was then evaporated and replaced
with methanol. Ni(OAc)2·4H2O was then added and the reaction mixture again held
at reflux for a further 4 h. This procedure led to very low yields of the desired
products as well as recovery of significant amounts of the starting materials
(Table 3.2).
Table 3.2: Effect of changing reaction conditions on the yield and purity of (53),
(54) and (55) obtained in reactions using organic precursor compounds.
Product
(53)

Two-step process
Reaction time (h)
% Yield
1, 4
impure
24, 24

(54)

24, 24

impure

(55)

24, 24

impure

One-step process
Reaction time (h)
% Yield
4
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4
24
4
24

42
54
28
50

Increasing the reaction time of one or both of the two steps did not improve the yield
or purity of any of the desired products (Table 3.2). Attempts to purify the free Schiff
base ligand obtained via the first step were unsuccessful. This included washing the
product with water and recrystallisation from different organic solvents including
EtOH, acetone and mixtures of DCM/Et2O and DCM/petroleum spirit. In contrast,
when the reaction was performed by bringing to reflux in methanol all of the starting
materials in one step the desired products were obtained in low to moderate yield and
with high purity (Table 3.2). The formation of the desired tetra-alkylated complexes
was confirmed by elemental analysis, mass spectrometry and NMR spectroscopy.
The one step reaction pathway used to synthesise complexes (53), (54) and (55) was
used to synthesise all of the remaining targeted tetra-alkylated complexes, except for
(65) and (66), which contain the 1,2-meso-diphenylenediamine moiety. The latter
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two complexes were, however, able to be successfully synthesised using the two-step
reaction approach. In contrast, when attempts were made to prepare these complexes
using a one-step procedure, impure products were obtained.
A total of fourteen new nickel Schiff base complexes were synthesised by the
reaction of (68), (69) or (70) with one of five different diamines in the presence of
nickel acetate, as outlined in Figure 3.4. Each of these synthetic procedures were
performed using methanol as the solvent. Upon completions of the reactions, the
methanol was removed under reduced pressure, leaving clay like materials, which
after washing with acetone or diethyl ether afforded the final products as coloured
solids. This purification procedure was sufficient to obtain alkylated complexes with
sufficient purity for DNA-binding studies. The purity of the nickel Schiff base
complexes was confirmed by elemental analysis, ESI mass spectrometry and NMR
spectroscopy.

Figure 3.4: General synthetic scheme for the synthesis of nickel Schiff base
complexes via organic precursor compounds.
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3.3 Experimental section
N,N′-Bis-4,6-(hydroxysalicylidine)phenylenediaminenickel(II) (50)
Method A: 2,4,6-Trihydroxybenzaldehyde (302 mg,
1.96 mmol) and 1,2-phenylenediamine (109 mg, 1.00
mmol) were dissolved in MeOH (30 mL), forming a
transparent orange solution. This was heated for 1 h
under reflux with constant stirring, during which time
the solution colour changed to dark orange-brown. Ni(OAc)2·4H2O (499 mg, 2.00
mmol) was then added to the mixture, and immediately resulted in a deep red-brown
precipitate. The solution continued to be heated under reflux for 24 h, after which it
was allowed to cool to room temperature. The precipitate that had formed was
separated by vacuum filtration and dried. It was subsequently washed with MeOH
(50 mL), diethyl ether (25 mL) and water (50 mL), before being dried under vacuum
for a further 2 h and then dried in an oven (24 h, 80 °C). Yield: 350 mg (79%). ESIMS calc: [M+H]+ = 437.0, Found: [M+H]+ = 437.0. 1H NMR (500 MHz, DMSO-d6):
δ 5.68 (d, 2H, J = 2.1 Hz, H10); 5.71 (d, 2H, J = 1.9 Hz, H8); 7.17 (m, 2H, H1); 7.77
(m, 2H, H2); 8.54 (s, 2H, H5); 10.04 (br-s, 2H, H14); 10.37 (br-s, 2H, H13).
Method

B:

2,4,6-Trihydroxybenzaldehyde

(71.6

mg,

0.46

mmol),

1,2-

phenylenediamine (25 mg, 0.23 mmol) and Ni(OAc)2·4H2O (115 mg, 0.461 mmol)
were reacted via ball milling (Millmix 20, Domel) for 2 h at 25 Hz. A stainless steel
jar of volume 10 mL and stainless steel balls of 10 mm diameter were used. This
resulted in formation of a brown solid, which was then washed with methanol (1 x 2
mL), then the filtrate from methanol washing (1 × 2 mL) and finally water (5 × 2
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mL) before being oven-dried (24 h, 80 °C). Yield 93 mg (92%). ESI-MS calc:
[M+H]+ =437.0, Found: [M+H]+ = 437.0. 1H NMR (500 MHz, DMSO-d6): δ 5.68 (d,
2H, J = 1.97 Hz, H10); 5.72 (d, 2H, J = 1.88 Hz, H8); 7.16 (m, 2H, H1); 7.75 (m,
2H, H2); 8.54 (s, 2H, H5); 10.09 (br-s, 1H, H14); 10.44 (br-s, 1H, H13).
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C NMR

(125 MHz DMSO-d6): δ 91.96 (C8); 96.42 (C10); 106.55 (C6); 115.11 (C2); 126.61
(C1); 143.13 (C3); 148.07 (C5); 160.90 (C7); 165.44 (C9); 167.94 (C11).
The proton resonances in the 1H NMR spectrum of (50) (Figure 3.5) were assigned
on the basis of their chemical shifts, integration, multiplicity and coupling constants.
For example, the spectrum exhibited three singlets at 10.44, 10.09 and 8.54 ppm
which integrated to two hydrogen atoms each. Since imine groups are electron
withdrawing, their protons are typically found at relatively high chemical shifts.
Therefore, the singlet at 8.54 ppm was assigned to H5.
In addition, as it was expected that the protons of the OH groups would give rise to
even more deshielded singlets, the resonances at 10.44 and 10.09 ppm were assigned
to H13 and H14, respectively. The broadness of these two resonances is consistent
with their assignment to OH groups, which was confirmed after consideration of the
NOESY (Nuclear Overhauser Effect Spectroscopy) spectrum of (50) shown in
Figure 3.5b. The latter showed the more deshielded singlet (H13) had a cross peak
with only one of the two aromatic protons (H8) in the same ring, whereas the singlet
at 10.09 ppm exhibited two such cross peaks (to both H8 and H10). The two doublets
at 7.16 and 7.75 ppm were assigned to H1 and H2 also with the help of the NOESY
spectrum, and in particular the observation of a strong cross peak between the imine
protons (H5) and the resonance at 7.75 ppm, which allowed the latter to be identified
definitively as H2.
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(a)

(b)

Figure 3.5: (a) 1H NMR spectrum and (b) NOESY spectrum of (50) in DMSO-d6,
with highlighted correlations shown.
The 13C NMR spectrum of (50) is presented inFigure 3.6(a) and showed the expected
number of resonances. An HSQC (Heteronuclear Single-Quantum Correlation
Spectroscopy) spectrum (Figure 3.6 (b)) was also obtained to facilitate assignment of
resonances from carbon atoms with at least one hydrogen attached. For example, in
the HSQC spectrum the carbon resonance at 148.07 ppm showed a cross peak with
the proton resonance assigned to H5, thereby allowing assignment of this 13C signal
to C5. In addition, the 13C resonances at 91.96, 96.42, 115.11 and 126.61 ppm were
able to be assigned to C8, C10, C2 and C1, respectively, via this approach. Since
quaternary carbon atoms do not have any C-H bonds they did not exhibit any HSQC
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cross peaks. Their assignment therefore required an HMBC (Heteronuclear MultipleBond Correlation) spectrum to be obtained.

(a)

(b)

(c)

Figure 3.6: (a) 13C NMR, (b) HSQC and (c) HMBC spectra of (50), with selected CH correlations highlighted.
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The HMBC spectrum of (50) is shown in Figure 3.6(c) and contains two or three
cross peaks for each of the five quaternary carbon resonances. Of these, the most
shielded was at 106.55 ppm. This resonance was assigned to C6, as it is the only
quaternary carbon atom not directly bonded to an O or N atom. Evidence in support
of this assignment was provided by the observation of cross peaks in the HMBC
spectrum with H5, which is located only two bonds away from C6, and both H8 and
H10 which are located three bonds away from C6. The carbon resonance at 143.13
ppm was assigned to C3 as it showed cross peaks in the HMBC spectrum with H5,
H2 and H1, which are located two or three bonds away. It was also possible to
readily assign the resonance at 165.44 ppm to C9 as it showed cross peaks in the
HMBC spectrum with H8 and H10, which are two bonds away, but not H5. This left
the two resonances at 160.90 and 167.94 ppm, which showed cross peaks in the
HMBC spectrum with H5, to be assigned. The former resonance also showed a cross
peak with H8, while the second showed a cross peak with H10. This allowed the
assignment of these two resonances to C7 and C11, respectively.
N,N′-Bis-4,5-(hydroxysalicylidine)phenylenediaminenickel(II) (51)
Method A: 2,4,5-Trihydroxybenzaldehyde (154
mg, 1.00 mmol) and 1,2-phenylenediamine (53
mg, 0.49 mmol) were dissolved in MeOH (50
mL), forming a transparent yellow solution.
This was heated for 30 min at reflux with
constant stirring, during which time the solution colour changed to dark orange.
Ni(OAc)2·4H2O (125 mg, 0.501 mmol) was then added to the mixture, and
immediately resulted in a brown precipitate. This solution continued to be heated
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under reflux for 3 h, after which it was allowed to cool to room temperature. The
precipitate that had formed was separated by vacuum filtration and dried. It was
subsequently washed with MeOH (50 mL), diethyl ether (25 mL) and water (50 mL),
before being dried under vacuum for a further 2 h and then dried in an oven (24 h, 80
°

C). Yield: 390 mg, 90%. Complex (2) was obtained as an insoluble solid and

therefore could not be characterised by NMR spectroscopy or ESI mass
spectrometry.
Method

B:

2,4,5-Trihydroxybenzaldehyde

(73

mg,

0.48

mmol),

1,2-

phenylenediamine (25 mg, 0.23mmol) and Ni(OAc)2·4H2O (61 mg, 0.24 mmol)
were reacted using ball milling (Millmix 20, Domel) for 2 h at 25 Hz. A stainless
steel jar of 10 mL volume and stainless steel balls of 10 mm diameter were used.
This resulted in a brown solid, which was washed with methanol (1 × 2 mL), then the
filtrate from methanol washing (1 × 2 mL) and finally water (5 × 2 mL) before being
oven-dried (24 h, 80 C). Yield 96 mg (95%). ESI-MS calc: [M+H]+ = 437.0, Found:
[M+H]+ = 437.0. 1H NMR (500 MHz, DMSO-d6): δ 6.26 (s, 2H, H10); 6.82 (s, 2H,
H7); 7.15 (m, 2H, H1); 7.98 (m, 2H, H2); 8.41 (s, 2H, H5); 8.57 (s, 2H, H14); 10.11
(s, 2H, OH13).

13

C NMR (125 MHz DMSO-d6): δ 104.28 (C10); 113.06 (C6);

115.62 (C2); 115.75 (C7); 126.15 (C1); 138.12 (C8); 142.86 (C3); 152.68 (C5);
156.04 (C9); 163.16 (C11).
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N,N′-Bis-3,4-(hydroxysalicylidine)phenylenediaminenickel(II) (52)
Method A: 2,3,4-Trihydroxybenzaldehyde (157 mg,
1.02 mmmol) and 1,2-phenylenediamine (54 mg,
0.50 mmol) were dissolved in MeOH (50 mL),
forming a transparent yellow solution. This was
heated for 30 min at reflux with constant stirring,
during which time the solution colour changed to dark orange. Ni(OAc)2·4H2O (127
mg, 0.51 mmol) was then added to the mixture, and immediately resulted in a deep
brown color solution. This solution continued to be heated under reflux for 3 h, after
which it was allowed to cool to room temperature. The MeOH was removed under
reduced pressure, leaving a solid black residue, which was suspended in water and
filtered using a vacuum filtration to afford the product as a black solid. It was
subsequently washed with MeOH (50 mL), diethyl ether (25 mL) and water (50 mL),
before being dried under vacuum for a further 2 h and then dried in an oven (24 h, 80
°

C). Yield: 143 mg, 65%. (3) was obtained as an insoluble solid and therefore could

not be characterised by NMR spectroscopy and ESI mass spectrometry.
Method

B:

2,3,4-Trihydroxybenzaldehyde

(73

mg,

0.47

mmol),

1,2-

phenylenediamine (25 mg, 0.23mmol) and Ni(OAc)2·4H2O (61 mg, 0.24 mmol)
were reacted using ball milling (Millmix 20, Domel) for 2 h at 25 Hz. A stainless
steel jar and stainless steel balls of 10 mm diameter were used. This resulted in a
brown solid, which was washed with methanol (1 × 2 mL), then the filtrate from
methanol washing (1 × 2 mL) and finally water (5 × 2 mL) before being oven-dried
(24 h, 80 ˚C). Yield 100 mg (98%). ESI-MS calc: [M+H]+ = 437.0, Found: [M+H]+ =
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437.0. 1H NMR (500 MHz, DMSO-d6): δ 6.28 (d, 2H, J = 8.76 Hz, H7); 6.95 (d, 2H,
J = 8.84 Hz, H8); 7.24 (m, 2H, H1); 8.03 (m, 2H, H2); 8.10 (s, 2H, H13); 8.60 (s,
2H, H5); 9.43 (s, 2H, H14). 13C NMR (125 MHz DMSO-d6): δ 108.74 (C8); 114.41
(C6); 116.07 (C2); 124.63 (C7); 127.02 (C1); 134.14 (C10); 142.93 (C3); 148.78
(C9); 155.27 (C5); 155.41 (C11).
1

H NMR spectra of (50), (51) and (52) obtained via the mechanochemical route are

shown in Figure 3.7. Comparison of the three spectra reveals that changing the
position of the hydroxyl groups significantly affected the chemical shifts of a number
of protons. For example, the chemical shifts of one or both of the hydroxyl protons in
(50) are far less shielded compared to the corresponding resonances in the spectra of
(51) and (52). In addition, notable differences in chemical shift were also observed
for some of the protons attached to the same aromatic ring as the hydroxyl groups.
The 1H NMR spectra therefore show that by using the mechanochemical approach it
was possible to synthesise (50), (51) and (52). In contrast, using the original solution
based method only complex (50) could be obtained. A further advantage of the
mechanochemical method was that it afforded (50) in higher yield in a shorter period
of time compared to the solution based approach.
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Figure 3.7: 1H NMR spectra of complexes (50), (51) and (52) with atom numbering
schemes shown.
2-Hydroxy-4,6-bis(2-(piperidin-1-yl)ethoxy)benzaldehyde (68)
This compound was prepared by modifying a
previously reported method.125 A mixture of 2,4,6trihydroxybenzaldehyde (100 mg, 0.649 mmol) and
anhydrous potassium carbonate (224 mg, 1.62 mmol)
in anhydrous acetone (6 mL) was stirred under reflux
at 40 °C for 30 min. 1-(2-chloroethyl)piperidine hydrochloride (239 mg, 1.30 mmol)
in anhydrous acetone (4 mL) was then added dropwise forming a light pink/orange
suspension. The reaction mixture was then heated at 40 °C for a further 72 h. During
this time a red precipitate and orange solution developed. The precipitate was
removed via gravity filtration, and the acetone filtrate evaporated resulting in an
orange oil. The latter was taken up in CHCl3, washed with water seven times, then
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dried with MgSO4. The CHCl3 was removed under low pressure to yield an orange
oil, which was added to 5 mL ethyl acetate. The undissolved material was removed
by gravity filtration before the ethyl acetate solution was left to evaporate in air to
afford the product as an orange oil. Yield: 78 mg, 32%. Microanalysis calc. for
C21H32N2O4·0.1CHCl3: C = 65.24; H = 8.33; N = 7.21%. Found: C = 65.22; H =
8.16; N = 7.05%. ESI-MS calc. [C21H32N2O4+H]+ = 377.2, Found: [C21H32N2O4+H]+
= 377.2. 1H NMR (400 MHz, CDCl3): δ 1.45 (m, 4H, H15 and H24); 1.60 (m, 8H,
H14, H16, H23 and H25); 2.48 (m, 8H, H13, H17, H22 and H26); 2.75 (t, 2H, J =
5.89 Hz, H11); 2.80 (t, 2H, J = 5.79 Hz, H20); 4.11 (t, 2H, J = 5.61 Hz, H10); 4.12
(t, 2H, J = 5.61 Hz, H19); 5.93 (d, 1H, J = 2.1 Hz, H6); 5.99 (d, 1H, J = 2.03 Hz,
H4); 10.09 (s, 1H, H1); 12.45 (br-s, 1H, H8). 13C NMR (125 MHz CDCl3): δ 24.06
(C15); 24.10 (C24); 25.83 (C14, C16); 25.92 (C23, C25); 54.98 (C13, C17, C22 and
C26); 57.47 (C11); 57.48 (C20); 66.39 (C10); 66.94 (C19); 91.68 (C6); 93.67 (C4);
106.09 (C2); 162.75 (C5); 166.18 (C3); 167.33 (C7); 191.88 (C1).
The 1H NMR spectrum of compound (68) (Figure 3.8) showed two very deshielded
singlets which each integrated to one proton. The first was at 12.45 ppm, which
together with its broadened appearance supported assignment to hydroxyl proton H8.
The very deshielded chemical shift and broadness of this resonance can be attributed
to formation of a hydrogen bond with the neighbouring carbonyl group. The second
deshielded singlet at 10.09 ppm was assigned to the aldehyde proton H1. The
spectrum also contained two resonances in the aromatic region at 5.93 and 5.99 ppm.
These were assigned to H6 and H4, respectively, with the assistance of a NOESY
spectrum. It is important to mention that during the assignment of 1H-NMR
spectrum, referring to a proton signal is in general referring to all the equivalent
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protons on that site. For example, H1 refers to the one proton attached to C1 while
H11 refers to the two protons attached to C11.

Figure 3.8: 1H NMR spectrum of (68) in CDCl3.
The two methylene groups at C11 and C20 were in slightly different chemical
environments, resulting in resolvable triplets as a result of coupling to neighbouring
CH2 groups at C10 and C19. In contrast, resonances from the latter two methylene
groups were in almost identical chemical environments, resulting in significant
overlap of signals that appeared as a quartet. The protons of the piperidine groups
gave rise to three multiplets in the most upfield region of the spectrum. These were
assigned based on their chemical shifts and relative integrations. For example, the
signal at 1.45 ppm integrated to four hydrogens and was assigned to H15 and H24.
Assignment of the remaining signals arising from the piperidine protons was
facilitated by the observation of cross peaks in the corresponding gCOSY spectrum
(Figure 3.9).
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Figure 3.9: gCOSY spectrum of (68), with H-H correlations highlighted.
Additional evidence in support of the above assignments was provided by a NOESY
spectrum (Figure 3.10). For example, the observation of two strong sets of cross
peaks between the quartet at 4.11 ppm and both H4 and H6 provided strong support
for the former signal to be assigned to both H10 and H19. A further set of cross
peaks was observed for the apparent quartet with the two triplets assigned to H11 and
H20. In addition, the latter resonances showed strong cross peaks with the intense
multiplet at 2.48 ppm, confirming that the latter should be assigned to the nearest
protons on the piperidine ring systems (H13, H17, H22 and H26). Finally, the
multiplet at 2.48 ppm showed a set of cross peaks with the resonance at 1.60 ppm,
confirming that the latter should be assigned to H14, H16, H23 and H25. The latter
resonances showed strong cross peaks with the multiplet at 1.45 ppm, confirming
that the latter should be assigned to H15 and H24.
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Figure 3.10: NOESY spectrum of (68), with H-H correlations highlighted.
The 13C NMR spectrum of (68) is shown in Figure 3.11 and exhibited the expected
number of resonances. Since the 1H NMR spectrum of (68) had been fully assigned,
most resonances in the

13

C NMR spectrum were able to be attributed to specific

carbon atoms on the basis of their C-H correlations in the corresponding HSQC
spectrum (also shown in Figure 3.11). For example, the two carbon signals at 91.68
and 93.68 ppm exhibited cross peaks with proton signals at 5.93 and 5.99 ppm,
allowing assignment of the former to C6 and C4, respectively. Similarly, the
apparent quartet in the 1H spectrum at 2.48 ppm exhibited cross peaks with two
carbon resonances at 66.39 and 66.94 ppm, allowing their assignment to C10 or C19.
One of the few 13C resonances to not show a cross peak in the HSQC spectrum was
that at 191.88 ppm. This was assigned to the carbonyl carbon atom C1 in view of its
very deshielded chemical shift.
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Figure 3.11:
highlighted.

13

C and HSQC NMR spectra of (68), with selected C-H correlations

Assignments for the four quaternary carbon resonances in the aromatic ring was
completed after examination of the HMBC spectrum of (68) (Figure 3.12). For
example, the

13

C resonance at 106.09 ppm was the only signal from a quaternary

carbon atom to show cross peaks in the HMBC spectrum with H1, H6 and H4. Since
each of these resonances is located either two or three bonds away from C2, the
former

13

C signal was assigned to the latter carbon atom. In contrast, the

13

C

resonance at 166.18 only showed cross peaks with H1 and H4, strongly suggesting it
should be assigned to C3, which is located only two or three bonds away from these
two hydrogen atoms. The absence of a cross peak involving the remaining hydrogen
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atom, H6, is consistent with this assignment as it is located four bonds away from
C3.

Figure 3.12: HMBC NMR spectrum of (68), with selected C-H correlations
highlighted.
2-Hydroxy-4,6-bis(2-morpholinoethoxy)benzaldehyde (69)
This compound was prepared by modifying a
previously reported method.125 A mixture of 2,4,6trihydroxybenzaldehyde (100 mg, 0.649 mmol) and
anhydrous potassium carbonate (224 mg, 1.62 mmol)
in anhydrous acetone (6 ml) were stirred under reflux
at 40 °C for 30 min. 1-(2-chloroethyl)morpholine hydrochloride (242 mg, 1.30
mmol) in anhydrous acetone (4 mL) was then added dropwise forming a light
pink/orange suspension. The reaction mixture was maintained under reflux for a
further 6 days. During this time, a red precipitate and red solution developed. The
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precipitate was removed via gravity filtration, and the filtrate evaporated resulting in
a red oil, which was taken up in DCM. The DCM solution was washed with water
seven times, and then dried with MgSO4. The solvent was then removed under low
pressure to yield a red oil, which was added to 5 mL ethyl acetate. A small amount of
undissolved material was removed by gravity filtration and the ethyl acetate allowed
to evaporate in air to afford the product as a red oil. Yield: 61 mg (25%).
Microanalysis calc. for C19H28N2O6·0.4H2O: C = 58.87; H = 7.49; N = 7.23%.
Found: C = 58.89; H = 7.22; N = 7.24%. ESI-MS calc. [C19H28N2O6+H]+ =381.2,
Found: [C19H28N2O6+H]+ = 381.2. 1H NMR (400 MHz, CDCl3): δ 2.48-2.50(m, 8H,
H13, H17, H22 and H26); 2.72 (t, 2H, J = 5.63 Hz, H11); 2.75 (t, 2H, J = 5.60, H20);
3.63-3.67 (m, 8H, H14, H16, H23 and H25); 4.03 (t, 2H, J = 5.55 Hz, H10); 4.04 (t,
2H, J = 5.55 Hz, H19); 5.85 (d, 1H, J = 2.04 Hz, H6); 5.93 (d, 1H, J = 1.92 Hz, H4);
10.02 (s, 1H, H1); 12.38 (br-s, 1H, H8). 13C NMR (125 MHz CDCl3): δ 53.00 (C13,
C17, C22 and C26); 56.20 (C11 and C20); 65.19 (C10, C19); 65.89 (C14, C16, C23,
C25); 90.78 (C6); 92.57 (C4); 105.10 (C2); 161.57 (C5); 165.25 (C3); 166.10 (C7);
190.76 (C1).
2-Hydroxy-4,6-bis(3-(piperidin-1-yl)propoxy)benzaldehyde (70)
This compound was prepared by modifying a previously
reported

method.125

A

mixture

of

2,4,6-

trihydroxybenzaldehyde (100 mg, 0.649 mmol) and
anhydrous potassium carbonate (224 mg, 1.62 mmol) in
anhydrous acetone (6 mL) were stirred under reflux at 40
°C

for

30

min.

1-(3-chloropropyl)piperidine

hydrochloride (258 mg, 1.30 mmol) in anhydrous acetone (4 mL) was then added
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dropwise forming a light pink/orange suspension. The reaction mixture was
maintained under reflux for a further 5 days. During this time, a red precipitate and
orange solution developed.
The precipitate was removed via gravity filtration, and the filtrate evaporated
affording an orange oil. The latter was taken up in DCM and washed with water
seven times, then dried with MgSO4. Subsequently the DCM was removed under low
pressure to yield an orange oil, which was added to 5 mL ethyl acetate. A small
amount of insoluble material was removed by gravity filtration and then the ethyl
acetate solution allowed to evaporate in air to afford the product as an orange oil.
Yield: 100 mg (39%). ESI-MS calc. [C23H36N2O4+H]+ = 405.3. Found:
[C23H36N2O4+H]+ =.405.4 Microanalysis calc. for C23H36N2O4·0.5DCM: C = 63.14;
H = 8.34; N = 6.27%. Found: C = 63.32; H = 8.42; N = 6.49%.1H NMR (400 MHz,
CDCl3): δ 1.36 (m, 4H, H16 and H26); 1.51 (m, 8H, H15, H17, H27 and H25); 1.90
(m, 4H, H11, H21); 2.31 (m, 8H, H14, H18, H24 and H28); 2.38 (m, 4H, H12 and
H22); 4.03 (t, 2H, J = 6.26 Hz, H10); 4.04 (t, 2H, J = 6.26 Hz, H19); 5.83 (d, 1H, J =
2.09 Hz, H6); 5.92 (d, 1H, J = 1.98 Hz, H4); 10.01 (s, 1H, H1); 12.38 (br-s, 1H, H8).
C NMR (101 MHz CDCl3): δ 24.43 (C16, C26); 25.99 (C15, C17, C25, C27);

13

26.58 (C11, C21); 54.66-54.70 (C14, C18, C24, C28); 55.68-55.83 (C12, C22);
67.04-67.12 (C10, C20); 91.53 (C6); 93.37 (C4); 106.00 (C2); 163.00 (C5); 166.23
(C3); 167.67 (C7); 191.74 (C1).
Figure 3.13 shows the 1H NMR spectra of compounds (68), (69) and (70). All
assignments for the latter two compounds were made by following the same
approach used previously with (68).
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Figure 3.13: 1H NMR spectra of (68), (69) and (70).
Comparison of the three 1H NMR spectra reveals a number of similarities. For
example, analogous resonances to those assigned to H1, H6, H4, H10/H19,
H13/H17/H22/H26 and H8 in the spectrum (68) were found at similar chemical
shifts in the spectra of (69) and (70) and assigned to the corresponding protons in
latter complexes. A number of differences were also observed, including observation
of an extra signal at 1.98 ppm in the 1H NMR spectrum of (70), which was not
present in the spectrum of (68). This was a consequence of the additional methylene
group in the linkers connecting the piperidine moieties to the rest of (70). This signal
was assigned to H11 and H21. A second difference was that the signal from H15 and
H24 in the spectrum of (68) was, as expected, no longer present in the spectrum of
(69). This was a consequence of the replacement of two methylene groups in (68) by
oxygen atoms in (69). This change also resulted in the chemical shifts of the
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resonances from protons adjacent to the oxygen atoms in (69) being more deshielded
than for the corresponding protons in (68).
N,N′-Bis-(4,6-((1-(2-ethyl)piperidine)oxy)salicylidine)phenylenediaminenickel(II)
(53)
Method A: A suspension of (50) (72.9 mg, 0.167
mmol), 1-(2-chloroethyl)piperidine hydrochloride (245
mg, 1.33 mmol) and K2CO3 (367 mg, 2.67 mmol) in
anhydrous DMF (5 mL) was stirred for 10 d under N2 at
25 °C. DMF was then evaporated under low pressure to
yield a dark brown sludge, which was then dissolved in
DCM (15 mL), and washed with water ten times. After
the washing step, the DCM solution was dried with
MgSO4, and evaporated yielding 39 mg of a dark brown solid. The 1H NMR
spectrum of the product showed many signals related to impurities. One of them was
assigned to the hydroxyl groups from (50), indicating that the starting material did
not fully react. Therefore, the obtained product was further purified by using column
chromatography on alumina, using DCM/methanol (95/5, v/v) as the eluent, to yield
the desired compound (1.9 mg, (1%)). Once again, however, the 1H NMR spectrum
of the product showed impurities. In other attempts to synthesise sufficiently pure
(53), the same procedure as above was followed but higher reaction temperature
and/or different concentrations of either (50) or 1-(2-chloroethyl) piperidine
hydrochloride were used. Again 1H NMR spectra did not show any improvement in
the purity of the (53) that was obtained. After the limited success of these attempts to
synthesise (53), it was decided to try a different method to synthesise this complex.
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Method B: A solution of (68) (68 mg, 0.18 mmol), 1,2-phenylenediamine (9.9 mg,
0.092 mmol) and Ni(OAc)2·4H2O (23 mg, 0.092 mmol) were dissolved in MeOH (4
mL). The solution was heated with constant stirring under reflux at 65 °C for 4 h.
During this time a brown precipitate appeared in the dark brown solution. At the end
of the reaction, the MeOH was removed under reduced pressure, leaving a solid
brown residue, which was suspended in acetone and then filtered using vacuum
filtration to afford the product as a brown powde. Yield: 95 mg (59%). Microanalysis
calc. for C48H66N6NiO6·2DCM: C = 57.10; H = 6.71; N = 7.99; Ni = 5.58%. Found:
C = 57.26; H = 7.02; N = 8.25; Ni = 5.40%. ESI-MS calc: [C48H66N6NiO6 +2H]2+ =
441.5, [C48H66N6NiO6 + 2H]2+ = 441.2. 1H NMR (500 MHz, CDCl3): δ 1.46 (m, 4H,
H19, H28); 1.62 (m, 16H, H18, H20, H27 and H29); 2.48 (m, 8H, H26 and H30);
2.56 (m, 8H, H17 and H21); 2.75 (t, 4H, J = 5.80 Hz, H24); 2.85 (t, 4H, J = 5.71 Hz,
H15); 4.08 (t, 4H, J = 5.86 Hz, H23); 4.12 (t, 4H, J = 5.70 Hz, H14); 5.72 (d, 2H, J =
1.93, H8); 6.23 (d, 2H, J = 1.73 Hz, H10); 7.13 (m, 2H, H1), 7.58 (m, 2H, H2), 8.65
(s, 2H, H5). 13C NMR (101 MHz, CDCl3): δ 24.16 (C19); 24.20 (C28); 25.88 (C18,
C20); 26.06 (C27, C29) 54.89 (C26, C30); 55.00 (C17, C21); 57.66 (C24), 57.74
(C15), 65.80 (C23); 66.56 (C14); 90.13 (C8); 96.67 (C10); 107.12 (C6); 114.30 (C2);
125.97(C1); 143.58 (C3); 147.98 (C5); 159.97 (C7); 165.11 (C9); 168.44 (C11).
The 1H NMR spectrum of (53) is shown in Figure 3.14. Since (50) and (53) have
closely related chemical structures, it is not surprising that there were strong
similarities between some aspects of their NMR spectra. For example, the resonances
from H1, H2 and H5 were found at 7.16, 7.75, 8.54 ppm, respectively for (50), and at
7.13, 7.58, 8.65 ppm, respectively in the spectrum of (53). In addition, the resonance
corresponding to H8 was found at the same chemical shift (5.72 ppm) in both
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spectra. The main difference between the two spectra, aside from the lack of
resonances from the dimethylenepiperidine moieties in the case of (50), was the
location of the resonance from H10. This was found at 5.68 ppm in the spectrum of
(50) but was located at a significantly more deshielded chemical shift of 6.23 ppm in
the case of (53).

Figure 3.14: 1H NMR spectrum of (53), with an expansion of some regions for
clarity.
The 1H resonances from the pendant dimethylenepiperidine groups in the top and
bottom portions of (53) were found at slightly different chemical shifts; however, all
appeared in the upfield region of the spectrum at similar chemical shifts to those of
the corresponding protons in (68). For example, the resonances from H19 and H28 in
the spectrum of (53) were found at 1.60 and 1.62 ppm, which is near the chemical
shifts of the same protons in the spectrum of (68) (1.45 and 1.46 ppm). In addition,
the resonances from H15 were found at 2.80 ppm and 2.85 ppm in the spectrum of
(50) and (53), respectively, whilst that from H24 was found at the same chemical
shift (2.75 ppm) in both spectra. The resonances from H14 and H23 were also found
at similar chemical shifts in the spectra of (68) and (53). This resulted in two close
89

but resolved triplets at 4.08 and 4.12 ppm, respectively in the spectrum of (53).
However, overlap of some of the individual signals in these multiplets resulted in an
apparent quartet in the spectrum of (68).
The above assignments for (53) were confirmed using COSY (Figure S3.1) and
NOESY (Figure 3.15) spectra of the complex. For example, the single set of cross
peaks between the resonance from H5 and that at 7.58 ppm in the NOESY spectrum
provided strong support for the latter to be assigned to H2. Additional sets of cross
peaks were observed between both H8 and H10, and the nearest methylene groups in
the two dimethylene linker moieties in the NOESY spectrum. In addition, the cross
peak between H14 and the triplet at 2.85ppm and the cross peak between H23 and
the triplet at 2.75 ppm confirmed these two signals should be assigned to the nearest
protons on the piperidine ring systems, which are H15 and H24, respectively. The
assignments of the remaining protons were confirmed using the same approach.

Figure 3.15: NOESY spectrum of (53), with selected H-H correlations highlighted.
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All of the resonances in the

13

C NMR spectrum of (53) were readily assigned

through a comparison with those in the spectra of (50) and (68) (Figure 3.16). It was
expected, for example, that the

13

C resonances from the piperidine ring systems in

(68) and (53) would have similar chemical shifts. This was found to be the case with
the resonances from C19 and C28 being found at 24.16 and 24.20 ppm, respectively,
in the 13C spectrum of (53), whilst the corresponding resonances in the spectrum of
(68) were observed at 24.06 and 24.10 ppm.
Confirmation of the assignments of the carbon atoms in the spectrum of (53) was
confirmed after examination of both the HSQC and HMBC spectra of the complex
(Figure S3.2 and Figure S3.3, respectively).

Figure 3.16: Comparison of 13C- NMR spectra of (53), (50) and (68).
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N,N′-Bis-(4,6-((1-(2-ethyl)morpholine)oxy)salicylidine)phenylenediaminenickel(II)
(54)
A solution of (69) (87 mg, 0.23 mmol), 1,2 phenylenediamine

(14

mg,

0.12

mmol)

and

Ni(OAc)2·4H2O (29 mg, 0.12 mmol) was dissolved in
MeOH (4 mL). The solution was heated under reflux
with constant stirring for 24 h. At the end of the
reaction, the MeOH was removed under reduced
pressure, leaving a red-brown residue, which was
suspended in acetone and then isolated using vacuum
filtration to afford the product as a red-brown powder. Yield: 110 mg (54%).
Microanalysis calc. for C44H58N6NiO10.1.5H2O: C = 57.65; H = 6.71; N = 9.17; Ni =
6.40%. Found: C = 57.47; H = 6.53; N = 9.38; Ni = 6.40%. ESI-MS calc:
[[C44H58N6NiO10]+ + 2H]2+ = 445.8. Found: [[C44H58N6NiO10]+ + 2H]2+ = 445.8. 1H
NMR (400 MHz, CDCl3): δ 2.55 (t, 8H, J = 4.47 Hz and 4.53 Hz, H26 and H30);
2.62 (t, 8H, J = 4.59 Hz and 4.59 Hz, H17 and H21); 2.78 (t, 4H, J = 5.60 Hz and
5.52 Hz, H24); 2.87 (t, 4H, J = 2.57 Hz and 2.55 Hz, H15); 3.74 (m, 16H, H18, H20,
H27 and H29); 4.09 (t, 4H, J = 5.55 Hz and 5.57 Hz, H23); 4.14 (t, 4H, J = 5.61Hz
and 5.56Hz, H14); 5.73 (d, 2H, J = 2.06 Hz, H8); 6.23 (d, 2H, J = 1.82 Hz, H10);
7.15 (m, 2H, H1), 7.58 (m, 2H, H2), 8.64 (s, 2H, H5). 13C NMR (101 MHz, CDCl3):
δ 54.01 (C26, C30); 54.09 (C17, C21); 57.36 (C24); 57.50 (C15); 65.66 (C23), 66.47
(C14), 66.91 (C27, C29); 67.01 (C18, C20); 90.19 (C8); 96.70 (C10); 107.16 (C6);
114.25 (C2); 126.23 (C1); 143.53 (C3); 147.91 (C5); 159.89 (C7); 164.95 (C9);
168.45 (C11).
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The 1H NMR spectrum of (54) is displayed in Figure 3.17, and shows a number of
resonances at very similar chemical shifts to what was observed in the spectrum of
(53).

However,

replacing

the

dimethylenepiperidine

moieties

with

dimethylenemorpholines resulted in two main differences. The first was the absence
of the resonances from H19 and H28 in the spectrum of (54), owing to the
replacement of methylene groups with oxygen atoms. The second difference was that
the resonances of all protons (H18, H20, H27 and H29) adjacent to the oxygen atoms
in the morpholine groups were found at more deshielded chemical shifts in the
spectrum of (54).

Figure 3.17: 1H NMR spectrum of (54), with expansions of some signals, for clarity.
N,N′-Bis-(4,6-((1-(3-propyl)piperidine)oxy]salicylidine)phenylenediaminenickel(II)
(55)
A solution of (70) (98 mg, 0.24 mmol), 1,2-phenylenediamine (14 mg, 0.13 mmol)
and Ni(OAc)2·4H2O (31 mg, 0.13 mmol) was dissolved in MeOH (6 mL). The
solution was heated under reflux with constant stirring for 24 h. At the end of the
reaction, the MeOH was removed under reduced pressure, leaving a solid residue.
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The latter was suspended in acetone and
filtered using vacuum filtration to afford the
product as a brown powder. Yield: 110 mg
(50%).

Microanalysis

calc.

for

C52H74N6NiO6.0.25H2O: C = 66.27; H = 7.97;
N = 8.92; Ni = 6.23%. Found: C = 66.27; H
=8.06; N = 9.11; Ni = 6.40%. ESI-MS calc:
[C52H74N6NiO6 + 2H]2+ = 469.9. Found:
[C52H74N6NiO6 + 2H]2+ = 469.9. 1H NMR (500
MHz, CDCl3): δ 1.47 (m, 8H, H20 and H30); 1.66 (m, 16H, H21, H19, H29 and
H31); 2.02 (m, 4H, H25); 2.09 (m, 4H, H15); 2.52 (m, 16H, H18, H22, H28 and
H32); 2.58 (m, 8H, H16 and H26); 3.96 (t, 4H, J = 6.13 and 6.15Hz, H24); 4.03 (t,
4H, J = 6.21 Hz, and 6.20 Hz H14); 5.68 (d, 2H, J = 1.81, H10); 6.21 (d, 2H, J =
1.53 Hz, H8); 7.14 (m, 2H, H1), 7.62 (m, 2H, H2), 8.62 (s, 2H, H5). 13C NMR (101
MHz, CDCl3): δ 24.42 (C20, C30), 25.93 (C19, C21); 25.96 (C29, C31), 26.57
(C15); 26.72 (C25); 54.59 (C18, C22); 54.79 (C28, C32); 55.89 (C16); 56.19(C26);
66.62 (C24); 66.89 (C14); 89.83(C8); 96.50 (C10); 106.97 (C6); 114.30 (C2); 125.94
(C1); 143.54 (C3); 147.67 (C5); 160.12(C7); 165.36 (C9); 168.50 (C11).
The 1H NMR spectrum of (55) is shown in Figure 3.18, and is similar to that of (53).
However, replacing the dimethylenepiperidine groups with trimethylenepiperidine
moieties resulted in some changes to the aliphatic region of the spectrum. The two
methylene groups nearest the phenolic oxygen atoms in (55) were again found to be
the most deshielded and gave rise to triplets at 3.96 and 4.03 ppm (H24 and H14,
respectively). A complex set of overlapping resonances at 2.52 - 2.58 ppm was
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assigned to the two methylenes in the linker nearest the piperidine nitrogen atoms
(H16 and H26) as well as to H18, H22, H28 and H32. Finally, the two quintets at
2.02 and 2.09 ppm were assigned to the central methylene groups (H25 and H15,
respectively) in the alkyl linker regions. All resonances assigned to the aromatic
protons and the imine protons of (55) were found at similar chemical shifts to the
corresponding protons in the 1H NMR spectrum of (53).

Figure 3.18: 1H NMR spectrum of (55), with an expansion of some signals, for
clarity.
N,N′-Bis-(4,6-((1-(2-ethyl)piperidine)oxy)salicylidine)ethylenediaminenickel(II) (56)
A solution of (68) (60 mg, 0.16 mmol), ethylenediamine (4.8 mg, 0.080 mmol) and
Ni(OAc)2·4H2O (20 mg, 0.080 mmol) was dissolved in MeOH (4 mL). The solution
was heated under reflux with constant stirring for 24 h. During this time a brown
precipitate appeared in the dark brown solution. At the end of the reaction, the
MeOH was removed under reduced pressure, leaving a solid residue which was
suspended in acetone and filtered using vacuum filtration to afford the product as a
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brown powder. Yield: 83 mg (63%). Microanalysis
calc. for C44H66N6NiO6·1.5H2O: C = 61.40; H = 8.08;
N = 9.76; Ni = 6.82%. Found: C = 62.07; H = 7.80; N
= 9.48; Ni = 6.7%. ESI-MS calc: [C44H66N6NiO6 +
2H]2+ = 417.5, [C44H66N6NiO6 + 2H]2+ = 417.2. 1H
NMR (400 MHz, CDCl3): δ 1.43 (m, 8H, H17 and
H26); 1.59 (m, 16H, H16, H18, H25 and H27); 2.47
(m, 16H, H15, H19, H24 and H28); 2.74 (m, 8H, H13
and H22); 3.31 (s, 4H, H1); 4.03 (m, 8H, H12 and H21); 5.63 (d, 2H, J = 2.05, H6);
6.12 (d, 2H, J = 1.84 Hz, H8); 7.83 (s, 2H, H3).

C NMR (101 MHz, CDCl3): δ

13

24.17-24.22 (C17 and C26); 25.91-25.98 (C16, C18, C25 and C27); 54.89-54.92
(C15, C19, C24 and C28); 57.75-57.76 (C13 and C22); 58.78 (C1); 65.75-66.14
(C12 and C21); 89.19 (C6); 96.90 (C8); 106.04 (C4); 155.97 (C3); 159.29 (C5);
163.73 (C7); 167.26 (C9).
The resonances in the 1H NMR spectrum of (56) (Figure 3.19) were readily
identified through a comparison with the corresponding spectrum of (53), which has
a nearly identical, symmetric structure. The only difference between the two
structures is that the phenylenediamine moiety in (68) is replaced by an
ethylenediamine moiety in (56). The absence of the aromatic system led to the
resonance from the imine protons H3 in (56) moving further upfield to 7.83 ppm. In
addition, the singlet at 3.31 ppm was assigned to H1 as its integration corresponded
to four hydrogen atoms.
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Figure 3.19: 1H NMR spectrum of (56), with expansions of some signals, for clarity.
N,N′-Bis-(4,6-((1-(2-ethyl)morpholine)oxy)salicylidine)ethylenediaminenickel(II)
(57)
A

solution

of

ethylenediamine

(69)
(3.6

(45
mg,

mg,
0.060

0.12

mmol),

mmol)

and

Ni(OAc)2·4H2O (15 mg, 0.060 mmol) was prepared in
MeOH (3 mL). The solution was heated under reflux
with constant stirring for 4 h. At the end of the reaction,
the MeOH was removed under reduced pressure,
leaving a solid residue. The latter was then suspended
in anhydrous diethyl ether and filtered using vacuum filtration to afford the product
as

a

brown

powder.

Yield:

50

mg

(50%).

Microanalysis

calc.

for

C40H58N6NiO10·1.5H2O: C = 55.31; H = 7.08; N = 9.68; Ni = 6.76%. Found: C =
55.26; H = 7.11; N = 9.78; Ni = 6.40%. ESI-MS calc: [C40H58N6NiO10 + 2H]2+ =
421.8. Found: [C40H58N6NiO10 + 2H]2+ = 421.8. 1H NMR (400 MHz, CDCl3): δ 2.54
(m, 16H, H15, H19, H24 and H28); 2.77 (m, 8H, H13 and H22); 3.32 (s, 4H, H1);
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3.73 (m, 16H, H16, H18, H25 and H27); 4.04 (m, 8H, H12 and H21); 5.63 (d, 2H, J
= 2.15 Hz, H6); 6.11 (d, 2H, J = 1.97 Hz, H8); 7.82 (s, 2H, H3).
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C NMR (101

MHz, CDCl3): δ 53.98-53.99 (C15, C19, C24 and C28); 57.42-57.47 (C13 and C22);
58.82 (C1); 65.42 (C21); 65.98 (C12), 66.91-66.95 (C16, C18, C25 and C27), 89.21
(C6); 96.89 (C8); 106.06 (C4); 155.88 (C3); 159.18 (C5); 163.57 (C7); 167.28 (C9).
N,N′-Bis-(4,6-((1-(3-propyl)piperidine)oxy]salicylidine)ethylenediaminenickel(II)
(58)
A solution of (70) (72 mg, 0.18 mmol),
ethylenediamine (5.5 mg, 0.092 mmol) and
Ni(OAc)2·4H2O (22 mg, 0.088 mmol) was
prepared in MeOH (4 mL). The solution was
heated under reflux with constant stirring for
24 h. At the end of the reaction, the MeOH was
removed under reduced pressure, leaving a
solid residue. The latter was suspended in
anhydrous diethyl ether and filtered using vacuum filtration to afford the product as
an

orange

powder.

Yield:

90

mg

(57%).

Microanalysis

calc.

for

C48H74N6NiO6·0.5C4H10O: C = 64.79; H = 8.59; N = 9.07; Ni = 6.30%. Found: C =
65.13; H = 8.78; N = 9.14; Ni = 6.30%. ESI-MS calc: [C48H74N6NiO6 + 2H]2+ =
445.9. Found: [C48H74N6NiO6 + 2H]2+ = 445.9. 1H NMR (400 MHz, CDCl3): δ 1.44
(m, 8H, H18 and H28); 1.60 (m, 16H, H17, H19, H27 and H29); 1.94 (m, 8H, H13
and H23); 2.42 (m, 12H, H14, H20, H16, H24, H26 and H30); 3.31 (s, 4H, H1); 3.92
(m, 8H, H12 and H22); 5.6 (d, 2H, J = 1.96 Hz, H6); 6.11 (d, 2H, J = 1.62 Hz, H8);
7.82 (s, 2H, H3).13C NMR (101 MHz, CDCl3): δ 24.34 (C18); 24.37 (C28); 25.90
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(C17, C19, C27 and C29); 26.58 (C13); 26.73 (C23), 54.55 (C16, C20); 54.61 (C26,
C30); 55.92 (C14); 56.07 (C24); 58.71 (C1); 66.33(C12); 66.54 (C22); 88.73 (C6);
93.62 (C8); 105.74 (C4); 155.66 (C3); 159.35 (C5); 163.86 (C7); 167.22 (C9).
The 1H NMR spectra of (57) and (58) are shown in Figure S3.4 and Figure S3.5 Both
are, not surprisingly, similar to the 1H NMR spectrum of (56), as the only difference
between the three structures is that the ethylpiperidine moieties in the latter molecule
have been replaced with ethylmorpholine and propylpiperidine moieties in (57) and
(58), respectively.
N,N′-Bis-((4-((1-(3-propyl)piperidine)oxy)salicylidine)-1,3-propylenediaminenickel(II) (59)
A solution of (68) (72 mg, 0.19 mmol), 1,3diaminopropane

(7

mg,

0.09

mmol)

and

Ni(OAc)2·4H2O (24 mg, 0.096 mmol) was prepared in
MeOH (4 mL). The solution was heated under reflux
with constant stirring for 24 h. At the end of the
reaction, the MeOH was removed under reduced
pressure, leaving a solid residue, which was suspended
in anhydrous diethyl ether and filtered using vacuum
filtration to afford the product as a deep brown powder. Yield: 44 mg (55%).
Microanalysis calc. for C45H68N6NiO6.3MeOH: C = 61.08; H = 8.54; N = 8.90; Ni =
6.22%. Found: C = 60.75; H = 8.17; N = 8.85; Ni = 5.90%. ESI-MS calc:
[C45H68N6NiO6 +3H]3+ =283.6. Found [C45H68N6NiO6 +3H]3+ =283.6. 1H NMR (400
MHz, CDCl3): δ 1.43 (m, 8H, H18, and H27); 1.59 (m, 16H, H17, H19, H26 and
H28); 1.85 (m, 2H, H1); 2.46 (m, 16H, H16, H20, H25 and H29); 2.71 (m, 8H, H14
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and H23); 3.42 (t, 4H, J = 6.54 Hz, H2); 4.02 (t, 8H, J = 5.90, H13 and H22); 5.60
(d, 2H, J = 1.83 Hz, H7); 6.07 (d, 2H, J = 1.47 Hz, H9); 7.49 (s, 2H, H4) 13C NMR
(101 MHz, CDCl3): δ 24.32-24.37 (C18 and C27); 26.05-26.13 (C17, C19, C26 and
C28); 26.71 (C1); 55.01-55.07 (C16, C20, C25 and C29); 55.77 (C2); 57.88-57.90
(C14 and C23); 65.68-66.24 (C13 and C22); 89.03 (C9); 96.03 (C7); 106.40 (C5);
158.46 (C4); 159.53 (C6); 164.03 (C8); 166.65 (C10).
The 1H NMR spectrum of (59) is shown in Figure 3.20, and is similar to that of (56).
This was not surprising as the only difference between the two structures is that the
ethylenediamine moiety in (56) is replaced by a 1,3-propylenediamine moiety in
(59). Therefore, the aliphatic region of the 1H NMR spectrum of the latter complex
was slightly different. The triplet at 3.42 ppm was assigned to H2 as its integration
corresponded to four hydrogen atoms. A gCOSY spectrum (Figure 3.21) was then
used to identify that the quintet at 1.85 ppm corresponded to H1.

Figure 3.20: 1H NMR spectrum of (59), with expansions of some signals, for clarity.
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Figure 3.21: gCOSY spectrum of (59), with selected H-H correlations highlighted.
N,N′-Bis-(4,6-((1-(2-ethyl)morpholine)oxy)salicylidine)-1,3-propylenediaminenickel(II) (60)
A solution of (69) (45 mg, 0.12 mmol), 1,3diaminopropane

(4.4

mg,

0.059

mmol)

and

Ni(OAc)2·4H2O (15 mg, 0.060 mmol) was prepared in
MeOH (2.5 mL). The solution was heated under reflux
with constant stirring for 24 h. At the end of the
reaction, the MeOH was removed under reduced
pressure, leaving a solid residue, which was suspended
in anhydrous diethyl ether and filtered using vacuum
filtration to afford the product as a red-brown powder. Yield: 60 mg (59%).
Microanalysis calc. for C41H60N6NiO10·0.2C4H10O: C = 57.67; H =7.18; N = 9.65; Ni
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= 6.74%. Found: C = 57.5; H = 7.46; N = 9.6; Ni = 6.60%. ESI-MS calc:
[[C41H60N6NiO10]+ + 2H]2+ = 428.8. Found: [[C41H60N6NiO10]+ + 2H]2+ = 428.8. 1H
NMR (400 MHz, CDCl3): δ 1.86 (m, 2H, H1); 2.53 (m, 16H, H16, H20, H25 and
H29); 2.77 (m, 8H, H14 and H23), 3.43 (t, 4H, J = 6.57 Hz and 6.57 Hz, H2); 3.72
(m, 16H, H17, H19, H26 and H28); 4.04 (m , 8H, H13 and H22); 5.60 (d, 2H, J =
2.13 Hz, H9); 6.07 (d, 2H, J = 2.00 Hz, H7); 7.48 (s, 2H, H4). 13C NMR (101 MHz,
CDCl3): δ 26.61 (C1); 53.97 (C16, C20, C25 and C29); 55.80 (C2); 57.43 (C14 and
C23); 65.36 (C22), 65.89 (C13), 66.89-66.93 (C17, C19, C26 and C28); 88.93 (C7);
96.05 (C9); 106.32 (C5); 158.28 (C4); 159.32 (C6); 163.78 (C8); 166.49 (C10).
The 1H NMR spectrum of (60) (Figure S3.6) was, not surprisingly, found to be
similar to that of (59), with the only differences being changes to the chemical shifts
of some resonances noted previously to occur when the terminal methylenes of the
piperidine groups are replaced by oxygen atoms in the morpholines.
N,N′-Bis-((4,6-((1-(3-propyl)piperidine)oxy)salicylidine)-1,3-propylenediaminenickel(II) (61)
A solution of (70) (100 mg, 0.25 mmol), 1,3-diaminopropane (9.3 mg, 0.13 mmol)
and Ni(OAc)2·4H2O (32 mg, 0.13 mmol) was prepared in MeOH (3.5 mL). The
solution was heated under reflux with constant stirring for 24 h. At the end of the
reaction, the MeOH was removed under reduced pressure, leaving a solid residue,
which was suspended in n-hexane and filtered using vacuum filtration to afford the
product as a brown powder. Yield: 140 mg (61%). Microanalysis calc. for
C49H76N6NiO6·2MeOH: C = 63.28; H = 8.75; N = 8.68; Ni = 6.06%. Found: C =
63.33; H = 8.67; N = 8.52; Ni = 6.30%. ESI-MS calc: [C49H76N6NiO6 + 2H]2+
=452.3, Found: [C49H76N6NiO6 + 2H]2+ = 452.3. 1H NMR (400 MHz, CDCl3): δ 1.44
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(m, 8H, H19, and H29); 1.59 (m, 16H, H18, H20, H28 and H30); 1.85 (m, 2H, H1);
1.93 (m, 8H, H14, and H24); 2.40 (m, 12H,
H15, H17, H21, H25, H27 and H31); 3.42 (t,
4H, J = 5.89 Hz, H2); 3.91 (m, 8H, H13 and
H23); 5.57 (d, 2H, J = 1.61 Hz, H7); 6.07 (d,
2H, J = 1.19 Hz, H9); 7.49 (s, 2H, H4).
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C

NMR (101 MHz, CDCl3): δ 24.41 (C19 and
C29); 26.10 (C18, C20, C28 and C30); 26.726.92 (C1, C14 and C24); 54.76-54.81 (C17,
C21, C27 and C31); 55.71 (C2); 56.14-56.28
(C15 and C25); 66.55-66.78 (C13 and C23); 88.69 (C7); 96.01 (C9); 106.22 (C5);
158.23 (C4); 159.70 (C6); 164.30 (C8); 166.65 (C10).
The 1H NMR spectrum of (61) is shown in Figure S3.7 and was found to be similar
to that of (59). A gCOSY spectrum (Figure S3.8) was used to identify that the
overlapping resonances at 1.93 and 1.85 ppm corresponded to H14/H24 and H1,
respectively.
N,N′-Bis-(4-((1-(3-propyl)piperidine)oxy]salicylidine)-1,2-propylenediaminenickel(II) (62)
A solution of (68) (74 mg, 0.19 mmol), 1,2-diaminopropane (8.4 mg, 0.11 mmol)
and Ni(OAc)2·4H2O (25 mg, 0.10 mmol) was prepared in MeOH (4.3 mL). The
solution was heated under reflux with constant stirring for 24 h. At the end of the
reaction, the MeOH was removed under reduced pressure, leaving a solid residue,
which was suspended in anhydrous diethyl ether and filtered using vacuum filtration
to afford the product as a red-brown powder. Yield: 77 mg (46%). Microanalysis
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calc: for C45H68N6NiO6·0.5H2O: C = 63.08; H =
8.12; N = 9.81; Ni = 6.85%. Found: C = 63.23; H =
8.30; N = 9.63; Ni =6.60%. ESI-MS calc:
[C45H68N6NiO6 + 2H]2+ = 424.2, [C45H68N6NiO6 +
2H]2+ = 424.2. 1H NMR (500 MHz, CDCl3): δ 1.39
(d, 3H, J = 6.59 Hz, H1); 1.43 (m, 8H, H28, H37,
H46 and H55); 1.59 (m, 16H, H27, H29, H36, H38,
H45, H47, H54 and H56); 2.47 (m, 16H, H26, H30,
H35, H39, H44, H48, H53 and H57); 2.73 (m, 8H, H24, H33, H42, and H51); 2.83
(dd, 1H, J = 2.22 Hz and 12.69 Hz, H21B), 3.34 (m, 1H, H2); 3.58 (dd, 1H, J = 5.65
Hz and 12.25 Hz, H21A); 4.03 (m , 8H, H23, H32, H41 and H50); 5.64 (s, 2H, H7
and H16); 6.12 (s, 2H, H9 and H14); 7.79 (s, 2H, H4 and H19). 13C NMR (101 MHz,
CDCl3): δ 21.50 (C1); 24.18-24.23 (C28, C37, C46 and C55); 25.92-26.02 (C27,
C29, C36, C38, C45, C47, C54 and C56); 54.89-54.94 (C26, C30, C35, C39, C44,
C48, C53 and C57); 57.75 (C24, C33, C42 and C51); 63.61 (C2); 65.11 (C21);
65.57-66.20 (C23, C32, C41 and C50); 89.10-89.17 (C7, C16); 96.84-96.93 (C9,
C14); 106.09-106.13 (C5 and C18); 154.83 (C19); 156.30 (C4); 159.23-159.26 (C6
and C17); 163.67-163.69 (C8 and C15); 167.13-167.27 (C10 and C13).
Complexes (62), (63) and (64) differ in structure from those described above in
having a 1,2-diaminopropane group as the diamine moiety. A consequence of this
change was that not only were the atoms in the pendant groups in the top and bottom
halves of the molecules in slightly different chemical environments, so too were
those on the left- and right-hand sides. This manifested itself in very slight
differences in chemical shift for certain clusters of protons. For example, the 1H
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NMR spectrum of (62) shown in Figure 3.22 shows a broad peak near 1.6 ppm from
H27, H29, H36, H38, H45, H47, H54 and H56. In addition, the 1H NMR spectrum of
the above three complexes showed a characteristic set of multiplets arising from the
protons in the 1,2-diaminopropane groups. This is exemplified by the 1H NMR
spectrum of (62) shown in Figure 3.22. This shows two doublet of doublets from the
diastereotopic protons H21A and H21B, as well as an apparent triplet at 3.34 ppm
from H2 and a doublet at 1.39 ppm from the methyl protons. Each of these
assignments was confirmed through the use of gCOSY and NOESY spectra.

Figure 3.22: 1H NMR spectrum of (62), with expansions of some signals, for clarity.
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N,N′-Bis-(4,6-((1-(2-ethyl)morpholine)oxy)salicylidine)-1,2-propylenediaminenickel(II) (63)
A solution of (69) (62 mg, 0.16 mmol), 1,2diaminopropane

(6.1

mg,

0.082

mmol)

and

Ni(OAc)2·4H2O (21 mg, 0.084 mmol) was prepared
in MeOH (4 mL). The solution was heated under
reflux with constant stirring for 24 h. At the end of
the reaction, the MeOH was removed under reduced
pressure, leaving a solid residue, which was
suspended in anhydrous diethyl ether and filtered
using vacuum filtration to afford the product as a red-brown powder. Yield: 50 mg
(36%). Microanalysis calc: for C41H60N6NiO10: C = 57.55; H = 7.07; N = 9.82; Ni =
6.86%. Found: C = 57.31; H = 7.39; N = 9.79; Ni = 6.60%. ESI-MS calc:
[C41H60N6NiO10 + 2H]2+ = 428.2. Found: [[C41H60N6NiO10]+ + H]+ = 428.2. 1H NMR
(400 MHz, CDCl3): δ 1.40 (d, 3H, J = 6.52 Hz, H1) 2.54 (m, 16H, H26, H30, H35,
H39, H44, H48, H53 and H57); 2.77 (m, 8H, H24, H33, H42 and H51); 2.88 (dd, 1H,
J = 1.89 Hz and 12.58 Hz, H21B); 3.36 (m, 1H, H2), 3.58 (dd, 1H, J = 5.27 Hz and
12.48 Hz H21A); 3.73 (m, 16H, H27, H29, H36, H38, H45, H47, H54 and H56);
4.03 (m, 8H, H23, H32, H41 and H50); 5.64 (s, 2H, H9 and H14); 6.12 (s, 2H, H7
and H16); 7.80 (s, 2H, H4 and H19).
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C NMR (101 MHz, CDCl3): δ 21.45 (C1);

53.98 (C26, C30, C35, C39, C44, C48, C53 and C57); 57.41-57.45 (C24, C33, C42
and C51); 63.63 (C2); 65.16 (C21); 65.38-66.01 (C23, C32, C41 and C50); 66.8966.94 (C27, C29, C36, C38, C45, C47, C54 and C56); 89.12-89.19 (C9, C14); 96.81-
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96.90 (C7, C16); 106.13-106.17 (C5, C18); 154.74 (C4); 156.22 (C19); 159.14159.17 (C6 and C17); 163.52-163.54 (C8 and C15); 167.12-167.27 (C10 and C13).
N,N′-Bis-(4,6-((1-(3-propyl)piperidine)oxy]salicylidine)-1,2-propylenediaminenickel(II) (64)
A solution of (70) (99 mg, 0.24 mmol), 1,2diaminopropane (9.1 mg, 0.12 mmol) and
Ni(OAc)2·4H2O (31 mg, 0.12 mmol) was
prepared in MeOH (5 mL). The solution was
heated under reflux with constant stirring for
24 h. At the end of the reaction, the MeOH
was removed under reduced pressure,
leaving

a

solid

residue,

which

was

suspended in acetone then filtered using
vacuum filtration to afford the product as an orange powder. Yield: 120 mg (54%).
Microanalysis calc: for C49H76N6NiO6·2H2O: C = 62.62; H = 8.58; N =8.94; Ni =
6.25%. Found: C = 62.36; H = 8.51; N = 8.94; Ni = 6.1%. ESI-MS calc:
[C49H76N6NiO6 + 2H]2+ = 452.3, [[C49H76N6NiO6]+ + 2H]2+ = 452.4. 1H NMR (400
MHz, CDCl3): δ 1.40-1.45 (m, 11H, H1, H29, H39, H49 and H59); 1.55-1.62 (m,
16H, H28, H30, H38, H40, H48, H50, H58 and H60); 1.90-1.98 (m, 8H, H24, H34,
H44 and H54); 2.39-2.42 (m, 24H, H25, H27, H31, H35, H37, H41, H45, H47, H51,
H55, H57 and H61); 2.82 (d, 1H, J = 12.42 Hz, H21B); 3.34 (t, 1H, J = 6.98 Hz H2),
3.58 (dd, 1H, J = 5.48 Hz and 12.11 Hz, H21A); 3.91 (m, 8H, H23, H33, H43 and
H53); 5.61 (s, 2H, H9 and H14); 6.12 (s, 2H, H7 and H16); 7.78 (s, 2H, H4 and
H19). 13C NMR (101 MHz, CDCl3): δ 21.73 (C1); 24.44-24.47 (C29, C39, C49 and
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C59); 26.00-26.01 (C28, C30, C38, C40, C48, C50, C58 and C60); 26.69-26.83
(C24, C34, C44 and C54); 54.63 (C27, C31, C47 and C51); 54.67-54.70 (C25 and
C45), 55.98 (C37, C41, C57 and C61); 56.14-56.18 (C35 and C55); 63.64 (C2);
65.07 (C21); 66.43-66.66 (C23, C33, C43 and C53); 88.80 (C9 and C14); 96.67 (C7
and C16); 105.92 (C5 and C18); 154.66 (C4); 156.08 (C19); 159.37 (C6 and C17);
163.92 (C8 and C15) and 167.33 (C10 and C13).
The 1H NMR spectra of (63) and (64) (Figure S3.9 and Figure S3.10, respectively)
were very similar to that of (62), with the only significant differences being those
described previously for other related series of complexes, which arose from the
changes in the structure of the pendant groups.
N,N′-Bis-(4,6-((1-(2-ethyl)piperidine)oxy)salicylidine)meso-diphenylethylenediaminenickel(II) (65)
A solution of (68) (340 mg, 0.90
mmol)

and

diphenylethylene-diamine

1,2-meso(96

mg,

0.45 mmol) in EtOH (25 mL) was
heated under reflux with constant
stirring for 1h. At this time the EtOH
was replaced with MeOH (25 mL) and
Ni(OAc)2·4H2O (110 mg, 0.45 mmol) added. The reaction mixture was then brought
again to reflux with constant stirring for a further 24 h. At the end of the reaction, the
MeOH was removed under reduced pressure, leaving a solid residue, which was
suspended in anhydrous diethyl ether and filtered using vacuum filtration to afford
the product as a brown powder. Yield: 300 mg (66%). Microanalysis calc: for
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C56H74N6NiO6: C = 68.22; H = 7.57; N = 8.52; Ni = 5.95%. Found: C = 68.13; H =
7.79; N = 8.41; Ni =5.80%. ESI-MS calc: [C56H74N6NiO6 + H]+ = 985.5,
[C56H74N6NiO6 + 2H]2+ = 493.3. Found: [C56H74N6NiO6 + H]+ = 985.6,
[C56H74N6NiO6 + 2H]2+ = 493.5. 1H NMR (400 MHz, CDCl3): δ 1.33 (m, 4H, H32);
1.44 (m, 12H, H23, H31 and H33); 1.60 (m, 8H, H22 and H24); 2.20 (m, 8H, H30
and H34); 2.47 (m, 8H, H21 and H25); 2.52 (m, 4H, H19); 2.73 (t, 4H, J = 5.71 Hz,
H28); 3.87 (m, 4H, 18); 4.05 (t, 4H, J = 5.72 Hz, H27); 4.69 (s, 2H, H7); 5.56 (s, 2H,
H12), 6.17 (s, 2H, H14), 7.19 (m, 4H, H1 and H5), 7.25 (m, 2H, H3), 7.37 (broad-s,
4H, H2 and H4), 7.66 (s, 2H, H9).

13

C NMR (101 MHz, CDCl3): δ 23.99 (C32);

24.19 (C23); 25.88 (C22, C24, C31 and C33); 54.51 (C30, C34); 54.86 (C21, C25);
57.56 (C19); 57.70 (C28), 65.55 (C27); 66.11 (C18); 77.74 (C7), 89.07 (C12); 96.74
(C14); 106.22 (C10); 128.17 (C1 and C5); 128.42 (C3); 129.63 (C2 and C4); 135.85
(C6); 156.43 (C9); 159.39 (C11); 164.03 (C13); 167.22 (C15).
The 1H NMR spectra of (65), (66) and (67) showed that the chemical environments
of a number of related protons in the top and bottom pendant groups were more
dissimilar than for a number of the complexes discussed previously. This is
illustrated by Figure 3.23, which compares the 1H NMR spectra of (65) and (56). For
example, resonances from the two sets of methylene groups in the linker regions
adjacent to the oxygen atoms in (65) (H18 and H27) were found at 3.87 and 4.05
ppm, respectively. This is a greater chemical shift difference than what was found for
the analogous methylene 1H resonances (for H12 and H21) in the spectrum of (56),
which overlapped to give a single multiplet at 4.03 ppm. Similar differences were
also found for the resonances arising from the linker methylene groups adjacent to
the nitrogen atoms in (56) and (65). A further difference between the 1H NMR
109

spectra of (65) on the one hand, and those of the complexes discussed above also
involves the linker methylene groups. Whilst typically two triplets were observed for
both methylene groups in a dimethylene linker moiety, in the case of (65) one of the
methylene groups (H18) gave rise to two broad and closely spaced multiplets. This
was also found to be the case in the spectrum of (66) shown in Figure S3.11

Figure 3.23: Comparison of the 1H NMR spectra of (56) and (65).
N,N′-Bis-(4,6-((1-(2-ethyl)morpholine)oxy)salicylidine)-meso-diphenylethylenediaminenickel(II) (66)
A solution of (70) (150 mg, 0.39 mmol), 1,2-meso-diphenylethylene-diamine (63
mg, 0.30 mmol) was prepared in EtOH (2.5 mL). The solution was heated under
reflux with constant stirring for 1 h. At this time, the EtOH was replaced with MeOH
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(2.5 mL) and Ni(OAc)2·4H2O (49 mg, 0.20 mmol) added to the reaction mixture.
The solution was again brought to reflux with constant stirring for a further 24 h. At
the end of the reaction, the MeOH was
removed

under

reduced

pressure,

leaving a solid residue, which was
suspended in anhydrous diethyl ether
and filtered using vacuum filtration to
afford the product as a brown solid.
Yield: 150 mg (38%). Microanalysis
calc: for C52H66N6NiO10·2H2O: C = 60.64; H = 6.85; N = 8.16; Ni = 5.70%. Found:
C = 60.69; H = 6.88; N = 8.33; Ni = 5.70%. ESI-MS calc: [C52H66N6NiO10 + 2 H]2+
= 497.9. Found: [C52H66N6NiO10 + 2H]2+ = 497.9. 1H NMR (400 MHz, CDCl3): δ
2.26 (m, 8H, H30, and H34); 2.54 (m, 12H, H19, H21 and H25); 2.75 (t, 4H, J = 5.53
Hz, H28); 3.54 (t, 8H, J = 4.55 Hz, H31, H33); 3.73 (t, 8H, J = 4.58 Hz, H22 and
H24); 3.88 (m, 4H, H18); 4.05 (t, 4H, J = 5.55 Hz, H27); 4.69 (s, 2H, H7); 5.56 (s,
2H, H12); 6.17 (s, 2H, H14); 7.21 (m, 4H, H1 and H5); 7.25 (m, 2H, H3); 7.36 (m,
4H, H2 and H4); 7.66 (s, 2H, H9). 13C NMR (101 MHz, CDCl3): δ 53.89 (C30, C34);
54.17 (C21, C25); 57.49 (C28); 57.58 (C19); 65.60 (C18), 66.40 (C27); 67.03 (C31,
C33); 67.09 (C22, C24); 77.95 (C7); 89.31 (C12); 96.90 (C14); 106.45 (C10); 128.44
(C1 and C5); 128.76 (C3); 129.78 (C2 and C4); 135.98 (C6); 156.59 (C9); 159.49
(C11); 164.09 (C13); 167.41 (C15).
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N,N′-Bis-(4,6-((1-(3-propyl)piperidine)]oxy)salicylidine)meso-diphenylethylenediaminenickel(II).(67)
A solution of compound (70) (88 mg, 0.22
mmol), and 1,2-meso-diphenylenediamine (31
mg, 0.015 mmol) in EtOH (5 mL) was heated
under reflux with constant stirring for 1h. At
this time the EtOH was replaced with MeOH
(5 mL) and Ni(OAc)2·4H2O (28.3 mg, 0.11
mmol) ) added to the reaction mixture. The
solution was again brought to reflux with
constant stirring for a further 48 h. At the end
of the reaction, the MeOH was removed under reduced pressure, leaving a solid
residue, which was then dissolved in DCM (15 mL), and washed with water seven
times. After the washing step, the DCM solution was dried with MgSO4. The solvent
was then removed under low pressure to afford the product as a red- orange solid.
Yield: 66.9 mg, 30 %. ESI-MS calc: [[C60H82N6NiO6]+ +2H]2+ = 521.3. Found:
[[C60H82N6NiO6]+ +2H]2+ = 521.4. 1H NMR (400 MHz, CDCl3): δ 1.40-1.44 (m, 8H,
H24 and H34); 1.50-1.55 (m, 8H, H23 and H25); 1.56-1.61 (m, 8H, H33 and H35);
1.68-1.75 (m, 4H, H19); 1.89-1.96 (m, 4H, H29); 2.15 (t, 4H, J = 7.81 Hz and 7.19
Hz, H20); 2.21 (m, 8H, H22, H26), 2.39 (m, 8H, H32, H36). 2.43 (t, 4H, J = 7.78 Hz
and 7.31 Hz, H30); 3.75-3.83 (m, 4H, H18); 3.93 (t, 4H, J = 6.38 Hz and 6.36 Hz,
H28); 4.69 (s, 2H, H7); 5.54 (d, 2H, J = 2.05 Hz, H12); 6.17 (d, 2H, J = 1.82 Hz,
H14); 7.17-7.23 (m, 6H, H2, H3 and H4); 7.38-7.40 (m, 4H, H1, H5); 7.66 (s, 2H,
H9).
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C NMR (101 MHz, CDCl3): δ 24.41 (C34); 24.47 (C24); 25.93 (C33, C35);
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26.01 (C23, C25); 26.50 (C19); 26.67 (C29); 54.49 (C32, C36), 54.63 (C20), 55.92
(C22, C26); 55.96 (C30); 66.46 (C28); 66.51 (C18); 77.81 (C7); 88.86 (C12); 96.58
(C14); 106.13 (C10); 128.36 (C1, C5); 128.15 (C3); 129.57 (C2, C4); 135.94 (C6);
156.27 (C9); 159.59 (C11); 164.32 (C13); 167.30 (C15).
The 1H NMR spectra of (67) is shown in Figure S3.12. Owing to the low yield and
difficulties of reproducing (67), there was not sufficient quantity of this complex to
run elemental analysis and DNA binding studies.

3.4 X-ray

crystallographic

characterisation

of

nickel

complexes
Single-crystal X-ray structure determinations were performed by Dr Christopher
Richardson of the School of Chemistry and Molecular Bioscience, University of
Wollongong, Australia. Crystals of (53) suitable for single crystal X-ray analysis
were obtained by slow diffusion of diethyl ether into a solution of the complex in
DCM. Crystals of (54) and (63) were obtained by slow evaporation from
DCM/petroleum spirit (1:3) solvent mixtures, and crystals of (65) were obtained by
slow evaporation from a DCM/pentane (1:3) solvent mixture. The solid-state
structures of these complexes are presented as ORTEPs, together with the numbering
systems for the non-hydrogen atoms, in Figure 3.24. Details of the collected
crystallographic data and structural refinements for the four complexes are
summarised in Table 3.3.
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Complex (53) crystallised in a triclinic crystal system with space group P-1, with one
molecule of the nickel Schiff base complex and one water molecule in the
asymmetric unit. One oxygen atom coordinated to the nickel atom is participating in
a hydrogen bond interaction with the oxygen atom of the lattice water molecule. The
structure of (63) also belongs to a triclinic crystal system with space group P-1, but
with one molecule of the nickel Schiff base complex and six water molecules in the
asymmetric unit. The asymmetric unit of (54) belongs to the monoclinic space group
C2/c and consists of one full metal complex and one water molecule. One oxygen
atom coordinated to the nickel atom was found to be participating in hydrogen
bonding with a hydrogen atom of the lattice water molecule.
The asymmetric unit of (65) belongs to the monoclinic space group P21/c, and
consists of one full metal complex and one water molecule.
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(53)

(54)

(63)

(65)

Figure 3.24: Molecular structures of (53), (54), (63) and (65)
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Table 3.3: Summary of crystallographic data.
Complex label

(53)

(54)

(63)

(65)

Formula
M

C48H66N6NiO6·H2O
899.79

C44H58N6NiO10·2H2O
925.70

C41H60N6NiO10·6H2O
966.15

(C56H74N6NiO6)4·H2O
990.42

Crystal system

Triclinic

monoclinic

triclinic

monoclinic

Space group

P-1

C2/c

P-1

P21/c

a (Å)

11.6711(8)

30.6127(5)

9.7651(2)

10.7829(3)

b (Å)

12.5315(9)

15.8401(3)

14.6637(3)

21.9025(5)

c (Å)

16.5737(11)

9.8494(2)

16.8916(3)

22.2389(5)

α (˚)

101.847(6)°

90

78.2060(10)

90

β (˚)

96.035(6)°

96.209(2)

83.1790(10)

99.678(3)

γ(˚)

97.628(6)°

90

89.109(2)

90

V (Å3)

2329.4(3)

30.6127(5)

2350.83(8)

5177.4(2)

Dcalc (g m-3)

1.283

1.295

1.365

1.271

Z

2
-16 ≤ h ≤ 16
-18 ≤ k ≤ 17
-23 ≤ l ≤ 23
13757
R1 = 0.0485
wR2 = 0.1131

4
-42 ≤ h ≤ 42
-22 ≤ k ≤ 21
-13 ≤ l ≤ 13
6653
R1 = 0.0348
wR2 = 0.0989

2
-13 ≤ h ≤ 13
-20 ≤ k ≤ 20
-23 ≤ l ≤ 23
12431
R1 = 0.0631
wR2 = 0.1432

4
-12 ≤ h ≤ 14
-28 ≤ k ≤ 29
-28 ≤ l ≤ 29
12745
R1 = 0.0631
wR2 = 0.1432

R1 = 0.0802
wR2 = 0.1232

R1 = 0.0432
wR2 = 0.1028

R1 = 0.1025
wR2 = 0.1609

R1 = 0.1025
wR2 = 0.1609

(h,k,l)
Number of unique reflections
Final R indexes
[I>=2σ (I)]
Refinement
Final R indexes
[all data]
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It was observed that the nickel atom in all four crystal structures adopts a square
planar coordination geometry. All bond lengths and angles involving the central
nickel ion (Table 3.4) are consistent with standard values.125,135 The arrangement of
the phenylenediamine moieties in (53) and (54) results in torsion angles N2-C3-C3′N1 of 2.6(2)˚ and 0.24(2)˚, respectively. In contrast, the arrangement of the meso1,2-diphenylethylenediamine moiety in (65) produces a torsion angle of -40.8(3)˚
This results in one phenyl ring being in an equatorial position, whilst the other is
found in an axial position (Figure 3.25).
Table 3.4: Selected bond lengths (Å) and angles (˚) for nickel Schiff base complexes.
Bonds

(53)

(54)

(63)

(65)

Ni-O1

1.8372(12)

1.8585(17)

1.8406(10)

Ni-O2

1.8411(13)

1.8602(17)

1.8407(10)

Ni-N1

1.8468(15)

1.859(2)

1.8514(11)

Ni-N2

1.8547(14)

1.852(2)

1.8514(11)

1.8581(10)
1.8674(17)
1.8561(11)
1.8717(19)
1.8418(13)
1.855(2)
1.8398(13)

O1-Ni-O2

84.12(5)

84.97(7)

83.31(6)

85.28(4)
1.855(2)

O2-Ni-N2

94.73(6)

93.96(8)

94.99(5)

O1-Ni-N2

175.52(6)

176.56(9)

178.22(4)

O2-Ni-N1

176.77(6)

177.41(9)

178.22(5)

94.78(5)
86.49(8)
179.64(7)
94.17(9)
179.03(7)

O1-Ni-N1

95.02(6)

94.88(8)

94.99(5)

175.35(9)
94.70(5)

N1-Ni-N2

86.37(6)

86.34(9)

86.72(7)

85.24(6)
175.42(9)
94.55(9)
85.16(10)

117

Figure 3.25: Solid state structure of (65) highlighting the arrangement of the meso1,2-diphenylethylenediamine group in in the crystal lattice. Some hydrogen atoms
and the top ethylpiperidine moieties have been omitted for clarity.
In the crystal lattice of (53), the two nickel Schiff base molecules possess a
crystallographic inversion centre and are arranged in a slipped co-facial manner
(Figure 3.26). The shortest intermolecular distance between the two molecules is
3.168 Å between oxygen atom O1 (coordinated to the nickel atom) and the imine
carbon atom C4.
In the solid-state structure of (54), the molecules of the complex are again arranged
in a slipped co-facial manner (Figure 3.27). There are contacts between C3, which is
bonded to N1 of one molecule and C10 which is bonded to O1 of the second
molecule. The closest contact (2.335 Å) between the two molecules was found
between H6B and H22A of the morpholine moieties.
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Figure 3.26: Perspective view of the stacking of pairs of complexes in the lattice of
(53).
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.
Figure 3.27: Crystal packing of two molecules of (54).
Just like the previous two complexes, the two nickel Schiff base molecules in the
structure of complex (65) are arranged in a slipped co-facial manner. Here the closest
separation of 3.287 Å is between the Ni atoms (Figure 3.28).
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Figure 3.28: Arrangement of nickel molecules in the crystal lattice of (65).
The solid state structure of (63) possesses a crystallographic inversion centre with the
nickel complexes sitting directly on top of one another (Figure 3.29) with a Ni-Ni
distance of 3.436 Å. The 1,2-propanediamine moiety is not coplanar with the six
membered chelate rings coordinated to the nickel ion. This arrangement results in a
torsion angle N1-C2-C17-N2 of -54.7(4)°. A hydrogen bond was observed between
the water hydrogen atom H1WB and the nitrogen atom N3 of the morpholine moiety
of one of the complexes.
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Figure 3.29: Arrangement of nickel molecules in the crystal lattice of (63).

122

Chapter 4

Effect of varying the diamine

moiety on DNA binding properties of nickel
Schiff base complexes containing four pendant
groups
4.1 Introduction and scope
Previous studies have reported that the affinity of organic compounds and metal
complexes for G-quadruplex DNA is enhanced by the presence of pendant groups,
including those with positive charges which can participate in electrostatic
interactions with the phosphate residues of the DNA backbone. For example, the
nickel salphen complex (18) (Section 1.4.3), which has two pendant ethylpiperidine
groups, was found to induce a high degree of stabilisation of telomeric G-quadruplex
DNA, and inhibit telomerase activity.124 In addition, the nickel salphen complex (44)
(Section 1.4.3) which contains three dimethylimidazole pendant groups exhibited a
high degree of binding affinity towards a G-quadruplex, and telomerase inhibition
(IC50 = 70 nM) in a TRAP-G4 assay.134 More recently, (49) (Section 1.4.3), which
features four pendant groups showed notable binding affinity and selectivity towards
G-quadruplexes.137 Furthermore, the tetra-substituted Mn(III) porphyrin complex
(54) (Section 1.4.2) was found to stabilise the human telomeric quadruplex and to
exhibit a 10000-fold degree of binding selectivity in favour of G-quadruplex DNA
over

dsDNA

in

SPR

experiments.119
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In

addition,

the

tetra-substituted

naphthalenediimide derivative MM41 (5) (Section 1.4.1) has been characterised as a
potent stabiliser of various G-quadruplex sequences and found to have significant
anti-tumour activity against pancreatic cancer cells.111
Changing the size and position of aromatic moieties present in nickel Schiff base
complexes has also been shown to have a significant effect on their binding
interactions with both G-quadruplex and dsDNA.135,136 For example, the nickel
Schiff base complex (45) (Section 1.4.3) which contains three coplanar aromatic
groups in the top portion of the ligand structure, showed limited ability to bind to Gquadruplex DNA.136 This was perhaps due to the ability of the large aromatic ring
system to hinder interactions with the loops of G-quadruplex DNA structures. In
contrast, the large aromatic ring system facilitated participation in intercalative
interactions with dsDNA resulting in high binding affinity towards the latter. In
contrast, nickel Schiff base complex (46) (Section 1.4.3) which contains the nonplanar meso-1,2- diphenylethylenediamine moiety showed much lower affinity
towards the same dsDNA molecule but still showed the ability to significantly
interact with a tetramolecular G-quadruplex.135
Taking the above results into account, it was decided to systematically explore the
effect of altering the structure of the diamine moiety in the “top” of the well-studied
nickel Schiff base complex (18) as well as increasing the number of ethylpiperidine
groups, on affinity towards dsDNA and multiple G-quadruplex topologies. To
accomplish this, five new nickel Schiff base complexes (Figure 4.1) were
synthesised. Each features four ethylpiperidine pendant groups. These were expected
to increase both the affinity and selectivity of the complexes toward G-quadruplex
DNA as a result of electrostatic interactions with the grooves and loops of the latter
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structures, and also improve the aqueous solubility of the metal complexes
themselves. Interactions between the metal complexes and different topologies of Gquadruplex DNA were investigated by ESI-MS, CD and UV-Vis spectroscopy, a FID
assay, FRET melting assay and molecular docking. The combination of more than
one technique is required for a detailed understanding of DNA-metal complex
interactions. Results obtained using these different techniques are presented and
discussed in this chapter.

Figure 4.1: Structures of nickel Schiff base complexes containing different diamine
moieties used in DNA binding studies. Each contains four ethylpiperidine pendant
groups.
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4.2 Results and discussion
4.2.1 DNA binding studies performed using ESI mass spectrometry
ESI-MS is a useful screening technique when investigating the interactions between
small molecules and DNA.180-182 During the electrospray process, free DNA
molecules and ligand/DNA non-covalent complexes are transferred from solution to
the gas phase inside the mass spectrometer with minimal fragmentation, thus
preserving the weak interactions present within the latter complexes.180
ESI-MS was first used to investigate and compare the binding affinity of the nickel
Schiff base complexes shown in Figure 4.1 towards the dsDNA D2, parallel
tetramolecular G-quadruplex Q4 and parallel unimolecular G-quadruplex Q1.
Initially, a series of negative ion ESI mass spectra were obtained of solutions
containing free D2 alone, or a 6:1 ratio of one of the nickel complexes and D2. These
spectra are shown in Figure 4.2. Each spectrum shows ions at m/z 1626.5 and 1952.0,
which are attributed to [D2 - 6H]6- and [D2 - 5H]5-, respectively. The abundances of
these ions vary from one spectrum to another, suggesting that the nickel complexes
bind to different extents to the DNA. For example, ions at m/z 1626.5 from D2 are of
lowest abundance in Figure 4.2 (b), which is a spectrum of a solution containing a
6:1 ratio of (53), which contains the phenylenediamine moiety, and D2. This
suggests that (53) has the highest affinity towards D2 among the five studied
complexes. Evidence in support of this is provided by the observation that the
abundances of ions from non-covalent complexes containing one or more nickel
complexes bound to D2 appeared to be equal to or slightly greater in the case of the
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spectrum shown in Figure 4.2 (b), than for any of the other spectrum. Therefore it
appears that (53), exhibited the highest affinity of the five nickel complexes for D2.

Figure 4.2: Negative ion ESI mass spectra of solutions containing a 6:1 ratio of
different nickel Schiff base complexes and D2: (a) Free D2; (b) D2 + (53); (c) D2 +
(56); (d) D2 + (59); (e) D2 + (62) and (f) D2 + (65). = free D2;  = [D2 + (Ni)];
 = [D2 + 2(Ni)];  = [D2 + 3(Ni)];  = [D2 + 4(Ni)].
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Inspection of Figure 4.2 also revealed that the relative abundances of ions from noncovalent complexes containing different numbers of nickel molecules bound to DNA
is similar in the case of spectra obtained using (53) and (56). This provided evidence
these complexes have similar abilities to form non-covalent complexes with D2 and
suggests that changing the diamine moiety of the complex from phenylenediamine to
ethylenediamine had little effect on affinity towards dsDNA.
Figure 4.2 (f) provides evidence that ions of high abundance were formed which
contained one or two molecules of (62) bound to DNA. In contrast to what can be
seen in either Figure 4.2 (b) or (c), however, the combined abundances of ions from
free DNA were much greater. This suggests that (62) has a lower binding affinity
towards D2 than either (53) or (56). Further analysis of Figure 4.2 indicates that the
complex with the next highest affinity towards D2 was (65), whilst (59) showed the
lowest ability to interact with the dsDNA. The latter conclusion is supported by the
observation of ions of high abundance from free D2, together with ions of only low
to medium abundance from non-covalent complexes in Figure 4.2 (d). These results
suggest that changing the head-group of the complex from phenylenediamine, to
either meso-1,2-diphenylethylenediamine or 1,3-diaminopropane significantly
reduced binding to the dsDNA. Overall, the results presented in Figure 4.2 suggests
that changing the diamine moiety present in a nickel Schiff base complex can have a
significant effect on their ability to bind to and form stable non-covalent complexes
with D2.
Additional DNA binding experiments were conducted by ESI-MS with each of the
five nickel complexes and two parallel G-quadruplex DNA molecules (parallel
tetramolecular Q4 and parallel unimolecular Q1). The relative abundances of ions
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from free DNA and different types of non-covalent complexes observed in these
experiments were calculated by adding the individual abundances of all ions from
either free DNA or a specific non-covalent complex in a given spectrum, and
dividing the result by the sum of the abundances of all ions present in that spectrum.
The resulting values were then converted to percentages and are shown graphically
Figure 4.3.
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Figure 4.3: Relative abundances of ions in ESI mass spectra of solutions containing a
6:1 ratio of nickel Schiff base complexes and dsDNA (D2), unimolecular Gquadruplex (Q1) or tetramolecular G-quadruplex (Q4): (a) solutions containing (53);
(b) solutions containing (56); (c) solutions containing (59); (d) solutions containing
(62) and (e) solutions containing (65).
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Presenting the results of mass spectrometry experiments in this fashion facilitates
observation of trends in binding affinities amongst complexes for a specific DNA
molecule. For example, inspection of Figure 4.3 (e) suggests (65) exhibited greater
affinity towards both types of G-quadruplexes than D2. This is supported by the
observation of ions of high abundance from non-covalent complexes containing one
or two bound nickel molecules only in the case of the two G-quadruplexes. In
contrast, ions of only low abundance corresponding to [D2 + 2 (65)] were observed
in the spectrum of the solution containing the dsDNA. Complex (65) also appeared
to be the only nickel molecule which showed at least comparable affinity towards the
unimolecular Q1 and tetramolecular Q4.
Although the structure of (59) differs from that of (56) in only having an additional
methylene group as part of the diamine moiety, comparison of Figure 4.3 (b) and (c)
suggests this alteration resulted in the former molecule exhibiting significantly lower
affinities towards each of the three DNA molecules. For example, Figure 4.3 (b)
shows that the most abundant ions observed in the spectrum of the solution
containing (56) and Q4 were from non-covalent complexes containing two bound
nickel molecules. In contrast, Figure 4.3 (c) shows when (59) was present the most
abundant ions present in the spectrum of a solution containing the same DNA
molecule contained only a single bound nickel molecule. Inspection of Figure 4.3
also suggests that the affinity of the nickel molecules was generally greater towards
Q4 than Q1, and that only rarely were non-covalent molecules containing more than
two bound nickel molecules formed. This is consistent with binding interactions
occurring primarily at the ends of the G-quadruplexes. Overall, the results presented
in Figure 4.3 suggest that changing the diamine moiety in this class of nickel
130

complexes can have a significant effect on their affinity and selectivity towards the
three types of DNA molecules studied.

4.2.2 DNA binding studies performed using CD spectroscopy
Circular Dichroism (CD) binding studies were undertaken as described in Chapter 2
to gain further insight into the affinities of the nickel complexes towards the different
types of DNA molecules as well as the influence of unimolecular G-quadruplex
topology on intermolecular interactions. CD spectroscopy is routinely used to study
conformational changes of DNA upon ligand binding, as it is very sensitive to
changes in the chirality of nucleic acids,183,184 with different DNA structures
displaying unique CD spectral signatures.185-187 Furthermore the topology of a
unimolecular G-quadruplex is very sensitive to the condition used during the
annealing process. Figure 4.4 illustrates the effect of structural variations, including
differences in topology, on the CD spectra of nucleic acid molecules. For example,
the spectrum of the dsDNA molecule D2 in Figure 4.4 (a) shows positive and
negative CD bands with large ellipticities centred at 282 nm and 249 nm,
respectively. These are consistent with what has been reported previously for B-form
dsDNA.185
Figure 4.4 (b) shows the CD spectra of parallel Q4, Q1 and c-KIT1 were essentially
identical to each other, and significantly different from that of D2. In each case two
positive CD bands with large ellipticities were observed at 210 and 263 nm, whilst a
much weaker negative CD band was present at 241 nm. These spectral features are
also similar to those observed previously in CD spectra of the same and other parallel
G-quadruplexes.135-137,184,185,188,189
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Figure 4.4: CD spectra of different DNA structures. (a) Circular dichroism spectra of
D2. B-form D2 was obtained in 150 mM NH4OAc, pH 7.4. (b) Comparison of the
CD spectra of different parallel G-quadruplex DNA molecules (unimolecular Q1,
tetramolecular Q4 and unimolecular c-KIT1). The parallel conformations of these
molecules were obtained in 150 mM NH4OAc, pH 7.4. (c) Comparison of the CD
spectra of different topologies of the unimolecular G-quadruplex Q1. The antiparallel conformation was obtained in solutions containing 100 mM NaCl, 15 mM
NaH2PO4, 15 mM Na2HPO4, pH 7.4 while the hybrid conformation was obtained in
solutions containing 100 mM KCl, 15 mM KH2PO4, 15 mM K2HPO4, pH 7.4.
Significant variations were observed between the CD spectra of the different
topologies of the unimolecular G quadruplex Q1 (Figure 4.4 (c)). For example, the
CD spectrum of anti-parallel Q1 showed two positive CD bands at 245 and 296 nm
and a negative CD band at 265 nm. In contrast, the CD spectrum of hybrid Q1
showed a strong positive band at 291 nm with two shoulders at ~ 269 and ~ 255 nm
and a negative peak at 233 nm. Similar features were reported previously for CD
spectra of the same and other anti-parallel and hybrid unimolecular Gquadruplexes.137,164,189,190 In addition to variations in DNA class and topology, the
CD spectrum of a nucleic acid may be affected by the binding of small molecules. In
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some cases, the same general spectral features have been observed although the
energy and ellipticity of the CD bands may alter depending on the extent and nature
of binding interactions. On other occasions, the CD spectrum may change from that
corresponding from one type of topology to another, providing another potential
source of information about the nature of the intermolecular interactions occurring.
In the following sub-sections, the results of CD spectroscopic investigations
performed with the nickel complexes and a variety of DNA molecules is presented
and analysed. It was of particular interest to see if some of the trends in binding
affinity that were suggested by the results of the ESI-MS studies presented earlier in
this chapter were also evident in the data obtained using this additional method.
4.2.2.1 CD titrations using double stranded DNA D2
The CD spectra presented in Figure 4.5 show the effect of addition of increasing
amounts of the five nickel complexes on the CD spectrum of D2. Changes to the
positions and ellipticity of the CD bands were observed that varied significantly with
the identity of the nickel complex. These changes are summarised in Table 4.1.
Inspection of Figure 4.5 (a) shows addition of (53) to D2 caused large decreases in
ellipticity for both the positive and negative CD signals of ~ 50%. Whilst there was
also a significant shift to higher energy for the negative CD signal, the positive band
remained centred close to its initial position. Overall these observations suggest that
there was a significant degree of interaction between (53) and D2, which is in
agreement with the pronounced ability of (53) to form non-covalent adducts with D2
in ESI-MS experiments noted earlier.
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Figure 4.5: Circular dichroism spectra (200-400 nm) of solutions containing different
ratios of nickel Schiff base complexes and D2: (a) D2 + (53); (b) D2 + (56); (c) D2 +
(59); (d) D2 + (62) and (e) D2 + (65).
Addition of (53) did not result in any change to the general appearance of the CD
spectrum of D2, including the number of spectral features. In contrast, addition of the
other nickel complexes resulted in the emergence of a shoulder or distinct peak near
265 nm, which is where a CD band would be expected if the dsDNA was now
present in the A-form. A similar effect was reported previously when the complex
[(Chro)2-Fe(II)] was added to hairpin DNA duplexes containing a GGCC
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sequence.191 This suggests that addition of some of the nickel complexes may be
causing distortions to the structure of D2 resulting in it having characteristics of both
A- and B-forms.
Table 4.1: Effect of addition of nickel Schiff base complexes on the CD spectrum
of D2.*
Nickel complex
(53)
(56)
(59)
(62)
(65)

Positive CD band at 282 nm Negative CD band at 249 nm
Δλmax (nm)
Δɛ (%)
Δλmax (nm)
Δɛ (%)
1.7
-48.5
-11.6
-59.7
3.3
-2.5
3.7
0.0
5.9
59.7
0.8
-12.0
5.5
44.2
1.8
0.3
3
-1.00
-1.3
-28.5

* All Δλmax and Δε(%) values are the difference between the values for free DNA and
those for a solution containing a nickel:DNA ratio of 9:1. Negative Δλmax values indicate
a blue shift; positive values indicate a red shift.

Despite observation of a number of similar changes to the CD spectrum of D2 when
(56), (59), (62) or (65) were added, there were also several notable differences
involving the major CD bands. Addition of (56), for example, did not cause
significant changes to the ellipticity of either major CD band. This result was
somewhat surprising as (56) showed a notable ability to form non-covalent adducts
with D2 in ESI-MS experiments. In contrast, addition of either (59) or (62) resulted
in large changes in ellipticity for the positive CD band accompanied by the largest
shifts in position of this band, but only relatively small changes to the ellipticity and
position of the negative CD band. The large changes to the CD spectrum caused by
addition of (59) was surprising in view of the limited ability it exhibited to form noncovalent adducts with D2 in ESI-MS experiments. Addition of (65) resulted in yet
another distinct pattern of changes to the CD spectrum of D2 including the second
largest decrease in ellipticity for the negative CD band and an almost negligible
influence on the positive CD band. Overall the above changes demonstrate how
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sensitive CD spectra are to changes in DNA conformation caused by nickel
complexes that in some instances differ only slightly in their structures.
4.2.2.2 CD titrations using parallel tetramolecular Q4
The CD spectra illustrated in Figure 4.6 show the effect of adding increasing
amounts of each of the five nickel complexes on the CD spectrum of Q4, while
Table 4.2 summarises the changes to the position and ellipticity of the major CD
bands.
Inspection of Figure 4.6 shows that none of the nickel complexes caused major
changes to the fundamental structure of the CD spectrum of Q4, such as the
appearance of new CD bands or shoulders on the side of existing bands. In addition,
Table 4.2 shows that addition of the nickel complexes had no significant effect on the
position of the major positive and negative CD bands. In contrast, addition of
increasing amounts of the nickel complexes resulted in decreases in ellipticity of the
positive CD band that varied dramatically. For example, addition of (65) to Q4
caused the largest changes to the ellipticity of both the positive and negative CD
bands (66 and 71%, respectively). This suggests (65) interacts strongly with Q4
which is supported by the results obtained from ESI-MS experiments involving this
complex.
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Figure 4.6: Circular dichroism spectra (200-400 nm) of solutions containing different
ratios of nickel Schiff base complexes and parallel Q4: (a) Q4 + (53); (b) Q4 + (56);
(c) Q4 + (59); (d) Q4 + (62) and (e) Q4 + (65).
Addition of (56) or (62) on the other hand failed to induce significant changes to the
CD spectrum of Q4. This result suggests these nickel complexes do not interact
strongly with Q4, which is in contrast to what was concluded from ESI-MS
experiments, which revealed ions of significant abundance from non-covalent
complexes consisting of two molecules of these nickel complexes bound to the DNA.
Variations between binding affinity series derived using CD spectroscopy and other
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methods have been noted previously and attributed to differing sensitivities to
alternative aspects of the metal complex/DNA interaction. It may be, for example,
that (56) and (62) are both capable of forming thermally stable non-covalent
complexes with Q4, but the mechanism of interaction is different from that used by
(65) and does not result in significant change to the conformation of the nucleic acid.
Table 4.2: Effect of addition of nickel Schiff base complexes on the CD spectrum
of parallel Q4.*
Nickel complex
(53)
(56)
(59)
(62)
(65)

Positive CD band at 263 nm Negative CD band at 242 nm
Δλmax (nm)
Δɛ (%)
Δλmax (nm)
Δɛ (%)
0.1
-33.4
0.2
-22.1
0.6
2.2
-1
12.3
0
-23.2
0
0.8
-0.1
5.2
-0.4
-5.1
-0.9
-65.7
-2.7
-70.8

* All Δλmax and Δε(%) values are the difference between the values for free DNA and
those for a solution containing a nickel:DNA ratio of 9:1. Negative Δλmax values indicate
a blue shift; positive values indicate a red shift.

4.2.2.3 CD titrations using parallel unimolecular Q1
The potential of nickel Schiff base complexes as therapeutic agents will depend on
their cytotoxicity and ability to interact selectively with different G-quadruplex
structures. Circular dichroism spectroscopy is perhaps the most convenient technique
for exploring the latter property, as the technique can be applied to nucleic acid
solutions containing a variety of buffers, designed to confer different specific Gquadruplex topologies. In contrast, ESI-MS can only be applied to studying
interactions with the parallel conformation of G-quadruplexes as the buffers required
to stabilise the nucleic acid in other topologies result in numerous adducts with
univalent cations that result in poor quality spectra.
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A series of CD experiments were therefore performed in which the nickel complexes
were added to three different conformations of the unimolecular G-quadruplex Q1,
as well as the parallel form of a second G-quadruplex, c-KIT1. The results obtained
from the experiments performed using parallel Q1 are presented in Figure 4.7 and
Table 4.3.
Inspection of Figure 4.7 shows that all nickel complexes caused significant changes
to the CD spectrum of Q1, suggesting each interacts with the nucleic acid. This
conclusion is in general agreement with the results obtained from ESI-MS
experiments which showed each nickel complex was able to form non-covalent
adducts with Q1. It should be noted, however, that while the abundance of ions from
non-covalent complexes formed between the nickel complexes and parallel Q1 was
not generally as great as what was seen with the other two DNA molecules, there
were in a number of cases very large changes to the ellipticity of the CD bands in a
the spectra shown in Figure 4.7. For example, addition of three of the nickel
complexes resulted in decreases in the ellipticity of the large positive CD band at 263
nm of > 50%, while all similarly affected the ellipticity of the much smaller negative
CD band at 241 nm. In the case of (53) the CD spectrum had almost entirely
disappeared at the highest Ni:DNA ratio examined.
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Figure 4.7: Circular dichroism spectra (200-400 nm) of solutions containing different
ratios of nickel Schiff base complexes and parallel Q1: (a) Q1 + (53); (b) Q1 + (56);
(c) Q1 + (59); (d) Q1 + (62) and (e) Q1 + (65).
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Table 4.3: Effect of addition of nickel Schiff base complexes on the CD
spectrum of parallel unimolecular Q1.*
Nickel
complex
(53)
(56)
(59)
(62)
(65)

Positive CD band at 263 nm
Δλmax (nm)
Δɛ (%)
-0.5
-90.9
-0.6
-57.4
1.2
-45.6
3
-38.5
4.9
-73.9

Negative CD band at 241 nm
Δλmax (nm)
Δɛ (%)
3.2
-100.0
0.2
-59.5
-0.2
-53.3
2.9
-56.1
1.7
-74.5

* All Δλmax and Δε(%) values are the difference between the values for free DNA and
those for a solution containing a nickel:DNA ratio of 9:1. Negative Δλ max values
indicate a blue shift; positive values indicate a red shift.

4.2.2.4 CD titrations using anti-parallel unimolecular Q1
CD spectra obtained after adding increasing amounts of the nickel complexes to antiparallel Q1 are shown in Figure 4.8 while Table 4.4 compiles the changes to both the
position and maximum ellipticity of the CD bands observed in these experiments.
Inspection of Table 4.4 shows (56) had perhaps the greatest effect on the CD
spectrum of anti-parallel Q1, with changes in maximum ellipticity for the CD bands
at 265 and 296 nm of -42% and -33%, respectively. This complex also caused
significant changes to the CD spectrum of parallel Q1, suggesting it does not
discriminate between these two unimolecular G-quadruplex topologies
Figure 4.8 shows that (53), (65), (59) and (62) all produced changes to one or more
of the bands present in the CD spectrum of anti-parallel Q1, however these were
generally not as great as what was observed during the corresponding studies
performed with the parallel topology of this G-quadruplex. This suggests many of
these complexes exhibit binding selectivity with a preference for parallel
unimolecular Q1 over the anti-parallel conformation.
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Figure 4.8: Circular dichroism spectra (200-400 nm) of solutions containing different
ratios of nickel Schiff base complexes and anti-parallel Q1: (a) Q1 + (53); (b) Q1 +
(56); (c) Q1 + (59); (d) Q1 + (62) and (e) Q1 + (65).
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Table 4.4: Effect of addition of nickel Schiff base complexes on the CD spectrum
of anti-parallel unimolecular Q1.*
Nickel complex Positive CD band at 296 nm Negative CD band at 265 nm
Δλmax (nm)
Δɛ (%)
Δλmax (nm)
Δɛ (%)
(53)
-0.8
-16.6
-1.9
-21.9
(56)
-0.4
-42.1
-1.6
-33.4
(59)
-0.7
-11.7
-2
18.4
(62)
1.1
-3.2
-2.7
-7.2
(65)
-1.8
-19.6
-5.1
-26.3
* All Δλmax and Δε(%) values are the difference between the values for free DNA and
those for a solution containing a nickel:DNA ratio of 9:1. Negative Δλmax values indicate
a blue shift; positive values indicate a red shift.

4.2.2.5 CD titrations using hybrid unimolecular Q1
The final unimolecular Q1 topology investigated was the hybrid conformation. Its
CD spectrum showed a strong positive peak at 291 nm with two shoulders at ~ 269
and ~ 255 nm. In addition, a negative CD band was also present at 233 nm.
Complexes (53) and (65) once again appeared to interact to the greatest extent with
this G-quadruplex topology. Upon addition of (53) or (65) to hybrid Q1, dramatic
changed to the CD spectrum were observed. These included the maximum ellipticity
of the CD bands at 291 and 233 nm decreasing by 40 % and > 90%, respectively
(Table 4.5). In addition, the shoulder at 255 nm disappeared, while a negative CD
band and a minor CD positive band appeared at 260 nm and 245 nm, respectively,
which are characteristic of an anti-parallel G-quadruplex conformation, (Figure 4.9
(a) and (e)). The same effect has been reported previously after the addition of (44)
to hybrid Q1.137 This suggests a population of anti-parallel folded Q1 molecules was
now present after the addition of these complexes to hybrid Q1. These observations
support the conclusion that both (53) and (65) exhibited the greatest affinity of all the
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nickel complexes examined towards hybrid Q1 and they may cause changes to the
conformation of the DNA.

Figure 4.9: Circular dichroism spectra (200-400 nm) of solutions containing different
ratios of nickel Schiff base complexes and hybrid Q1: (a) Q1 + (53); (b) Q1 + (56);
(c) Q1 + (59); (d) Q1 + (62) and (e) Q1 + (65).
Inspection of Figure 4.9 (b) shows that in the absence of (56), the peak at 290 nm,
which arises from the anti-parallel component of the hybrid topology dominates the
CD spectrum. In the presence of increasing amounts of the nickel complex, a gradual
increase in the parallel contribution to this topology resulted in the appearance of a
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shoulder at 269 nm. The maximum ellipticity of this shoulder increased by 27% and
it also shifted to higher energies by 3.5 nm as the amount of nickel complex in
solution increased. At the same time the second shoulder at 255 nm completely
disappeared. This suggests the proportion of parallel component in the hybrid
topology of Q1 increased after addition of (56).
Of the novel nickel Schiff base complexes, (59) and (62), had the smallest impact on
the CD spectrum of hybrid Q1, suggesting they display the lowest binding affinities.
Both nickel complexes exhibited a negligible ability to affect the CD spectrum of
anti-parallel Q1, and only had a small effect on the spectrum of parallel Q4. While
these complexes had a notable influence on the spectrum of parallel Q1, the changes
to the ellipticity of the CD bands they elicited were significantly less than those
caused by some of the other nickel complexes. Overall these two complexes
therefore do not appear to display any ability to interact selectively with any of the
different topologies of G-quadruplex DNA or other DNA molecules.
Table 4.5: Effect of addition of nickel Schiff base complexes on the CD spectrum
of hybrid unimolecular Q1.*
Nickel complex
(53)
(56)
(59)
(62)
(65)

Positive CD band at 296 nm Negative CD band at 265 nm
Δλmax (nm)
Δɛ (%)
Δλmax (nm)
Δɛ (%)
1.2
-40.1
4.2
-114.6
-1.9
-13.6
2
70.9
-0.5
15.2
-1.7
-24.6
0.7
-9.3
-2.4
0.0
1.3
-40.1
-3.9
-98.6

* All Δλmax and Δε(%) values are the difference between the values for free DNA and
those for a solution containing a nickel:DNA ratio of 9:1. Negative Δλmax values indicate
a blue shift; positive values indicate a red shift.
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4.2.2.6 CD titrations using parallel unimolecular c-KIT1
In order to see if the changes to the CD spectrum of parallel Q1 that were observed
upon binding of nickel complexes are typical for this type of G-quadruplex, a second
set of experiments were performed using the parallel form of the G-quadruplex cKIT1. The latter is a G-quadruplex-forming sequence containing four guanine tracts
found in the promoter region of the c-KIT oncogene.32,33,192 Over-expression and/or
mutations of the c-KIT gene have been implicated in a wide range of human cancers
including gastrointestinal stromal tumours (GISTs), small cell lung cancer, leukemia,
colorectal cancer and pancreatic cancer.193-196 It was found that stabilising the Gquadruplex structure of c-KIT1 with small molecules can downregulate the gene
expression, and thus suppress cancer cell proliferation.197,198 This suggests that
selective stabilisation of G-quadruplex structures of c-KIT1 may provide a method of
treating certain cancers.199,200 A number of small molecules capable of inducing and
stabilising G-quadruplex formation on c-KIT1 DNA have been reported.201-207
The CD spectrum of c-KIT1 was found to exhibit a negative peak with low ellipticity
at 240 nm and a positive peak with large ellipticity at 262 nm. These features are very
similar to those found for parallel Q1 and consistent with what has been reported for
G-quadruplexes with a parallel topology.185 The results obtained from CD studies
involving the nickel complexes and parallel c-KIT1 are presented in Table 4.6 and.
Figure 4.10.

146

Figure 4.10: Circular dichroism spectra (200-400 nm) of solutions containing parallel
unimolecular c-KIT1and different ratios of nickel Schiff base complexes: (a) c-KIT1
+ (53); (b) c-KIT1 + (56); (c) c-KIT1 + (59); (d) c-KIT1 + (62) and (e) c-KIT1 +
(65).
Inspection of the spectra shows changes similar to what was observed with parallel
Q1, with all five complexes having a significant influence on the CD spectrum of
parallel c-KIT1. While (59) was found to cause the largest reduction in ellipticity of
the positive CD band of the DNA molecule, the changes to this signal caused by all
five complexes were overall very similar in magnitude (Table 4.6).
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Table 4.6: Effect of addition of nickel Schiff base complexes on the CD spectrum
of c-KIT1.*
Nickel complex
(53)
(56)
(59)
(62)
(65)

Positive CD band at 296 nm Negative CD band at 265 nm
Δλmax (nm)
Δɛ (%)
Δλmax (nm)
Δɛ (%)
2.8
-59.07
1.5
-54.67
6.5
-58.66
1.3
-45.34
2.4
-63.03
0.3
-60.56
2.9
-56.54
0.9
-44.41
4.6
-56.41
1.7
-60.96

* All Δλmax and Δε(%) values are the difference between the values for free DNA and
those for a solution containing a nickel:DNA ratio of 9:1. Negative Δλmax values indicate
a blue shift; positive values indicate a red shift.

4.2.3 DNA

binding

studies

performed

using

UV-Vis

spectrophotometry
UV-Vis absorption spectrophotometry is a very common technique for detecting
whether a small molecule stabilises or destabilises dsDNA. This can be
accomplished, for example, by running DNA melting experiments in which the
melting temperature of free DNA is compared to that of DNA bound to a drug
molecule. A series of these experiments were undertaken as described in Chapter 2 to
gain insight into the ability of the nickel complexes to stabilise the ds DNA molecule
D2.
Melting temperature experiments were performed using solutions containing a 3:1 or
6:1 ratio of one of the nickel complexes and D2. Representative DNA melting
profiles for solutions containing D2 alone, and D2 and (53), are shown in
Figure 4.11. Figure 4.12 illustrates the average effect of adding either 3 or 6
equivalents of different nickel complexes on the Tm of D2.
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Figure 4.11: Melting curves for solutions containing 1 μM dsDNA D2 alone, and a
6:1 ratio of (53) and 1 μM D2.
The melting temperature, Tm, of D2 alone was determined to be 60.4±0.3 °C.
Figure 4.12 shows that the Tm of D2 decreased by 1.6 – 2.5 °C in the presence of
(59), (62) or (65). This result is similar to that reported for the tetra-alkylated Schiff
base complex (49),137 and is in accord with the low abundances of ions from noncovalent complexes in ESI mass spectra of solutions containing either (59) or (65)
and D2. The results obtained from the UV-Vis melting studies therefore provide
further evidence that (59) and (65) have low affinities towards dsDNA. In contrast,
ESI-MS showed that (62) was capable of forming non-covalent complexes with D2,
although not to the same extent as either (53) or (56). This result therefore does not
appear at first glance to be consistent with those obtained from the UV-Vis melting
studies, and may reflect the binding interactions of (62) with the nucleic acid leading
to destabilisation of the secondary structure of the latter molecule.
In contrast to what was observed with the other nickel complexes, both (53) and (56)
caused small increases in the Tm of D2 when added to the nucleic acid. This is
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consistent with the results obtained from ESI-MS experiments, which showed more
extensive formation of non-covalent complexes with these two nickel complexes
than the others. For example, the most abundant ions in ESI mass spectra of solutions
containing either (53) or (56) and D2 consisted of two nickel molecules bound to the
nucleic acid. For each of the other nickel complexes the most abundant ions observed
in the ESI mass spectrum of a solution containing a 6:1 ratio of Ni:DNA were either
attributable to free DNA or a non-covalent complex consisting of just one nickel
molecule bound to the nucleic acid.
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Figure 4.12: Mean melting temperatures (Tm) of solutions containing either a 3:1 or
6:1 ratio of a nickel complex and D2. The experiments were performed in triplicate
with error bars showing standard errors.

4.2.4 DNA binding studies performed using FRET melting assays
Fluorescence Resonance Energy Transfer (FRET) is another popular method for
studying G-quadruplex-ligand interactions. FRET occurs when an excited donor
chromophore transfers energy to an acceptor chromophore through non-radiative
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dipole–dipole coupling. The magnitude of the energy transfer is very dependent on
the distance between the donor and acceptor chromophores, which makes FRET an
extremely sensitive and valuable technique. For example, it can be used to study the
conformational changes in a molecule by labelling it at specific sites with donor and
acceptor fluorophores. More generally, measurement of the efficiency of FRET can
provide an ideal probe of intermolecular or intramolecular distances.
Another application of FRET is in melting assays which are used to measure the
degree of stabilisation that small molecules produce in human telomeric DNA
labelled with fluorescent donor and acceptor chromophores.208,209 These assays
typically use an oligonucleotide containing at least four repeats of the human
telomeric sequence and featuring a fluorophore (F) and quencher (Q) attached to the
5′ and 3′ ends, respectively (Figure 4.13 (a)). When the oligonucleotide is correctly
folded to form a G-quadruplex structure FRET occurs as a result of the short average
distance between the two chromophores. This involves fluorophore F absorbing
excitation energy, and then energy transfer occurring to the nearby acceptor
fluorophore Q. The net result is that fluorescence is not observed at room
temperature. When the temperature is increased however, the fluorophore and
quencher move further apart as a result of DNA denaturation resulting in measurable
fluorescence (Figure 4.13 (b)).
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Figure 4.13: Schematic illustration of the melting process of a tagged G-quadruplex:
(a) when the DNA is folded, (b) when the DNA is unfolded and (c) melting curves
for G-quadruplex DNA in the absence and presence of increased concentrations of
G-quadruplex ligand.208
Plotting fluorescence emission intensity against temperature yields a sigmoidal
melting curve as shown in Figure 4.13 (c), from which the melting temperature Tm, is
derived. The latter value is defined as the temperature at which only 50% of DNA is
still folded and corresponds to the midpoint between the minimum and maximum
emission fluorescence.208 When a small molecule that is able to bind to and stabilise
the DNA in its folded conformation is added, higher temperatures are required to
denature the G-quadruplex structure, resulting in shifts in the melting curve and a
higher value of Tm. The larger the increase in Tm the more effective the small
molecule is at binding to and stabilising the DNA in its quadruplex conformation.
In this project, FRET melting experiments were performed using solutions
containing either Na+ or K+ ions and the oligonucleotide F21T (FAMd[GGG(TTAGGG)3]-TAMRA). This has an identical DNA sequence to Q1 but
features the fluorophore FAM at the 5´ end and the quencher chromophore TAMRA
at the 3´ end.
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4.2.4.1 FRET melting studies of F21T in Na+ solution
The first set of FRET experiments undertaken were performed using F21T annealed
in 100 mM Na+-containing buffer in order to force the unimolecular DNA to adopt
an anti-parallel topology.208 After annealing the G-quadruplex was found to have a
Tm of 50.7 °C which is close to the reported value of 50 °C.208
Normalised FRET melting curves obtained using F21T in the presence of increasing
concentrations of nickel complexes (0-10 μΜ) are shown in Figure 4.14, while
values of ΔTm derived from the melting curves are presented in Figure 4.15. The
latter values are the difference between the Tm for F21T in the presence of a nickel
complex and the Tm of F21T alone.
The results presented in Figure 4.14 show that increasing the concentration of all
nickel complexes from 1 to 10 μM led to shifts in the melting curves toward higher
temperatures. This indicates that interactions with F21T resulted in stabilisation of
the nucleic acid secondary structure. Significant increases in Tm were found with
complexes (56), (59) and (62) even when the concentration of nickel complex was
only 1 M. Furthermore at higher concentrations (53) resulted in Tm values
comparable to those elicited by the previous three complexes. In contrast, addition of
(65) resulted in smaller changes to the melting temperature of F21T at all
concentrations examined. This suggests that the meso-diphenylethylenediamine
group does not enable (65) to bind as effectively to and/or stabilise the anti-parallel
G-quadruplex topology to the same extent. Addition of complex (65) was noted
earlier to have an effect on the position and ellipticity of a number of the bands
present in the CD spectrum of anti-parallel Q1, although it did not greatly alter the
major positive CD band at 296 nm. In contrast, complex (56) showed both the
153

highest degree of stabilisation of F21T (ΔTm = 34.9 μΜ at [Ni] = 10 M) and
resulted in by far the largest decrease in ellipticity of the positive CD band.

Figure 4.14: Results obtained from FRET melting assays performed using F21T in
Na+ solution with increasing concentrations of nickel Schiff base complexes. (a)
(53); (b) (56); (c) (59); (d) (62) and (e) (65).
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Figure 4.15: Comparison of ΔTm values for different concentrations of nickel Schiff
base complexes added to solutions containing 0.2 μM F21T. The DNA had an antiparallel topology after annealing in 100 mM NaCl, 10 mM lithium cacodylate pH
7.4. Error bars represent the standard error from six separate experiments.
4.2.4.2 FRET melting studies of F21T in K+ solution
A second series of experiments was performed using F21T annealed in 100 mM K+containing buffer in order to force the DNA to adopt a hybrid topology. The results
obtained from these experiments, which are presented in Figure 4.16 and
Figure 4.17, show a number of similarities to those observed in experiments
performed using the anti-parallel topology of the nucleic acid. Once again complexes
(56), (59) and (62) showed marked effects on Tm even at the lowest concentration of
added nickel complex (1 μM). Adding higher concentrations of these nickel
complexes resulted in only small additional increases in Tm.
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Figure 4.16: Results obtained from FRET melting assays performed using F21T in
solutions containing K+ ions and increasing concentrations of nickel Schiff base
complexes. (a) (53); (b) (56); (c) (59); (d) (62) and (e) (65).
Complex (53) again resulted in significant increases in Tm but only at higher
concentrations of added nickel complex, while the addition of (65) resulted in
comparatively small increases in Tm for the hybrid topology at all nickel
concentrations, just as it did for the anti-parallel conformation of F21T. These results
suggest that (53) and (65) do not have as marked a stabilising effect on the hybrid
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topology of F21T as the other nickel complexes, whereas they were noted earlier to
have the largest effects on the CD spectrum of hybrid Q1. This may indicate that the
interactions between (53) or (65) and hybrid unimolecular G-quadruplexes are both
different to those which the other nickel complexes participate in, and result in much
lower levels of stabilisation of the above topology.
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Figure 4.17: Comparison of ΔTm values for different concentrations of nickel Schiff
base complexes added to solutions containing 0.2 μM F21T. The DNA had a hybrid
topology after annealing in 100 mM KCl, 10 mM lithium cacodylate pH 7.4. Error
bars represent the standard error from six separate experiments.

4.2.5 DNA binding studies performed using FID assays
In order to further explore the DNA binding properties of the nickel complexes, their
interactions with different types of DNA were also studied using a Fluorescent
Indicator Displacement (FID) assay. This assay examines the ability of molecules of
interest to displace a fluorescent DNA-binding ligand such as thiazole orange (TO)
(Figure 4.18).210-213 Thiazole orange normally exhibits very low levels of
fluorescence in aqueous solution; however, it increases dramatically upon binding to
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nucleic acid molecules.210 For example, it has been reported that fluorescence
emitted by TO increases up to 2000- and 3000-fold upon interaction with dsDNA
and qDNA, respectively.125,210 When another molecule is present that has a higher
binding affinity towards the DNA under investigation TO is displaced, and
fluorescence decreases. Molecules that result in greater decreases in fluorescence are
then assumed to exhibit greater affinity for the DNA. This is expressed quantitatively
as a DC50 value, which is the concentration of the new molecule required to cause a
50% decrease in fluorescence intensity. Lower values of DC50 are therefore expected
for molecules with greater binding affinity towards the DNA under investigation.

Figure 4.18: a schematic representation of a FID assay performed using TO and a Gquadruplex or dsDNA molecule. Adapted from various references.214,215
Thiazole orange has been shown to intercalate between the base pairs of dsDNA and
interact with the external G-quartets of a G-quadruplex by an end-stacking
mechanism.212,216,217 Competitor molecules will most effectively displace TO from
DNA if they interact via the same mechanism. Therefore, FID assays may provide
information about DNA binding modes and sites in addition to overall affinity.
In this project, FID assays were performed by titrating nickel complexes into
solutions containing either a G-quadruplex or dsDNA and a pre-determined amount
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of TO. The decrease in fluorescence resulting from TO was then monitored resulting
in data such as that shown in Figure 4.19, which was derived from an experiment in
which increasing amounts of (56) were added to a Q4/TO complex. The addition of
(56) was continued until no further significant decreases in fluorescence were
observed, indicating that complete displacement of bound TO had occurred. The
resulting data was then plotted as shown in the inset in Figure 4.19 and the DC50
value calculated as described in section 2.7 from the gradient and y-intercept of the
regression line.

Figure 4.19: Results obtained from an FID assay involving addition of increasing
amounts of (56) to a TO/Q4 complex. The inset shows a Stern-Volmer plot derived
from the data, which was then used to determine the DC50 for the nickel complex.
Table 4.7 presents DC50 values for the five nickel complexes with three different
DNA molecules. The results obtained from FID assays support a number of
conclusions that correlate with those derived from analysis of the ESI-MS data
presented earlier. For example, the values of DC50 obtained for (59) in experiments
with all three DNA molecules were by far the largest measured, which indicates that
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this nickel complex exhibited the lowest binding affinity in each case. This is
consistent with the lower abundance of ions from non-covalent complexes containing
one or more molecules of this nickel complex in ESI-MS experiments performed
with each of the nucleic acid molecules.
Inspection of Table 4.7 also shows that the two lowest values of DC50 derived from
experiments performed with D2 were obtained with (53) and (56). These complexes
showed the most extensive formation of non-covalent complexes in ESI-MS
experiments, with ions from complexes containing two bound nickel molecules more
abundant than in experiments performed with the other metal complexes. The values
of DC50 determined from experiments performed with Q4 were, with the exception
of that obtained with (59), all very similar, suggesting near identical binding
affinities towards the parallel tetramolecular G-quadruplex. This is consistent with
the observation that the most abundant ions observed in ESI-MS experiments
performed with the other four nickel complexes and Q4 consisted of two nickel
molecules bound to the nucleic acid. Table 4.7 also shows that the values of DC50
obtained from experiments performed with Q1 were generally similar, aside from
that derived from experiments where (59) was the complex under investigation. This
once again suggests that the four remaining nickel complexes exhibit similar binding
affinities towards the nucleic acid. Comparison of the DC50 values for the five nickel
complexes suggests (53) exhibited the greatest binding affinity towards Q1.
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Table 4.7: DC50 values derived from FID assays performed using nickel
complexes and different DNA molecules.
Nickel
complex
(53)
(56)
(59)
(62)
(65)

dsDNA D2
0.31 ± 0.03
0.44 ± 0.04
2.23 ± 0.13
1.04 ± 0.09
0.82 ± 0.03

DC50( μM)
Parallel Q4
0.16 ± 0.02
0.09 ± 0.01
3.17 ± 0.13
0.19 ± 0.01
0.15 ± 0.02

Parallel Q1
0.15 ± 0.01
0.49 ± 0.03
1.18 ± 0.17
0.45 ± 0.03
0.31 ± 0.01

4.2.6 DNA binding studies performed using molecular docking
The results presented earlier in this chapter were obtained using techniques suited to
providing information about the extent of interaction between the nickel complexes
and different DNA molecules and, in some instances, whether those interactions
affected the conformation and/or stability of the nucleic acid. In contrast, they did not
provide much, if any indication about likely binding modes, with the possible
exception of the FID assays. To address this situation a series of computational
docking experiments were undertaken using crystal structures of a parallel,
unimolecular G-quadruplex (1KF1) and a dsDNA molecule (1KBD). Docking
experiments were performed as described in Chapter 2. Figure 4.20 illustrates the top
binding mode for each nickel complex with both DNA molecules, based on the
results of the computational studies, while the minimum binding energies (G)
resulting from these investigations are shown in Table 4.8.
Inspection of Figure 4.20 reveals a number of similarities amongst the binding modes
used by the various nickel complexes with both types of DNA, but also some
important differences. All nickel complexes except (65) preferred to interact via πstacking interactions with the top G-tetrad of the parallel unimolecular G-quadruplex.
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In addition, at least two pendant groups were always positioned to participate in
favourable intermolecular interactions with the loops and/or grooves of the nucleic
acid. In contrast, the location of nickel ion relative to the G-tetrad was found to vary
between complexes. For example, Figure 4.20 (a) shows the nickel ion of (53)
located directly above the centre of the G-tetrad. This result is similar to what was
obtained previously for the nickel Schiff base complex (18) which is an analogue of
(53) but contains only two ethylpiperidine groups in the 4′-positions.124 Further
inspection of Figure 4.20 (a) however, shows the nickel ions of the other molecules
were located in different positions above the G-tetrads.
Inspection of Figure 4.20 (a) also suggests that the interactions between (59) and
1KF1 were very different to those involving the other nickel complexes. This may be
due to this being the only complex featuring a diamine moiety containing a sixmembered chelate ring in contrast to the five-membered rings present in all the other
complexes. The nickel ion in (59) was positioned towards the edge of the guanine
residues. The two aromatic rings of the complex were not coplanar with each other,
and there was an angle of 47.3 °C between their planes. These rings are co-planar in
all the other complexes presented in this chapter with an angle of 2.3 – 19.8 °C
between their planes. Two of the pendant groups of (59) were found to interact with
the second and third TTA loops of 1KF1 while the other two were located on the
edge of the G-tetrad and orthogonal to the edge of the guanine residues.
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Figure 4.20: Most favourable binding mode resulting from molecular docking studies
performed using nickel Schiff based complexes and different DNA molecules: (a)
computational studies performed using the G-quadruplex 1KF1 and (b)
computational studies performed using the dsDNA 1KBD1.
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diphenylethylenediamine moiety of (65) was orientated parallel to, and therefore able
to π-stack with, the corresponding ring systems of the G-tetrad of 1KF1. In addition,
the two bottom pendant groups of (65) were bound to the first and second TTA loops
of the nucleic acid.
Inspection of Figure 4.20 (b) shows most of the nickel Schiff base complexes
participated in very similar binding interactions with the dsDNA 1KBD. In each case
the most favourable binding mode involved the minor groove of the nucleic acid.
The two pendant groups in the bottom halves of the nickel complexes and the
associated aromatic rings were typically positioned in the minor groove in order to
optimise favourable intermolecular interactions. Simultaneously, the two pendant
groups in the top halves of the nickel complexes and the diamine moieties were
positioned so they were orientated away from the minor groove towards the solvent,
perhaps in an attempt to avoid unfavourable steric interactions. The docking results
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are consistent with those obtained from CD spectroscopic studies, which suggested
the binding mode of the nickel complexes with dsDNA was more likely to be groove
binding than intercalation in the majority of cases. Inspection of Table 4.8 shows the
minimum binding energies of the nickel complexes with 1KBD were distributed over
a narrow range from -7.9 to -8.8 kcal/mol. This is consistent with the similar binding
mode exhibited by all nickel complexes shown in the docking images (Figure 4.20
(b)).
The largest binding energies were observed with complex (53), suggesting it has the
strongest overall binding interactions with 1KBD. In contrast, complexes (59) and
(65) exhibited the lowest binding energy with the dsDNA molecule. This is
consistent with the results presented in Figure 4.20 (b), which show that the diamine
moieties in (59) and (65) were orientated away from the minor groove more than
what was observed in the other complexes. The docking results are consistent with
those obtained from ESI-MS and UV-Vis spectroscopic studies, which also showed
(59) and (65) both exhibit low binding affinity towards dsDNA.
The docking results also showed the minimum binding energies of nickel complexes
with the G-quadruplex 1KF1 were distributed over a narrow range from -9.6 to -8.6
kcal/mol. This indicates that that the nickel complexes also exhibited very similar
binding affinities for 1KF1. The largest binding energy was observed with complex
(53), suggesting it has the strongest overall binding interactions with 1KF1. In
contrast, complex (59) exhibited the lowest binding energy with the G-quadruplex.
This is consistent with the results presented in Figure 4.20 (a), which show two
pendant groups of (59) were orientated away from the loops and grooves of the Gquadruplex and therefore unable to participate in favourable binding interactions.
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Table 4.8: Binding free energies obtained from docking studies performed using
nickel Schiff base complexes and either 1KF1 or 1KBD.
Structure
ID
(53)
(56)
(59)
(62)
(65)
a
b

1KF1(qDNA)
∆G
Binding modeb
(kcal/mol)a
-9.64 ± 0.05
Top, end stacking
-9.02 ± 0.04
Top, end stacking
-8.60 ± 0.10
Top, end stacking
-9.14 ± 0.05
Top, end stacking
-8.64 ± 0.09 Bottom, end stacking

1KBD (dsDNA)
∆G
Binding modeb
(kcal/mol)a
-8.8 ± 0.1
Minor groove
-8.4 ± 0.1
Minor groove
-7.9 ± 0.1
Minor groove
-8.7 ± 0.1
Minor groove
-8.4 ± 0.1
Minor groove

Average values of ∆G with standard errors obtained from the top five docking scores.
“Top” or “Bottom” indicates which terminal G-tetrad was the preferred binding site.

4.2.7 MTT assays
One of the principal objectives of this project was to develop new nickel complexes
which are effective anti-cancer agents that elicit biological activity as a result of
interacting selectively with G-quadruplex DNA. In order to explore the therapeutic
potential of the complexes a series of MTT assays was therefore performed to
measure their cytotoxicity.177 While MTT assays provide a convenient method for
achieving this goal, they do not provide specific information about the mechanism of
cell death induced by the tested compounds.
The assay is used to measure the cellular toxicity of small molecules by quantifying
the extent of mitochondrial enzymatic reduction of the yellow compound MTT to
form the purple formazan. The amount of purple formazan produced is directly
proportional to the number of viable cells, while non-viable cells exhibit impaired
enzymatic activity levels leading to lower production of the formazan. Data obtained
from MTT assays is generally presented in the form of a concentration-response
curve from which an IC50 can be determined. This value corresponds to the
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concentration of compound which results in a 50% reduction in formazan production
after treatment. The smaller the IC50 value, the more cytotoxic the compound.
For this project the in vitro cytotoxicity of complexes (53), (56) and (65) was
evaluated by the MTT assay using the V79 lung cancer cell line (Chinese hamster
cancer cells). For comparison purposes, the cytotoxicity of complexes (18), (20) and
(46) against the same cell line was also evaluated by the MTT assay. The latter three
complexes were obtained from Dr Kimberley Davis. Complexes (18), (20) and (46)
are analogues of (53), (56) and (65), respectively but contain only two
ethylpiperidine groups in the 4′-positions.
The concentration-response curves derived from results obtained from the MTT
assay are shown in Figure 4.21, while IC50 values derived from those curves are
provided in Table 4.9. Each of the curves in Figure 4.21 showed significant drops in
cell viability once a threshold concentration of nickel complex was reached.
Complex (65) exhibited the greatest cytotoxicity (IC50 = 6.1 μΜ) while (56)
exhibited the lowest (IC50 = 48.1 μΜ), among the tested complexes.
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Figure 4.21: Concentration-response curves obtained from 24 h MTT assays using
V79 cells treated with different nickel complexes. The error bars represent one
standard deviation calculated from triplicate plates.
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Table 4.9: IC50 values for nickel complexes obtained from 24 h MTT assays
performed using V79 Chinese hamster cancer cells.
Nickel complex
(18)
(20)
(46)

IC50( μM)*
9.4 ± 0.4
39.9 ± 0.7
9.3 ± 0.2

Nickel complex
(53)
(56)
(65)

IC50( μM)*
11.8 ± 0.5
48.1 ± 4.0
6.1 ±0.3

* IC50 value was determined using at least three independent MTT assays.

The IC50 values presented in Table 4.9 are greater than those obtained for some other
nickel complexes with other cancer cell lines. For example, some of the nickel(II)
thiosemicarbazone complexes synthesized by Bal Demirci et al. and Haribabu et al.
showed IC50 values < 0.7 μM against a number of cancer cell lines including K562
(leukemia), MCF-7 (breast) and A549 (lung) cell lines.218,219 The cytotoxicity of the
latter complexes was greater than that exhibited by the clinically used anti-cancer
drug cisplatin (IC50 = 13.2 ± 0.6 μM for K562 cells and IC50 = 13.9 ± 0.5 μM for
MCF-7 cells).218,220
On the other hand the cytotoxicity of the nickel complexes under investigation in this
project was more comparable to that of a nickel(II) hydrazone complex synthesized
by Li et al. This exhibited cytotoxicity towards A549 and HeLa cells with IC 50
values of 29.2 ± 1.1 and 34.9 ± 2.1 μM, respectively.221 These values indicate the
latter complex was less cytotoxic than cisplatin (IC50 = 13.2 ± 0.6 μM for HeLa cells
and IC50 = 17.2 ± 0.5 μM for A549 cells).222,223
The results presented in Table 4.9 suggest (65) was slightly more cytotoxic than its
analogue with only two pendant groups (46) towards V79 cells. In contrast, the
reverse trend was observed for the other two pairs of nickel complexes. Therefore,
although only a limited data set of complexes was investigated, introduction of two
additional pendant groups does not in general appear to confer additional cytotoxicity
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onto this class of nickel complexes. It should be remembered, however, that the
effects of such structural alterations may vary from one cancer cell line to another.

4.3 Summary
This chapter presents the results of DNA binding studies performed using a number
of different analytical techniques and nickel Schiff base complexes bearing different
diamine moieties and four ethylpiperidine pendant groups. There were a number of
instances where trends in binding affinity determined using one technique matched
closely those obtained using other methods. On other occasions, however, there was
a lack of correlation between results. This was not unexpected, as the affinities of the
complexes towards some DNA molecules were low and/or did not vary greatly, and
experimental approaches vary in their sensitivity to different aspects of the
drug/DNA interaction.
Changing the structure of the diamine moiety was found to influence both DNA
affinity and selectivity. When the phenylenediamine moiety was present, the results
of ESI-MS binding studies indicated that the resulting complex (53) was able to form
non-covalent complexes with dsDNA and both unimolecular and tetramolecular Gquadruplexes. The CD spectrum of D2 changed in a different way in response to
addition of (53) compared the other four nickel complexes, and (53) also produced
the greatest increase in Tm for D2 (1.6 ˚C). Both observations may reflect the
phenylenediamine group interacting in a unique manner with dsDNA. It should be
noted, however, that none of the nickel complexes investigated were very effective at
stabilising dsDNA, as larger changes in Tm would have been expected. For example,
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the nickel Schiff base complex (45) was found previously to increase the Tm of D2
by 6.3 °C.136
Complex (53) was also found to have a greater ability than most other nickel
complexes to affect the CD spectrum of unimolecular G-quadruplexes when the
latter were present in either a parallel or hybrid conformation. While the complex
containing the phenylenediamine moiety did not prove as effective as most other
complexes at displacing TO from D2, Q1 and Q4 molecules, the results obtained
from FID assays confirmed the ability of (53) to interact with all three nucleic acid
molecules noted in ESI-MS experiments.
Changing the diamine moiety from phenylenediamine to ethylenediamine, 1,3propanediamine or 1,2-propanediamine resulted in a series of complexes that
exhibited in some instances very different DNA binding characteristics. In general,
the 1,3-propanediamine-containing complex (59) exhibited the lowest DNA binding
affinity. For example, in ESI-MS experiments it demonstrated less ability to form
non-covalent complexes with any of the three DNA molecules investigated than the
other four nickel molecules. The low affinity of (59) for D2, Q1 and Q4 was
confirmed by the results of FID assays, which resulted in larger values of DC50 for
this nickel complex than for any other discussed in this chapter. Furthermore, whilst
addition of (59) did elicit changes to the CD spectrum of some DNA molecules these
were not as significant as what was seen with other nickel complexes.
Comparison of the data presented in Figure 4.3 shows that changing the diamine
moiety

from

1,3-propanediamine

to

either

1,2-ethylenediamine

or

1,2-

propanediamine resulted in complexes with a greater ability to form non-covalent
complexes with D2, Q1 and Q4. This suggests the above structural changes resulted
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in increased DNA binding affinity for (56) and (62), which is supported by the
results of FID assays performed with the same three DNA molecules. In contrast, the
results of FRET melting assays and CD studies suggested that the latter two
complexes and (59) all exhibited similar levels of DNA binding affinity towards the
anti-parallel and hybrid forms of F21T or Q1.
Complex (65), featuring the meso-1,2-diphenylethylenediamine moiety, exhibited
selectivity in its binding interactions in a number of experiments. For example, the
results of ESI-MS studies showed (65) exhibited a greater ability to form noncovalent complexes with Q1 and Q4 than with D2. The ability of (65) to interact with
Q1 in particular was notable as it was the only nickel complex for which no ions
attributable to free DNA were observed in ESI mass spectra. Further evidence in
support of a binding preference for G-quadruplex DNA over dsDNA was provided
by the results of FID assays and CD spectroscopic studies. Analysis of the former
afforded a value of DC50 for (65) with D2 which was in the middle of those exhibited
by the remaining nickel complexes. In contrast, complex (65) gave the lowest and
second lowest values of DC50 with Q4 and Q1, respectively, confirming its affinity
for these G-quadruplexes.
Complex (65) had little impact on the CD spectrum of D2, however it resulted in the
largest changes observed amongst all five nickel complexes to the corresponding
spectrum of Q4, and also resulted in major changes to the CD spectra of parallel Q1
and c-KIT1. The results of CD and FRET studies performed with anti-parallel and
hybrid forms of unimolecular G-quadruplexes indicated it also exhibited the ability
to bind to these forms of nucleic acid. More than any other diamine moiety, the
meso-1,2-diphenylethylenediamine group appears to confer a distinct binding
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selectivity trait upon complexes in which it is found. Previous investigations have
noted the ability of nickel Schiff base complexes bearing this group to interact more
selectively with parallel tetramolecular G-quadruplexes in particular.135,136
The results of molecular docking studies indicated that each of the nickel complexes
interact with dsDNA via a groove binding mechanism and that intercalation was not
a major contributor to the intermolecular interactions. This conclusion is supported
by the results obtained from CD studies, as larger changes to the CD spectra of DNA
would have been expected if the nickel complexes were interacting via an
intercalating binding mode. For example, the magnitude of the changes to the CD
spectrum of dsDNA caused by addition of the nickel complexes discussed here is
much lower than that reported for octahedral nickel complexes of the general
formula [Ni(phen)2L]2+ (L = dpq, dpqC, dppz), which are known to bind to dsDNA
via intercalative binding modes.224
Molecular docking studies also revealed the nickel complexes interact primarily via
an end-stacking mechanism with G-quadruplex DNA. The exact manner with which
the complexes interacted varied as a result of differences in their structure, however
the binding free energies fell within a relatively narrow range. This suggests that
additional changes to the structure of the complexes will be required in order to
produce more effective and selective G-quadruplex binding agents.
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Chapter 5

DNA-binding properties of nickel

Schiff base complexes with different pendant
groups
5.1 Introduction and scope
In the previous chapter, results obtained from DNA binding studies performed using
nickel Schiff base complexes that differ in the structure of the diamine moiety were
presented. Here results are presented from similar studies which were performed to
investigate whether DNA binding properties are enhanced by changing the pendant
groups on the complexes from ethylpiperidine to either ethylmorpholine or
propylpiperidine. The DNA binding properties of some nickel complexes bearing the
latter pendant groups has been reported previously.125,130,135 For example, it was
found that replacing the ethylpiperidine with propylpiperidine in the nickel salphen
complex (18) (Section 1.4.3) resulted in improved G-quadruplex binding and/or
selectivity. The synthesis and characterisation of the novel complexes discussed in
this chapter were presented in Chapter 3, and their structures are displayed in
Figure 5.1 together with those of their analogues discussed in Chapter 4. It was
hoped that by replacing the ethylpiperidines with other pendant groups the DNA
binding ability and/or selectivity of the resulting complexes would be enhanced. The
same biophysical techniques and DNA molecules used in the studies reported on in
the previous chapter were again used here to investigate the effects of these structural
changes.
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Figure 5.1: Structures of nickel Schiff base complexes containing different pendant
groups.

5.2 Results and discussion
5.2.1 DNA binding studies performed using ESI mass spectrometr
ESI-MS experiments were initially performed to compare the affinities of nickel
Schiff base complexes containing ethylmorpholine pendant groups and different
diamine moieties towards the dsDNA D2. The results of these experiments, which
were performed using a 6:1 ratio of Ni:D2, are presented in Figure 5.2.
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All of the spectra presented in Figure 5.2 show ions of low to high abundance at m/z
1626.5 and 1952.0, which are attributed to [D2 - 6H]6- and [D2 - 5H]5-, respectively.
The abundances of these ions varied from one spectrum to another, suggesting the
nickel complexes bind to D2 to different extents. For example, both ions from free
D2 were of lower abundance in Figure 5.2 (b) than for any of the other spectra. This
suggests (54) has the highest affinity towards D2 of the five complexes containing
ethylmorpholine pendant groups. Further evidence in support of this conclusion was
obtained after considering the abundances of ions from non-covalent complexes
containing two or more nickel molecules bound to DNA in the spectra shown in
Figure 5.2. These were much greater in the case of the spectrum in Figure 5.2 (b)
than for all other spectra except that shown in Figure 5.2 (c). Close examination of
the spectra in Figure 5.2 (b) and (c) showed the abundances of ions from noncovalent complexes containing two or more molecules of (54) bound to DNA were
slightly greater than for those containing multiple molecules of (57). The above
results therefore suggests that complex (54) containing a phenylenediamine moiety
has a slightly higher affinity towards D2 than (57), which has an ethylenediamine
group, and that the remaining complexes having significantly lower affinities.
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Figure 5.2: Negative ion ESI mass spectra of solutions containing different nickel
Schiff base complexes and D2 at a 6:1 ratio: (a) Free D2; (b) D2 + (54); (c) D2 +
(57); (d) D2 + (60); (e) D2 + (63) and (f) D2 + (66). = free D2;  = [D2 + (Ni)];
 = [D2 + 2(Ni)];  = [D2 + 3(Ni)];  = [D2 + 4(Ni)].
A similar conclusion was reached after comparing the spectra of solutions containing
D2 and complexes bearing ethylpiperidine pendant groups and different diamine
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moieties (Figure 4.2). In the case of the latter spectra, complexes (53) and (56),
which also contain phenylenediamine and ethylenediamine moieties, were found to
exhibit greater binding affinities towards D2 than complexes containing other
diamine groups.
Inspection of Figure 5.2 shows very low ion abundances corresponding to noncovalent complexes consisting of one or more molecules of (60), (63) or (66) bound
to D2. These observations suggest the presence of the 1,3-diaminopropane, 1,2diaminopropane or meso-1,2-diphenylethylenediamine moieties significantly inhibits
DNA binding interactions in the case of complexes also containing ethylmorpholine
pendant groups.
Additional binding experiments were conducted using nickel complexes containing
propylpiperidine pendant groups, as well as either unimolecular or tetramolecular Gquadruplex DNA (Q1 and Q4, respectively). The results of these experiments are
presented graphically in the form of relative abundances in Figure 5.3. Also included
in Figure 5.3 to facilitate comparison of relative binding affinities are the results of
experiments

that

were

performed

with

analogous

complexes

containing

ethylpiperidine pendant groups. These results were first presented in Chapter 4.
Analysis of Figure 5.3 reveals a number of clear trends in relative abundances. These
include the relative abundances of ions from non-covalent complexes containing
ethylmorpholine substituents were always lower than that of analogous complexes
containing either of the other pendant groups. In many cases this trend was very
pronounced. For example, in the case of binding experiments performed using nickel
complexes containing ethylmorpholine pendant groups and Q1, the most abundant
ions present in the ESI mass spectra were always from free DNA. Furthermore, ions
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from non-covalent complexes were always of low abundance. In contrast, for the two
other classes of nickel complexes ions from non-covalent complexes consisting of
one or more nickel molecules bound to Q1 were often of medium or high abundance.
The above results suggest that the affinities of nickel complexes containing
ethylmorpholine pendant groups may generally be less than that of the other two
classes of complexes. This conclusion was reported previously for a closely related
series of nickel Schiff base complexes also containing these pendant groups.125,162
One possible explanation for this observation is that the oxygen atoms in the
ethylmorpholine pendant groups may result in unfavourable electrostatic interactions
with electron rich groups in the DNA molecules.
Examination of Figure 5.3 (b), (e), (h), (k) and (n) show in each case ions of medium
abundance corresponding to non-covalent complexes of Q4. In contrast the most
abundant ions present in spectra of the same complexes and Q1 were always from
free DNA. This suggests a number of the nickel complexes bearing ethylmorpholine
substituents exhibited some binding selectivity in favour of Q4 over Q1. In the case
of (60), (63) and (66) very low levels of non-covalent complex formation were also
observed with D2, suggesting that these complexes exhibited a binding preference
for tetramolecular G-quadruplex DNA over both the unimolecular G-quadruplex and
dsDNA.
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Figure 5.3: Relative abundances of ions in ESI mass spectra of solutions containing a
6:1 ratio of nickel Schiff base complex and dsDNA (D2), tetramolecular qDNA (Q4)
or unimolecular qDNA (Q1): (a) solutions containing (53); (b) solutions containing
(54); (c) solutions containing (55); (d) solutions containing (56); (e) solutions
containing (57); (f) solutions containing (58); (g) solutions containing (59); (h)
solutions containing (60); (i) solutions containing (61); (g) solutions containing (62);
(k) solutions containing (63); (l) solutions containing (64); (m) solutions containing
(65) and (n) solutions containing (66).
The low binding affinity towards D2 exhibited by (66) was expected as other nickel
complexes including (65), which also contain the meso-1,2-diphenylethylenediamine
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moiety have been reported to show very low binding affinities towards dsDNA.135
The explanation put forward previously for this observation was that the presence of
the non-planar diamine moiety sterically hinders the approach of the nickel molecule
to dsDNA, resulting only in comparatively weak partial intercalation or groove
binding interactions.
Another important trend revealed upon examination of Figure 5.3 is the absence of
ions from free DNA in spectra of solutions containing a 6:1 ratio of nickel complexes
containing propylpiperidine groups and DNA. This was true for each of the three
DNA molecules examined, with the exception of solutions containing (55) and Q1,
which gave a spectrum containing ions of low to medium abundance from free
nucleic acid. In contrast, Figure 5.3 shows ions from free DNA were present in
spectra of many other solutions containing one of the other two classes of nickel
complexes and either D2 or Q4. These observations suggest nickel complexes
featuring propylpiperidine pendant groups have higher affinities for each of the three
DNA molecules than analogues containing the same diamine moiety, but one of the
other classes of pendant groups.
The above conclusion is generally supported by comparison of the relative
abundances of ions from non-covalent complexes formed in solutions containing the
same DNA molecule and nickel complexes with the same diamine moiety, but
different pendant groups. One such group of nickel complexes is (62), (63) and (64),
each of which contains the 1,2-propanediamine moiety. The most abundant ions
observed in spectra of solutions containing (64) (Figure 5.3 (l)) were always from
non-covalent complexes containing two nickel molecules bound to the DNA. In
contrast, the most abundant ions present in spectra of solutions containing (63) and
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either Q1 or D2 were from free DNA, while when Q4 was present ions from a noncovalent complex containing only one bound nickel molecule were most prevalent
(Figure 5.3 (k)). Figure 5.3 (j) shows that when (62) was present the most abundant
ions present in solutions containing either Q1 or D2 were from non-covalent
complexes containing only one bound nickel molecule.
Further analysis of Figure 5.3 suggests (55) and (58) may exhibit the highest affinity
for D2 amongst all the complexes examined as part of this project. Evidence in
support of this is provided by the absence of ions from free DNA, as well as
observation of ions of medium abundance from non-covalent complexes containing
three bound nickel molecules, as well as ions of low abundance containing up to five
nickel complexes bound to D2. It appears that the combination of propylpiperidine
pendant groups and either a phenylenediamine or ethylenediamine moiety in the top
half of the nickel complexes provided more favourable structures for binding to
dsDNA in comparison to the other nickel molecules.
While Figure 5.3 indicates that a number of the nickel complexes were able to form
non-covalent complexes with D2 that contained three or more bound molecules, this
was rarely the case with either of the G-quadruplexes. This is consistent with the
view that the nickel molecules can bind to dsDNA via a combination of electrostatic
interactions, groove binding and partial intercalation anywhere along the length of
the 16mer dsDNA molecule. In contrast, binding to either of the two G-quadruplexes
most likely involves end stacking, resulting in at most two very strong sets of
intermolecular interactions. In this context it is noteworthy that solutions containing
(58), (61) or (64) and Q1 resulted in spectra containing very high abundances of ions
from non-covalent complexes containing two bound nickel molecules, and very low
180

abundances of a small number of other ions. This suggests these complexes may be
very effective binding agents for unimolecular G-quadruplexes, although not highly
selective ones. For similar reasons (56), (58) and (64) appear to be the most effective
binding agents of those examined for tetramolecular G-quadruplexes.
Analysis of Figure 5.3 also reveals other similarities and differences in binding
behaviour for complexes bearing the same diamine moiety but different pendant
groups. One such pair of complexes is (65) and (66). The former complex was shown
previously to form non-covalent ions of medium to high abundance containing one
or two nickel molecules bound to either Q1 or Q4. In contrast, complex (66) exhibits
a binding preference in favour of the tetramolecular G-quadruplex over both of the
other types of DNA molecules (Figure 5.3 (n)). Another regular trend in binding
behaviour was observed when the 1,3-propanediamine moiety in nickel complexes
bearing ethylmorpholine or propylpiperidine pendant groups was replaced with either
1,2-ethylenediamine or 1,2-propanediamine. This was found to generally result in a
decrease in binding affinity towards each of the three DNA molecules. A similar
trend was noted in chapter 4 for the corresponding complexes featuring pendant
ethylpiperidine moieties, highlighting a consistent effect of altering structure on
DNA binding behaviour.

5.2.2 DNA binding studies performed using CD spectroscopy
5.2.2.1 CD titrations using double stranded DNA D2
CD spectroscopy was also used to investigate the effect of varying the pendant
groups in the nickel complexes on binding to different DNA molecules. The results
of experiments in which the effects of adding nickel complexes containing either
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ethylmorpholine or propylpiperidine groups on the CD spectrum of dsDNA D2 were
investigated are shown in Figure 5.4, and in Table 5.1. These may be compared to
results obtained using complexes containing ethylpiperidine groups which were
shown in Chapter 4.2.2.1. Inspection of Figure 5.4 shows that addition of (60) or (66)
had little effect on the CD spectrum of D2. This is in accord with the low abundance
of ions from non-covalent complexes and high abundance of ions from free D2
observed in ESI mass spectra of these systems (Figure 5.2 (h) and (n)). The
concordance between these results obtained using different techniques suggests (60)
and (66) have low affinities towards D2. In contrast, addition of most of the
remaining complexes with ethylmorpholine or propylpiperidine pendant groups
resulted in notable changes to the CD spectrum of D2. For example, addition of (54)
resulted in large decreases in ellipticity for both the positive and negative CD bands,
as well as a significant blue shift for the latter spectral feature. These changes were
very similar to what was reported in Chapter 4 for the same experiment performed
with (53). In addition, complex (55), which also bears the phenylenediamine moiety
but contains propylpiperidine pendant groups, also showed similar effects on the CD
spectrum with the exception of producing a small increase in ellipticity for the
negative CD band. This hints at a slight difference between how (54) and (55)
interact with D2. All three complexes with phenylenediamine groups were also
found to result in extensive formation of non-covalent complexes in DNA binding
experiments conducted using ESI-MS.

182

Figure 5.4: Circular dichroism spectra (200-400 nm) of solutions containing D2 and
different ratios of nickel Schiff base complexes. (a) D2 + (54); (b) D2 + (55); (c) D2
+ (57); (d) D2 + (58); (e) D2 + (60); (f) D2 + (61); (g) D2 + (63); (h) D2 + (64) and
(i) D2 + (66).
There were a number of other instances where the changes to the CD spectrum of D2
caused by addition of a complex containing propylpiperidine pendant groups were
slightly different to those caused by complexes containing the same diamine moiety
and one of the other two types of pendants. This is illustrated by comparison of the
effects observed after addition of the complexes containing ethylenediamine
moieties. Inspection of Table 4.1 and Table 5.1 show that (56) and (57) resulted in
similar changes to both major CD bands. For example, both caused very small (<
6%) decreases in ellipticity for the positive CD band, whereas the analogous complex
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bearing propylpiperidine substituents, (58), resulted in very large increase in
ellipticity (79.5%). In addition, only addition of (58) resulted in the appearance of a
new positive CD band at 395 nm. These results suggest that replacing ethylpiperidine
in (56) or ethylmorpholine in (57) with propylpiperidine to give (58) increased
binding affinity towards D2 and/or altered the nature of the intermolecular
interactions. Comparison of the spectra in Figure 5.4 further suggests that (58) may
interact more strongly than any of the other nickel complexes with D2. This
conclusion is consistent with the extensive formation of non-covalent complexes
observed in ESI mass spectra of solutions containing this complex and D2.
Table 5.1: Effect of addition of nickel Schiff base complexes on the CD spectrum
of D2.*
Nickel complex Positive CD band at 282 nm Negative CD band at 249 nm
Δλmax (nm)
Δɛ (%)
Δλmax (nm)
Δɛ (%)
1.6
-40.27
-8.0
-52.67
(54)
(55)
1.5
-47.19
-14.9
11.74
(57)
4.9
-5.74
0.9
-6.35
(58)
6.5
79.50
2.4
-4.45
1.5
14.75
-0.4
-0.23
(60)
(61)
9.8
49.02
1.5
-21.16
(63)
6.1
65.99
0.4
-13.77
(64)
5
35.85
0.4
0.14
(66)
0.8
19.73
-0.6
-10.63
* All Δλmax and Δε(%) values are the difference between the values for free DNA and
those for a solution containing a nickel:DNA ratio of 9:1. Negative Δλmax values indicate
a blue shift; positive values indicate a red shift.

Complex (63) had the second largest effect on the ellipticity of the positive CD band
of D2 of all complexes examined as part of this project. This result therefore suggests
(63) interacts more strongly than many of the other nickel complexes with D2, which
contrasts what would be expected based on results of the ESI-MS study, which
showed addition of (63) resulted in little formation of non-covalent complexes.
These observations may be rationalised by considering that the two techniques
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exhibit varying sensitivities to different aspects of the binding interaction. For
instance, the results from ESI-MS reflect the stability of non-covalent complexes in
the gas phase, while the results from CD spectroscopy reflect changes to DNA
conformation in solution. Therefore, it is possible that either the non-covalent
complexes formed between (63) and D2 were not stable enough to survive the ESI
conditions or that the relatively weak binding interactions of this complex with D2
were still strong enough to change the chirality of D2, and consequently its CD
spectrum. It is also noteworthy that addition of complexes (58), (61), (63) and (64)
all resulted in similar changes to the general appearance of the CD spectrum of D2,
suggesting these four complexes might all interact similarly with the dsDNA.
5.2.2.2 CD titrations using parallel tetramolecular Q4
The results obtained from CD spectroscopic experiments in which nickel complexes
containing either ethylmorpholine or propylpiperidine groups were added to Q4 are
presented in Figure 5.5 and Table 5.2. Inspection of the results reveals that most of
the complexes showed much smaller effects on the CD spectrum of the nucleic acid
than what was seen in the analogous experiments involving D2. This suggests most
of the nickel complexes do not interact strongly with the tetramolecular Gquadruplex. This may be contrast with the overall view of binding interactions
between these complexes and Q4 based on the results of ESI-MS experiments, where
most systems showed notable levels of formation of non-covalent complexes. A
possible explanation for this apparent discrepancy is that the non-covalent complexes
detected by ESI-MS do not perturb the chiral structure of the nucleic acid sufficiently
to result in notable changes to the CD spectrum of the latter.
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Figure 5.5: Circular dichroism spectra (200-400 nm) of solutions containing parallel
Q4 and different ratios of nickel Schiff base complexes. (a) Q4 + (54); (b) Q4 + (55);
(c) Q4 + (57); (d) Q4 + (58); (e) Q4 + (60); (f) Q4 + (61); (g) Q4 + (63); (h) Q4 +
(64) and (i) Q4 + (66).
The two complexes which most affected the CD spectrum of Q4 were (54) and (55),
both of which contain phenylenediamine moieties. In the case of (54), which also
contains ethylmorpholine pendant groups, the ellipticities of the major positive and
negative CD bands at 263 and 242 nm changed by -31% and -27%, respectively
(Table 5.2). These variations are comparable to the changes of -33% and -22% noted
earlier for the same experiments performed using the corresponding complex
containing ethylpiperidine pendants (53) (Table 4.2). When the corresponding
complex bearing the longer propylpiperidine pendants (55) was added to Q4 even
larger decreases in ellipticity of 92% and 89% were observed (Table 5.2). These
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results suggest that replacing the ethylmorpholine or ethylpiperidine pendant groups
with propylpiperidines enhanced binding affinity towards Q4 by a significant
amount.
The nickel complex featuring ethylpiperidine pendant groups which had the largest
impact on the CD spectrum of Q4 was (65). It is therefore surprising that (66), which
has the same meso-1,2-diphenylethylenediamine moiety but ethylmorpholine
pendant groups, had no impact on the CD spectrum of the nucleic acid.
Unfortunately, it was not possible to isolate the corresponding complex with
propylpiperidine pendant groups, (67). Therefore, it was not possible to fully
delineate the effects of changes in pendant groups and diamine moieties on binding
behaviour towards this nucleic acid molecule.

Table 5.2: Effect of addition of nickel Schiff base complexes on the CD spectrum
of Q4.*
Nickel complex Positive CD band at 263 nm Negative CD band at 242 nm
Δλmax (nm)
Δɛ (%)
Δλmax (nm)
Δɛ (%)
0.5
-31.2
-0.8
-27.4
(54)
(55)
4.4
-91.6
2.8
-89.4
(57)
1
8.8
-1
7.0
(58)
0.8
3.6
-1.5
11.9
0
3.5
-0.1
-0.4
(60)
(61)
0.2
-12.2
-0.1
-13.1
(63)
0
-2.3
-0.4
-7.0
(64)
0.5
-11.9
-0.4
-7.6
(66)
-0.6
4.0
0
-1.3
* All Δλmax and Δε(%) values are the difference between the values for free DNA and
those for a solution containing a nickel:DNA ratio of 9:1. Negative Δλmax values indicate
a blue shift; positive values indicate a red shift

5.2.2.3 CD titrations using parallel unimolecular Q1
The effect of varying pendant groups on the interactions between metal complexes
and G-quadruplexes was investigated further by CD spectroscopy using the parallel
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unimolecular G-quadruplex Q1. The results of these experiments are presented in
Figure 5.6 and Table 5.3. Comparison of the CD spectra in Figure 5.6 with those
shown in Figure 5.5 suggests that some of the nickel complexes may interact more
strongly with parallel Q1 than they did with parallel Q4. This is supported by the
observation of larger changes in ellipticity upon addition to Q1 in the case of
complexes (58), (61) and (64), each of which contain propylpiperidine pendant
groups. Large changes in ellipticity were also seen when a fourth complex containing
such pendants, (55) was added to Q1, although in this case the variations were not as
great as when the same complex was added to Q4. Overall the results obtained
suggest that complexes containing propylpiperidine pendant groups generally
exhibited significant binding interactions with towards Q1. This is consistent with
the more extensive formation of non-covalent complexes between these nickel
molecules and the unimolecular parallel G-quadruplex observed in ESI-MS
experiments, compared to when nickel molecules containing either of the other
classes of pendant groups was examined.
Addition of (54) to Q1 also caused significantly larger changes to the ellipticity of
the CD bands of the nucleic acid than when Q4 was present. This suggests that the
presence of the phenylenediamine moiety leads to interactions between the nickel
complex and DNA that are sufficiently strong to significantly affect the chirality of
the nucleic acid. Therefore, it might be expected that such interactions would result
in ions of medium or high abundance from non-covalent adducts formed between the
nickel complex and nucleic acid molecules in ESI mass spectra. In contrast,
inspection of Figure 5.3 (b) shows the mass spectrum of a solution containing (54)
and Q1 was dominated by ions from free DNA, whilst the abundances of ions from
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non-covalent adducts consisting of a single nickel complex bound to DNA were very
low. These results therefore provide further evidence that relatively weak binding
interactions between these nickel complexes and DNA may sometimes lead to large
changes to the chirality of the latter, and consequently its CD spectrum. Alternatively
the contrast between the results obtained using these two techniques may be
attributable to thermal instability of non-covalent adducts which makes them
undetectable by ESI-MS.

Figure 5.6: Circular dichroism spectra (200-400 nm) of solutions containing parallel
Q1 and different ratios of nickel Schiff base complexes. (a) Q1 + (54); (b) Q1 + (55);
(c) Q1 + (57); (d) Q1 + (58); (e) Q1 + (60); (f) Q1 + (61); (g) Q1 + (63); (h) Q1 +
(64) and (i) Q1 + (66).
Addition of (57), (60), (63) or (66) to parallel Q1 only resulted in minor changes to
the CD spectrum of the latter, including decreases in ellipticity of the major positive
189

CD band of < 13% (Table 5.3). These observations are similar to those made during
CD studies involving the same complexes and parallel Q4, and provide further
evidence of the lesser ability of this class of nickel complexes, each of which contain
ethylmorpholine pendant groups, to form non-covalent complexes with parallel Gquadruplexes. A similar conclusion was reached earlier in this chapter after
considering the results of ESI-MS experiments performed using all three classes of
nickel complexes and different DNA molecules (Figure 5.3).
Table 5.3: Effect of addition of nickel Schiff base complexes on the CD spectrum
of parallel unimolecular Q1.*
Nickel complex Positive CD band at 263 nm Negative CD band at 241 nm
Δλmax (nm)
Δɛ (%)
Δλmax (nm)
Δɛ (%)
13.4
-76.0
2.9
-93.2
(54)
(55)
7.1
-60.6
1
-44.2
(57)
2.4
-8.1
-2
-2.8
(58)
12.2
-69.6
2.2
-66.9
0.8
-2.1
-1
-4.5
(60)
(61)
1.2
-24.9
1.2
-26.4
(63)
0.9
-12.8
-0.7
-11.0
(64)
12.2
-66.5
1.1
-54.2
(66)
-1.2
-7.9
-2.2
-37.3
* All Δλmax and Δε(%) values are the difference between the values for free DNA and
those for a solution containing a nickel:DNA ratio of 9:1. Negative Δλmax values indicate
a blue shift; positive values indicate a red shift.

5.2.2.4 CD titrations using anti-parallel unimolecular Q1
In the previous section results were presented which demonstrated the ability of
nickel complexes with ethylmorpholine or propylpiperidine pendant groups to
interact with, and consequently alter the CD spectrum of parallel Q1 to different
extents. Since this DNA molecule can also fold into alternative conformations, it was
decided to examine whether these nickel complexes might interact in distinctively
different ways with these other topologies. The results obtained after adding
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increasing amounts of nickel complexes containing either ethylmorpholine or
propylpiperidine groups to anti-parallel Q1 are shown in Figure 5.7 and Table 5.4.
Comparison of the results shown in Figure 5.7 with those presented in Figure 5.6
reveals a number of trends. Foremost of these is that once again addition of
complexes bearing propylpiperidine substituents generally resulted in larger changes
to the CD spectra than when analogues containing ethylmorpholine groups were
present.

Figure 5.7: Circular dichroism spectra (200-400 nm) of solutions containing antiparallel Q1 and different ratios of nickel Schiff base complexes. (a) Q1 + (54); (b)
Q1 + (55); (c) Q1 + (57); (d) Q1 + (58); (e) Q1 + (60); (f) Q1 + (61); (g) Q1 + (63);
(h) Q1 + (64) and (i) Q1 + (66).
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The nickel complexes did not, however, uniformly affect the CD spectrum of one
type of nucleic acid topology to a greater extent than the other. For example,
Figure 5.7 shows addition of (57) had a greater effect on the CD spectrum of antiparallel Q1 than it did with parallel Q1 (Figure 5.6). In contrast, (54) had a smaller
effect on the CD spectrum of anti-parallel Q1 than what was observed with parallel
Q1. In addition, while (60) had no effect on the CD spectrum of parallel Q1, it
caused an increase of 28% in ellipticity for the major positive CD band of antiparallel Q1. These results suggest small changes in selectivity in favour of one Gquadruplex topology over another can occur as a result of changes to the structure of
the nickel complex.
Table 5.4: Effect of addition of nickel Schiff base complexes on the CD spectrum
of anti-parallel unimolecular Q1.*
Nickel complex Positive CD band at 296 nm Negative CD band at 265 nm
Δλmax (nm)
Δɛ (%)
Δλmax (nm)
Δɛ (%)
2
44.2
-2.2
11.5
(54)
(55)
4
-9.8
-5.6
-80.1
(57)
-2
18.6
0.4
-10.4
(58)
0.1
31.5
-4.4
-82.7
0.9
28.9
-0.9
-6.3
(60)
(61)
0.6
-12.4
-1.3
-48.5
(63)
-2.7
16.6
-1.7
3.4
(64)
-0.4
-6.3
-22.2
-73.0
(66)
-0.4
12.6
0
30.8
* All Δλmax and Δε(%) values are the difference between the values for free DNA and
those for a solution containing a nickel:DNA ratio of 9:1. Negative Δλmax values indicate
a blue shift; positive values indicate a red shift.

One of the most notable aspects of the results shown in Figure 5.7 was the complete
disappearance of the negative CD band at 265 nm and the neighbouring small
positive CD band at 245 nm when complexes containing propylpiperidine pendant
groups were added. The only exception to this trend was when (61) was added,
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however it still resulted in larger and different changes to the CD spectrum compared
to when the corresponding complex with the same diamine moiety but
ethylpiperidine groups was present (60). The above spectral changes were
accompanied by the appearance of shoulders on the high energy side of the 271 nm
CD band in the case of addition of either (55) or (64). Similar changes to the CD
spectrum were not observed when nickel complexes bearing ethylpiperidine pendant
groups were added to anti-parallel Q1. These results suggest that the complexes with
propylpiperidine pendant groups interact in a distinctly different manner with this Gquadruplex and/or elicit significantly different changes to its conformation which
result in the distinctive changes observed in the CD spectra.
5.2.2.5 CD titrations using hybrid unimolecular Q1
Binding experiments were also performed using CD spectroscopy and Q1 present in
a hybrid conformation, to see if any of the nickel complexes showed the ability to
selectively interact with this topology of the nucleic acid. The results of these
experiments are presented in Figure 5.8 and Table 5.5. Inspection of the data shown
in Figure 5.6, Figure 5.7 and Figure 5.8 shows that addition of (54) resulted in much
larger effects on the CD spectrum of the parallel conformation of Q1 than either of
its alternative topologies. This suggests that (54) may exhibit a degree of binding
selectivity in favour of the former G-quadruplex. In contrast, addition of (55)
resulted in significant changes to the CD spectrum of Q1 present in each of its three
conformations, suggesting this nickel complex exhibits little binding selectivity
towards unimolecular G-quadruplexes.
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Figure 5.8: Circular dichroism spectra (200-400 nm) of solutions containing hybrid
Q1 and different ratios of nickel Schiff base complexes. (a) Q1 + (54); (b) Q1 + (55);
(c) Q1 + (57); (d) Q1 + (58); (e) Q1 + (60); (f) Q1 + (61); (g) Q1 + (63); (h) Q1 +
(64) and (i) Q1 + (66).
Addition of (55) had the greatest effect on the CD spectrum of hybrid Q1. Inspection
of Figure 4.9 shows that large changes to the CD spectrum of this nucleic acid
topology also occurred when (53), which also contains a phenylenediamine moiety
was added. This suggests the identity of the diamine can alter the nature of the
binding interactions. When (58) and (64) were added to hybrid Q1 a different pattern
of spectral changes was observed compared to when other nickel complexes were
present. In the case of (58) and (64), upon first introducing the nickel complex, so
that the ratio of Ni:DNA was 1:1, 3:1 or 6:1, increases in ellipticity of the two
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positive CD bands were observed. At higher ratios the ellipticity of these two peaks
then decreased. The reasons for this biphasic pattern of changes to the CD spectrum,
which was not observed with any of the other nickel complexes, is currently unclear.
It is also noteworthy that the four nickel complexes containing propylpiperidine
pendant groups had larger effects on the general appearance of the CD spectrum of
hybrid Q1 than analogues containing ethylmorpholine groups.
Table 5.5: Effect of addition of nickel Schiff base complexes on the CD spectrum
of hybrid unimolecular Q1.*
Nickel complex Positive CD band at 291 nm Negative CD band at 235 nm
Δλmax (nm)
Δɛ (%)
Δλmax (nm)
Δɛ (%)
-2.5
12.8
-0.3
-22.5
(54)
(55)
2.9
-16.5
3.4
-49.4
(57)
-1.4
0.3
1.8
26.1
(58)
0.9
9.7
4
-41.3
-0.3
-1.5
1.3
47.7
(60)
(61)
-0.4
5.2
1.6
16.3
(63)
-1.5
4.5
0.5
38.4
(64)
-0.9
3.1
13.3
50.7
(66)
0.2
10.5
1.2
37.2
* All Δλmax and Δε(%) values are the difference between the values for free DNA and
those for a solution containing a nickel:DNA ratio of 9:1. Negative Δλmax values indicate
a blue shift; positive values indicate a red shift.

5.2.2.6 CD titrations using parallel unimolecular c-KIT1
The results presented in Chapter 4 showed that all five nickel complexes bearing
ethylpiperidine pendant groups significantly affected the CD spectrum of parallel Q1
as well as that of the parallel conformation of a second unimolecular G-quadruplex,
derived from the sequence for the oncogene promoter c-KIT1. This result afforded
greater confidence in the binding selectivity patterns revealed by CD spectroscopy.
In order to provide further confidence in the conclusions that can be drawn from
these DNA binding studies a second set of experiments was conducted by CD
spectroscopy using c-KIT1 and nickel complexes bearing either ethylmorpholine or
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propylpiperidine pendants. The results of studies described earlier in this chapter
showed that addition of nearly all nickel complexes bearing propylpiperidine
substituents caused large changes to the CD spectrum of parallel Q1, with the only
exception being (61). In contrast, nearly all nickel complexes containing
ethylmorpholine substituents had virtually no effect on the CD spectrum of parallel
Q1, with the only exception being (54). The effects of addition of these two classes
of nickel complexes on the CD spectrum of parallel c-KIT1 are shown in in
Figure 5.9 and Table 5.6.
Inspection of Figure 5.9 shows that once again many of the nickel complexes bearing
ethylmorpholine pendants (e.g. (57), (60) and (63)) had only a very minor influence
on the CD spectrum of parallel c-KIT1, in keeping with what was observed in
experiments with parallel Q1. This suggests that these three complexes generally
have a low binding affinity towards parallel unimolecular G-quadruplexes. In
addition, complex (54) once again deviated from the trend seen with the other nickel
complexes containing this type of pendant and caused significant changes to all CD
bands of parallel c-KIT1. This therefore confirmed that (54) consistently affects the
CD spectrum of parallel unimolecular G-quadruplexes, unlike all other nickel
complexes with this type of pendant group, and suggests that the diamine moiety
must play a significant role in the binding interactions.
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Figure 5.9: Circular dichroism spectra (200-400 nm) of solutions containing parallel
c-KIT1 and different ratios of nickel Schiff base complexes. (a) C-KIT1 + (54); (b)
C-KIT1 + (55); (c) C-KIT1 + (57); (d) C-KIT1 + (58); (e) C-KIT1 + (60); (f) C-KIT1
+ (61); (g) C-KIT1 + (63); (h) C-KIT1 + (64) and (i) C-KIT1 + (66).
The only nickel complex which produced contrasting results in experiments
conducted using CD spectroscopy and the two types of parallel unimolecular Gquadruplexes was (66). While this nickel complex caused only minor changes to the
CD spectrum of parallel Q1, it resulted in the largest changes observed to the
ellipticity of the major CD bands of parallel c-KIT1 (Table 5.6). It is worth noting
that (66) produced either negligible or very minor changes to the CD spectra of each
of the other DNA molecules examined using this spectroscopic technique. This

197

suggests that this nickel complex may exert some very specific binding selectivity in
favour of parallel c-KIT1 over each of the other DNA molecules studied.

Table 5.6: Effect of addition of nickel Schiff base complexes on the CD spectrum
of c-KIT1.*
Nickel complex Positive CD band at 262 nm Negative CD band at 240 nm
Δλmax (nm)
Δɛ (%)
Δλmax (nm)
Δɛ (%)
3.7
-58.2
2.1
-60.3
(54)
(55)
3.4
-44.8
1.3
0.3
(57)
0.6
-3.4
-0.6
-22.4
(58)
3.4
-54.8
-1.5
-50.7
-1.1
4.4
-0.7
-24.8
(60)
(61)
0.4
-50.1
1.3
-45.8
(63)
0.7
-5.9
-0.8
-11.2
(64)
1.5
-53.2
0.6
-66.0
(66)
2.1
-63.4
-2.5
-74.8
* All Δλmax and Δε(%) values are the difference between the values for free DNA and
those for a solution containing a nickel:DNA ratio of 9:1. Negative Δλmax values indicate
a blue shift; positive values indicate a red shift.

Comparison of the CD spectra in Figure 5.9 with those shown in Figure 5.6 suggests
that most of the nickel complexes with propylpiperidine pendant groups interacted
similarly with parallel c-KIT1 to how they did with parallel Q1. For example,
addition of (55), (58) or (64) caused dramatic changes to the ellipticity of the positive
CD bands of parallel c-KIT1 (Figure 5.9 (b), (d) and (h)), which were comparable to
what was observed with parallel Q1.This suggests that the interactions between these
three complexes and parallel c-KIT1 are similar to what was observed with parallel
Q1 and significantly affect the chirality of both nucleic acids. One small difference
between the results obtained with the two types of parallel unimolecular Gquadruplexes centred on complex (61). For example, addition of (61) resulted in a
decrease of 50% in ellipticity for the major positive CD band of c-KIT1 at 262 nm
(Table 5.6). This decrease was two times higher than what was observed with the
same CD band for parallel Q1 (24%, Table 5.3). Therefore, whilst it appears that (61)
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does interact in a similar fashion with both parallel unimolecular G-quadruplexes, the
magnitude of this interaction was greater in the case of c-KIT1.

5.2.3 DNA

binding

studies

performed

using

UV-Vis

spectrophotometry
To further investigate the interactions between nickel complexes bearing either
ethylmorpholine or propylpiperidine pendant groups and dsDNA a series of melting
experiments were performed using UV-vis spectrophotometry and D2. The results
obtained from these experiments, which were performed by measuring the effect of
temperature on the absorbance at 260 nm of solutions containing either 3:1 or 6:1
ratios of nickel complexes and D2, are presented in Figure 5.10. Inspection of
Figure 5.10 shows that each of the nickel complexes containing ethylmorpholine
groups caused the melting temperature (Tm) of D2 to decrease by between 1 and 2
°C. These results are similar to those obtained in most instances from similar
experiments performed using analogous nickel complexes bearing ethylpiperidine
pendant groups (Chapter 4.2.3) and suggest that the interactions between these nickel
complexes and D2 may be either very weak or destabilise the secondary structure of
the nucleic acid. Solutions containing D2 and (60), (63) or (66) gave ESI mass
spectra which were dominated by ions from free DNA, supporting the hypothesis
that in some of these systems non-covalent adducts were either not present or had
low thermal stability. Furthermore, addition of complexes (60) and (66) had little
impact on the CD spectrum of D2, providing further evidence for a general lack of
interaction between these nickel complexes and dsDNA.
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In contrast to the above, most of the nickel complexes containing propylpiperidine
pendant groups resulted in increases in Tm for D2 of between 3 and 12 °C. For
example, (55) caused the highest increase in Tm of 12 °C when present in a 6-fold
excess over the dsDNA. Complexes (58) and (64) produced smaller increases of 4.6
and 2.6 °C, respectively. These observations suggest that these nickel complexes and
in particular (55) may interact to a significant extent with D2. This conclusion is
consistent with those derived from binding studies performed using ESI-MS and CD
spectroscopy. In the case of the former experiments no ions from free DNA were
observed when (55), (58) or (64) was added to D2. In contrast, ions from noncovalent adducts containing four and even five nickel complexes bound to D2 were
detected. Furthermore, addition of (55), (58) or (64) resulted in very significant
changes to the CD spectrum of D2. Of the nickel complexes bearing propylpiperidine
pendant groups only (61) resulted in small decreases in Tm for D2. It is notable that
this complex exhibited a lower ability to form non-covalent adducts with D2 in ESIMS binding studies, and also resulted in small changes to the CD spectrum of the
nucleic acid.
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Figure 5.10: Mean melting temperatures (Tm) of solutions containing either a 3:1 or
6:1 ratio of different nickel complexes and D2. The experiments were performed in
triplicate with error bars showing standard errors.

5.2.4 DNA binding studies performed using FRET melting assays
In order to provide further support for the conclusions based on binding experiments
performed using ESI-MS and CD spectroscopy, it was decided to further investigate
the affinity of nickel complexes with either ethylmorpholine or propylpiperidine
pendant groups for unimolecular G-quadruplex DNA using FRET melting assays.
These were performed using the nickel complexes and two different conformations
of a unimolecular G-quadruplex produced from the labelled 21-mer 5′-FAMG3(TTAG3)3-TAMRA-3′. Initially F21T was annealed using a buffer containing 100
mM Na+ which resulted in the molecule adopting an anti-parallel conformation.
When an assay was performed using a solution containing anti-parallel F21T alone,
the melting temperature, Tm, was determined to be 50.4 ± 0.3 °C. The results
obtained from FRET melting assays performed using solutions containing anti201

parallel F21T and increasing concentrations of the nickel complexes are presented in
Figure 5.11 andFigure 5.12.

Figure 5.11: Results obtained from FRET melting assays performed using F21T in
solutions containing Na+ and increasing concentrations of nickel Schiff base
complexes: (a) (54); (b) (55); (c) (57); (d) (58); (e) (60); (f) (61); (g) (63); (h) (64)
and (i) (66).
Figure 5.12 shows that in general nickel complexes containing propylpiperidine
groups had a larger effect on the FRET melting curves than the corresponding
complexes containing the same diamine moiety but ethylmorpholine pendants. This
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result is consistent with the ability of the former complexes to produce more
dramatic changes to the CD spectrum of anti-parallel Q1 noted earlier in this chapter.
In contrast, nickel complexes containing ethylmorpholine groups had very little
effect on the FRET melting curves except in the case of complex (54), which
contains the phenylenediamine moiety. This result is consistent with that obtained
from CD studies performed using anti-parallel Q1 which showed (54) had the largest
effect on the ellipticity of the positive CD band among the nickel complexes
containing ethylmorpholine groups.
The results presented in Figure 5.12 also show that (66) had a negligible effect on the
FRET melting curve of anti-parallelF21T even at highest concentration of added
nickel complex (10 μM). This is consistent with the inability of this complex to alter
the CD spectrum anti-parallel Q1, and further demonstrates that the meso-diphenyl
ethylenediamine group inhibits binding interactions with this quadruplex structure.
Comparison of the FRET data shown in Figure 5.12 with that presented earlier in
Figure 4.15Figure 4.14, also suggests replacing ethylpiperidine groups with
ethylmorpholine resulted in a decrease in Tm values, reflecting weaker binding
interactions with anti-parallelQ1. For example, solutions containing 10 μM (57),
which contains ethylmorpholine pendant groups, resulted in an increase in the Tm for
F21T of 10.1 °C, which was much less than the change caused by (56) (34.9 °C),
which contains the same diamine moiety but ethylpiperidine pendants. In contrast,
replacing ethylpiperidine groups with propylpiperidines had the opposite effect on
the strength of binding interactions. This is illustrated by the observation that
solutions containing 10 μM (58), which has propylpiperidine pendant groups
increased the Tm of anti-parallel F21T by an even larger amount (39.6 °C). These
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findings are also consistent with trends seen in CD studies presented earlier in this
chapter.
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Figure 5.12: Comparison of ΔTm values for different concentrations of nickel Schiff
base complexes added to solutions containing 0.2 μM F21T. The DNA had an antiparallel topology after annealing in 100 mM NaCl, 10 mM lithium cacodylate pH 7.4
buffer. Error bars represent the standard errors from six separate experiments.
FRET experiments were also carried out with F21T in its hybrid conformation. To
achieve this, F21T was annealed in a buffer containing 100 mM K+ ions. The results
of these experiments are present in Figure 5.13 andFigure 5.14. Comparison of these
results with those shown in Figure 5.11 andFigure 5.12 show that in general, nickel
complexes containing propylpiperidine pendant groups had less effect on the FRET
melting curve of hybrid F21T than the anti-parallel conformation. For example,
solutions containing 10 μM (58) were shown to increase the Tm of hybrid F21T and
anti-parallel F21T by 23.7 °C and 39.6 °C, respectively. This is consistent with what
was observed in CD studies performed using Q1 present in its anti-parallel and
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hybrid conformations as the nickel complexes generally showed a greater ability to
alter the CD spectrum of Q1 when present in the former topology.

Figure 5.13: Results obtained from FRET melting assays performed using F21T in
solutions containing K+ and increasing concentrations of nickel Schiff base
complexes. (a) (54); (b) (55); (c) (57); (d) (58); (e) (60); (f) (61); (g) (63); (h) (64)
and (i) (66).

205

(54)

(55)

(57)

(58)

(60)

(61)

(63)

(64)

(66)

25

 Tm(°C)

20
15
10
5
0
1 uM

2 uM

4 uM

5 uM

10 uM

Nickel complex concentration (μM)
Figure 5.14: ΔTm induced by different concentrations of nickel Schiff base
complexes in the presence of 0.2 μM F21T. Samples were annealed and measured in
100 mM KCl, 10 mM lithium cacodylate pH 7.4 buffer to ensure the G-quadruplex
was present in a hybrid topology. Error bars represent the standard error from six
separate experiments.
In addition, comparison of the results obtained from both sets of FRET experiments
shows that all nickel complexes containing ethylmorpholine pendants except (54)
had a slightly greater effect on the FRET melting curve of hybrid F21T than on the
anti-parallel conformation. For example, solutions containing 10 μM (57) increased
the Tm of hybrid and anti-parallel F21T by 19.4 °C and 10.1 °C, respectively. These
findings are consistent with trends seen in CD spectroscopic studies involving Q1 in
its anti-parallel and hybrid conformations.
Whilst nickel complexes containing propylpiperidine groups did not affect the Tm of
hybrid F21T as much as for the anti-parallel topology of this nucleic acid, they still
produced larger increases than analogues containing ethylmorpholine groups. In
addition, (66) again had the smallest effect on the FRET melting curve. This suggests
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that this complex has limited ability to interact with either the anti-parallel or hybrid
topology of this G-quadruplex. Although complex (66) did result in small changes to
the CD spectrum of Q1 in its hybrid conformation, the effects were obtained only at
the highest Ni:DNA ratio (9:1) studied, and therefore are consistent with the result
from the FRET experiments.

5.2.5 DNA binding studies performed using FID assays
The results obtained from DNA binding studies conducted using ESI-MS and CD
spectroscopy revealed some consistent trends in binding affinities for nickel
complexes containing ethylmorpholine or propylpiperidine pendant groups. In order
to find further evidence in support of some of these trends and to further investigate
the selectivity of nickel complexes for both dsDNA (D2) and G-quadruplex DNA
(Q1 and Q4) sequences, a series of FID assays was performed. A representative set
of results obtained using complex (58) and parallel Q1 is shown in Figure 5.15, and
values of DC50 derived from experiments performed with all nickel complexes and
DNA sequences is presented in Table 5.7.
Inspection of the results reveals that the largest DC50 values for each of the three
types of DNA were obtained with complexes (63), (66) and, to a lesser extent (57).
These observations suggest that these complexes, each of which contain
ethylmorpholine pendant groups, exhibit the lowest affinity towards all three types of
DNA This conclusion is consistent with the results obtained from ESI MS and CD
experiments. For example, the abundances of ions from free DNA was greater in the
case of experiments performed with (63) and (66) and both Q1 and Q4 than for any
of the other nickel complexes examined as part of this project (Figure 5.3).
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Comparison of the values reported here with those presented earlier for nickel
complexes with ethylpiperidine pendant groups (Table 4.7) shows that (59) was the
only member of the latter class of complexes to also exhibit low binding affinity
towards each of the DNA molecules examined.

Figure 5.15: Results obtained from an FID assay involving addition of increasing
amounts of (58) to a solution containing thiazole orange and parallel Q1. The inset
shows a Stern-Volmer plot derived from the data, which was then used to determine
the value of DC50 for (58) with this DNA sequence.
Values of DC50 for (60) were not obtained with any of the three DNA molecules as
this complex did not produce a 50% decrease in fluorescence intensity even at the
highest Ni:DNA ratios used (100:1) (Figure S5.1,Figure S5.2 andFigure S5.3). These
results suggests (60), which also contains ethylmorpholine pendant groups, does not
interact strongly with any of the DNA molecules. This is consistent with the poor
ability of this complex to form non-covalent adducts in ESI-MS experiments
(Figure 5.3) as well as its inability to produce changes to the spectra of the same
DNA molecules in experiments performed using CD spectroscopy.
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Table 5.7: DC50 values derived from FID assays performed using nickel
complexes with either ethylmorpholine or propylpiperidine pendant groups and
different DNA molecules.
Nickel complex
(54)
(55)
(57)
(58)
(60)
(61)
(63)
(64)
(66)

DC50( μM)
Parallel Q4
0.41 ± 0.06
0.04 ± 0.01
1.24 ± 0.04
0.04 ± 0.00
0.19 ± 0.02
2.24 ± 0.12
0.06 ± 0.00
2.53 ± 0.23

dsDNA D2
0.39 ± 0.05
0.20 ± 0.03
0.80 ± 0.02
0.18 ± 0.02
0.35 ± 0.04
3.68 ± 0.04
0.09 ± 0.00
1.21 ± 0.07

Parallel Q1
0.23 ± 0.02
0.03 ± 0.003
15.53 ± 0.19
0.08 ± 0.00
0.27 ± 0.04
>25
0.09 ± 0.00
22.55 ± 0.11

Further analysis of the DC50 values in Table 5.7 reveals that the lowest DC50 values
for the three types of DNA were obtained in experiments performed with (55), (58)
and (64), each of which contain propylpiperidine pendant groups. These observations
suggest these three nickel complexes exhibit the greatest affinity towards all three
types of DNA of the two classes of complexes examined here. This conclusion is
consistent with the results presented earlier in this chapter obtained using other
methods. Furthermore, comparison of the results presented in Table 5.7 with those
shown in Table 4.7 suggests that the binding affinities of the above three complexes
were in all cases greater than that for any of the nickel complexes bearing
ethylpiperidine substituents.

5.2.6 DNA binding studies performed using molecular docking
Comparison of the DNA binding results presented in this chapter for nickel
complexes containing either ethylmorpholine or propylpiperidine pendant groups,
with those shown in Chapter 4 for analogues with ethylpiperidine pendants revealed
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a number of trends. One of the most notable of these was that nickel complexes with
propylpiperidine pendants generally exhibited the greatest binding affinity towards
most types of DNA examined, whereas those with ethylmorpholine substituents
showed the lowest. In addition, complexes featuring the 1,3-propanediamine moiety
often showed lower binding affinities towards specific DNA molecules than
analogues with the same pendant groups but featuring different diamines. The data
presented, however, does not directly shed light on any of the binding mechanisms
present in these systems. Molecular docking simulations were therefore performed
using the nickel complexes containing either ethylmorpholine or propylpiperidine
groups, and both a G-quadruplex DNA (PDB ID: 1KF1) and a dsDNA (PDB ID:
1KBD). The binding mode corresponding to the top docking score for each
combination of binding partners is illustrated in Figure 5.16 while Table 5.8
summarises the minimum binding energies (∆G) for each system.
Most of the nickel complexes preferred to interact via π-stacking interactions with
the top G-tetrad of the parallel unimolecular G-quadruplex. This was observed with
the complexes examined in chapter 4 as well and indicates that most of the nickel
complexes interact with 1KF1 in a similar binding mode. The two exception to this
trend were (58) and (61), which instead preferred to bind to the bottom G-tetrad.
Inspection of Figure 5.16 (a) reveals the nickel ions in (54), (55) and (60) were
located near the centre of the G-tetrads. This allowed all aromatic rings of these
complexes to bind effectively to the guanine bases within the G-tetrad of 1KF1 via πstacking interactions. In addition, the four positively charged pendant groups in these
three complexes were positioned favourably to participate in intermolecular
interactions with the loops and/or grooves of the G-quadruplex. In the case of
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complex (61), three of its pendant groups were involve in binding interactions with
different grooves of 1KF1 while the forth pendant group is positioned flat towards
the edge of the guanine residues.
Figure 5.16 reveals a slightly different preferred binding mode for complexes (57)
and (58), which feature ethylenediamine moieties, with 1KF1. While both aromatic
rings in these nickel complexes were positioned so that they are lying flat on the Gtetrads, the resulting interactions are not as optimal as for (54) and (55) as the nickel
ions were not located centrally above the G-tetrads. This resulted in the two lower
pendant groups of (57) and (58) being positioned on top of the guanine residues
instead of located so they could interact with the loops and grooves of the DNA. In
addition, one of the two remaining morpholine rings of (57) was positioned on the
surface of the groove and therefore also not able to participate in optimised
intermolecular interactions with the G-quadruplex. In contrast, both piperidine rings
in the top pendant groups of (58) were positioned so that they can participate in
favourable intermolecular interactions with the loops and/or grooves of the Gquadruplex. This supports the conclusions drawn from ESI MS studies which
showed (58) was able to form non-covalent complexes with parallel Q1 while (57)
did not.
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Figure 5.16: Most favourable binding modes resulting from molecular docking
studies performed using nickel Schiff base complexes containing ethylmorpholine or
propylpiperidine pendant groups and either: (a) and (c) the parallel unimolecular Gquadruplex 1KF1 or (b) and (d) the dsDNA 1KBD.
The nickel ions in (63) and (64), which contain 1,2-diaminopropane moieties, were
not positioned directly above the centre of the G-quartet of 1KF1. However, the four
positively charged pendant groups were positioned favourably to participate in
intermolecular interactions with the loops and/or grooves of the G-quadruplex. In
addition, similar to what was found with (62), the diamine moieties in (63) and (64)
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were not coplanar with the six membered chelate rings coordinated to the nickel ion.
Furthermore, the latter were not found to be coplanar with each other.
Figure 5.16 (a) shows that the two top pendant groups of (66) were bound to the
second and third TTA loops of 1KF1. In contrast, the two bottom pendant groups of
(66) were positioned on top of the guanine residues instead of located so they could
interact with the loops and grooves of the DNA. The two aromatic rings of the
diamine moiety were also not positioned to participate in favourable π-stacking
interactions with the G-tetrad. This supports the conclusions drawn from ESI MS
studies which showed (66) was an unable to form non-covalent complexes with
parallel Q1.
The docking results presented in Figure 5.16 (b) for the 1KBD showed that all nickel
complexes preferred to bind to the minor groove of the dsDNA. The two bottom
pendant groups of the nickel complexes and the two associated benzene rings were
typically positioned in the minor groove in order to optimise favourable
intermolecular interactions. The two top pendant groups and the diamine moieties
were positioned so that they were orientated away from the minor groove, perhaps in
an attempt to avoid unfavourable steric interactions. Inspection of Table 5.8 shows
that the minimum binding energies of the nickel complexes with 1KBD were
distributed over a narrow range from -8.04 to -8.78 kcal/mol, which is similar to that
for the complexes presented in chapter 4. This indicates that that the nickel
complexes had very similar affinities for 1KBD. The largest binding energy was
observed with complex (63), suggesting it has the strongest overall binding
interactions with 1KBD. In contrast, complex (58) exhibited the lowest binding
energy with the dsDNA molecule.
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The docking results also showed that the minimum binding energies of nickel
complexes with the G-quadruplex 1KF1 were distributed over a narrow range from 8.30 to -9.86 kcal/mol. The largest binding energy was observed with complex (54),
suggesting it has the strongest overall binding interactions with 1KF1. In contrast,
complex (58) exhibited the lowest binding energy with the G-quadruplex. This is
consistent with the results presented in Figure 5.16 (a), which show that two pendant
groups of (58) were positioned on top of the guanine residues and therefore not able
to interact with the loops and grooves of the G-quadruplex. In contrast, four pendant
groups of (54) were positioned favourably to participate in such intermolecular
interactions.
Table 5.8: Binding free energies obtained from docking studies performed using
nickel Schiff base complexes containing either ethylmorpholine or
propylpiperidine pendant groups and 1KF1 or 1KBD.
Structure
ID
(54)
(55)
(57)
(58)
(60)
(61)
(63)
(64)
(66)

1KF1(qDNA)
∆G
(kcal/mol)a
-9.86 ± 0.05
-9.42 ± 0.04
-8.74 ± 0.09
-8.3 ± 0.1
-9.0 ± 0.1
-8.56 ± 0.05
-9.2 ± 0.0
-8.94 ± 0.05
-8.84 ± 0.09

1KBD (dsDNA)
∆G
Binding
Binding modeb
a
(kcal/mol)
modeb
Top, end stacking
-8.78 ± 0.08 Minor groove
Top, end stacking
-8.3 ± 0.2 Minor groove
Top, end stacking
-8.56 ± 0.05 Minor groove
Bottom, end stacking -8.04 ± 0.05 Minor groove
Top, end stacking
-8.4 ± 0.1 Minor groove
Bottom, end stacking -8.05 ± 0.04 Minor groove
Top, groove
-8.9 ± 0.1 Minor groove
Top, groove
-8.3 ± 0.1 Minor groove
Top, groove
-8.5 ± 0.1 Minor groove

a

Average values of ∆G with standard errors obtained from the top five docking scores.

b

“Top” or “Bottom” indicates which terminal G-tetrad was the preferred binding site.
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5.3 Summary
The results presented in this chapter can be analysed to examine the effects on DNA
binding affinity of changing both the pendant groups and diamine moieties of the
nickel complexes. The largest effects were caused by varying the pendant groups. It
was found, for example, that nickel complexes with ethymorpholine pendant groups
did not interact strongly with any of the DNA molecules investigated. For example,
(66) only interacted in a relatively weak fashion with the DNA molecules examined.
This conclusion is supported by the absence of ions of high abundance from noncovalent adducts in ESI mass spectra, the lack of significant changes to the CD
spectra of DNA in most cases after addition of this nickel complex, the relatively
small change in Tm for F21T observed when (66) was added, and the large values of
DC50 obtained from FID assays performed with this complex. In the case of the
dsDNA D2, the reduction in Tm observed when (66) was added provides further
evidence that binding interactions are weak and/or have a destabilising effect.
Further evidence of the poor binding characteristics of complexes bearing
ethylmorpholine substituents was provided by the results of FID assays performed
using complex (60). The latter failed to displace TO sufficiently to enable values of
DC50 to be obtained with any of the three DNA molecules investigated. This
highlighted (60) as the only nickel complex whose binding interactions were not
strong enough with any DNA molecule to displace the indicator molecule.
In contrast to the above, the results obtained from ESI-MS and CD spectroscopic
studies, as well as FRET and FID assays, showed that nickel complexes with
propylpiperidine pendant groups generally interacted more strongly with different
DNA molecules than analogues containing the same diamine moiety but one of the
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other two types of pendants. For example, the relative abundances of ions in ESI
mass spectra from non-covalent complexes containing one or more (55) bound to D2,
Q1 or Q4 was greater than for non-covalent complexes containing either (53) or (54).
This was also found to be the case for all other groups of three nickel complexes
featuring the same diamine moiety but different pendants. Comparison of DC50
values amongst triads of nickel complexes with the same diamine moiety revealed
they were always lower for the complexes bearing propylpiperidine pendant groups,
and the latter consistently resulted in the largest values of ∆Tm in FRET experiments,
particularly with anti-parallel F21T.
Finally, it should also be noted that only complexes containing propylpiperidine
pendant groups significantly increased the Tm of D2 in melting experiments, with the
largest increases observed for (55), (58) and (64).
Whilst it was hoped that analysis of the results presented in this chapter might also
reveal additional information about the effects of changing the diamine moiety on
DNA binding, in practice it was hard to distinguish these from the larger influence of
altering the pendant groups. For example, it was noted in the previous chapter that
(53) resulted in ions of significant abundance in ESI-MS experiments with all three
types of DNA. This was also found to be the case with complex (55), but not (54),
despite both also featuring the phenylenediamine moiety. It is also worth noting that
complex (55) significantly changed the CD spectrum of Q4. This result suggests (55)
has an appropriate combination of structural features to endow it with high affinity
for this G-quadruplex. This conclusion is supported by the results of FID assays
involving Q4, which resulted in the lowest DC50 value being obtained for (55).
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The results presented in Chapter 4 also highlighted (59), which possess the 1,3propanediamine group, as generally exhibiting very low binding affinity towards
most DNA molecules. This was also found to be the case for complex (60) featuring
the same diamine moiety. For example, it was not possible to determine values of
DC50 from experiments performed with this complex and any DNA molecule owing
to its very poor DNA binding ability. Complex (61) on the other hand exhibited a
greater ability than either (59) or (60) to form non-covalent adducts in ESI-MS
experiments, despite having the same diamine moiety. This is attributed to the overriding influence of the propylpiperidine pendant groups in the former nickel
complex.
Another unique observation was that parallel c-KIT1 was the only G-quadruplex
whose CD spectrum was significantly affected by (61). This result suggests this
nickel complex may bind to parallel c-KIT1 with some selectivity over other types of
G-quadruplexes, however additional spectroscopic studies are required to corroborate
this result.
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Chapter 6

Conclusions and future directions

6.1 Conclusions
The main goal of this project was to prepare a range of new nickel Schiff base
complexes that could act as selective G-quadruplex DNA binding and stabilising
agents. The design of the new nickel Schiff base complexes was based on structural
features previously identified as favourable for these purposes. This included an
aromatic core as well as multiple positively charged pendant groups. It was proposed
that the above goal might be best achieved through incorporating four pendant
groups into the structures of each of the complexes. These would enable additional
binding interactions that would vary with the loops and the grooves of different Gquadruplex DNA structures, whilst simultaneously inhibiting intercalation with
dsDNA owing to steric hindrance.
Initial attempts to synthesise nickel Schiff base complexes with four pendant groups
were based on an adaptation of a widely used two-step literature method.124 It was
possible to synthesise the precursor hydroxylated nickel Schiff base complexes using
the first step of this method but not the final target complexes with the pendant
groups. For example, alkylation of the precursor complex (50) to form (53) using the
literature method was unsuccessful. One possible explanation for the failure of this
reaction centres on the presence of traces of water in reaction mixtures coming from
the hydrated starting material, complex (50). This is because in the presence of even
just traces of water, the K2CO3 used in the reaction mixture would have produced
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significant quantities of hydroxide ions which could have reacted with the alkylating
agent before it had a chance to react with (50).
In view of the above problem, an alternative mechanochemical synthetic procedure
was investigated for synthesising the desired complexes. Unfortunately, this method
also proved to be ultimately unsuccessful. The mechanochemical synthetic approach
was successfully applied to the synthesis of hydroxylated nickel Schiff base
complexes, with yields of up to 98 % being obtained with reaction times as short as 2
h. Despite this success, the subsequent attachment of pendant groups could not be
achieved under any set of reaction conditions.
In view of these problems, a third approach to obtaining the target complexes was
developed which employed a common organic precursor, and centred on a
modification of a previously reported method.125 This new synthetic approach was
based on selective dialkylation of 2,4,6-trihydroxybenzaldehyde to obtain a set of
organic precursor compounds featuring different pendant groups, which were then
used in condensation reactions with different diamines and nickel(II) acetate to
produce a suite of fourteen new tetra-alkylated nickel Schiff base complexes in
moderate to good yields. The complexes were fully characterised by NMR
spectroscopy, ESI-MS and microanalysis. In addition, the solid state structures of
four of the nickel complexes were determined using X-ray crystallography.
The solid state structures of (53), (54), (63) and (65) revealed that the nickel ion in
each case adopted a square planar coordination geometry. In addition, all bond
lengths and angles involving the central nickel ion were consistent with standard
values.125,135 The presence of the meso-1,2-diphenylethylenediamine moiety in (65)
produced a torsion angle of -40.8(3)˚ which resulted in one phenyl ring being in an
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equatorial position, whilst the other was located in an axial position. It is possible
that this structural feature may have inhibited the ability of (65) to interact
extensively with dsDNA. This proposal was supported by the results of a molecular
docking study performed using (65) and 1KBD, which showed that the diamine
moieties in the nickel complex was orientated further away from the minor groove
than what was observed with the other nickel complexes. This resulted in (65)
exhibiting the lowest free binding energy with 1KBD. In addition, the poor affinity
of (65) for dsDNA revealed by the docking study was consistent with results
obtained from ESI-MS and UV-Vis spectroscopic studies, which also highlighted
that (65) exhibits a low binding affinity towards dsDNA.
The synthetic strategy developed to obtain the new nickel complexes resulted in a
diverse range of chemical structures featuring different diamine moieties and pendant
groups. The results of DNA binding studies performed using various spectroscopic
methods showed that these different structural features resulted in a variety of Gquadruplex binding behaviours. For example, when examining a range of complexes
featuring the same pendant groups, such as (53), (56), (59), (62) and (65), the identity
of the diamine moiety was found to influence the DNA binding behaviour of the
complexes. In addition, when the DNA binding behaviour of a series of complexes
featuring the same diamine moiety and aromatic core was investigated, such as (53),
(54) and (55), the structure of the pendant groups was found to have a major effect
on DNA affinity.
There was generally good agreement between the results of DNA binding
investigations undertaken using different spectroscopic methods and molecular
docking simulations. For example, the results of ESI-MS binding studies indicated
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that (53) was able to form non-covalent complexes with dsDNA and both
unimolecular and tetramolecular G-quadruplexes. This suggested that (53) was able
to interact to a significant extent with each of these different types of DNA
molecules, which was consistent with the results obtained from FID assays.
Furthermore, (53) was also found to have a greater ability than most other nickel
complexes with ethylmorpholine pendant groups to affect the CD spectrum of
unimolecular G-quadruplexes when the latter were present in either a parallel or
hybrid conformation.
Changing the diamine moiety from phenylenediamine to ethylenediamine, 1,3propanediamine or 1,2-propanediamine, whilst retaining the same pendant groups,
often resulted in very different DNA binding characteristics for a series of related
nickel complexes. For example, complex (59), which contains the 1,3propanediamine moiety, gave larger values of DC50 for D2, Q1 and Q4 in FID assays
than any other complex bearing ethylmorpholine pendant groups. This suggests (59)
exhibited the lowest affinity of this group of nickel complexes towards each of these
DNA molecules. The results of ESI-MS binding studies supported this conclusion,
and also showed that changing the diamine moiety in (59) from 1,3-propanediamine
to either ethylenediamine or 1,2-propanediamine resulted in complexes with a greater
ability to form non-covalent complexes with D2, Q1 and Q4. This suggests the above
structural changes resulted in increased DNA binding affinity in the case of
complexes (56) and (62), which was also supported by the results of FID assays
performed with these nickel complexes and the same DNA molecules.
The presence of the meso-1,2-diphenylethylenediamine moiety in (65) resulted in a
complex which exhibited selectivity in its binding interactions in a number of
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experiments. For example, the results of ESI-MS studies showed (65) exhibited a
greater ability to form non-covalent complexes with Q1 and Q4 than with D2.
Further evidence in support of a binding preference for G-quadruplex DNA over
dsDNA was provided by the results of FID assays and CD spectroscopic studies. In
addition, the results of CD and FRET studies performed with anti-parallel and hybrid
forms of unimolecular G-quadruplexes indicated (65) also exhibited the ability to
bind to these nucleic acid structures. These results are consistent with previous
investigations which noted the ability of nickel Schiff base complexes bearing the
meso-1,2-diphenylethylenediamine moiety to interact selectively with parallel
tetramolecular G-quadruplexes.135,136
Some of the most profound effects on DNA binding behaviour were found to result
from varying the identity of the pendant groups present in the nickel complexes. For
example, the results obtained from ESI-MS and CD spectroscopic studies, as well as
FRET and FID assays, showed that nickel complexes with propylpiperidine pendant
groups generally interacted more strongly with different DNA molecules than
analogues containing the same diamine moiety but one of the other two types of
pendants. For example, (59), which possess the 1,3-propanediamine group and
ethylpiperidine pendant groups, generally exhibited very low affinity towards most
DNA molecules in binding experiments. This was also found to be the case for
complex (60) featuring the same diamine moiety but ethylmorpholine pendants.
Complex (61) on the other hand exhibited a much greater ability than either (59) or
(60) to form non-covalent adducts in ESI-MS experiments, despite having the same
diamine moiety. This was attributed to the over-riding influence of the
propylpiperidine pendant groups in (61). Similar trends in binding affinity were
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found for all other groups of three nickel complexes featuring the same diamine
moiety but different pendants. It should also be noted that only nickel complexes
containing propylpiperidine pendant groups significantly increased the Tm of D2 in
melting experiments. Another unique observation was that parallel c-KIT1 was the
only G-quadruplex whose CD spectrum was significantly affected by (61). This
result suggests this nickel complex may bind to parallel c-KIT1 with some selectivity
over other types of G-quadruplexes, however additional spectroscopic studies are
required to corroborate this result.
The results of molecular docking studies indicated that each of the nickel complexes
interacted with dsDNA via a groove binding mechanism and that intercalation was
not a major contributor to the intermolecular interactions. This conclusion was
supported by the results obtained from CD studies, as larger changes to the CD
spectra of dsDNA would have been expected if the nickel complexes were
interacting via an intercalating binding mode. Molecular docking studies also
revealed that each of the nickel complexes interacted primarily via an end-stacking
mechanism with a unimolecular G-quadruplex. The exact manner with which the
complexes interacted varied as a result of differences in their structure, however the
binding free energies fell within a relatively narrow range. This suggests that
additional changes to the structure of the complexes will be required in order to
produce more effective and selective G-quadruplex binding agents.
Complexes (53), (56) and (65) and their analogues with only two pendant groups
(18), (20) and (46) were evaluated for their cytotoxicity against V79 lung cancer
cells using MTT assays. The results obtained suggested (65) was slightly more
cytotoxic than its analogue (46). In contrast, the reverse trend was observed for the
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other two pairs of nickel complexes. Therefore, although only a limited data set of
complexes was investigated, introduction of two additional pendant groups does not
in general appear to confer additional cytotoxicity onto this class of nickel
complexes. It should be remembered, however, that the effects of such structural
alterations may vary from one cancer cell line to another.

6.2 Future directions
There is a range of approaches which can be taken to improve upon the DNA affinity
and selectivity of the novel nickel complexes reported in this thesis. First of all it
would be worthwhile to investigate the effects of changing the pendant groups from
those present in the current complexes to alternatives with different functional groups
such as amino acids or short peptides, alkyl pyrrolidines, quaternary amines, or alkyl
pyridinium moieties. In addition, it would be informative to investigate the effects of
changing the position of the pendant groups in the current complexes. A suitable
group of complexes for investigation could be obtained, for example, by preparing
the

initial

organic

precursor

starting

with

either

2,3,4-

or

2,4,5-

trihydroxybenzaldehyde, instead of the 2,4,6- isomer. Condensation of the resulting
compounds with diamines in the presence of nickel ions would then yield a range of
new complexes whose DNA-binding abilities could significantly differ from those
reported in this thesis, by virtue of being able to more favourably position their
pendant groups in the grooves of some G-quadruplexes. It would also be worth
investigating the effects of replacing the nickel ion in the complexes studied in this
thesis by other metal ions with a preference for a square planar coordination
geometry such as palladium(II) or platinum(II), on DNA-binding interactions.
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During the synthesis of the nickel complexes (65) and (66), the free ligands
corresponding to both complexes were successfully isolated, however their DNA
binding properties were not explored. It would be interesting to examine the effect of
the absence of the metal ion on the DNA binding interactions of these ligands, as
their more flexible structures may facilitate a different set of interactions with some
DNA molecules.
While the molecular docking experiments presented here predicted the expected
binding modes for the nickel complexes the results of these experiments should be
confirmed using molecular dynamics simulations (MDs). This is because a limitation
of molecular docking experiments is that they consider DNA molecules to be rigid
and therefore do not allow them to adjust conformation during the docking process as
would be expected in solution. Molecular dynamics simulations, on the other hand,
can incorporate conformational changes that occur as a result of DNA-ligand
interactions in solution. Furthermore the latter technique is more likely to generate
accurate results by also incorporating interactions with solvent molecules.
While MTT assays provided a convenient method for exploring the therapeutic
potential of the nickel complexes, they do not provide specific information about the
mechanism of cell death induced by the tested compounds. Therefore, other
biological assays such as fluorescence microscopy and flow cytometry assays are
required. For example, Annexin V staining in conjunction with flow cytometry could
be used to determine whether the mechanism of cell death caused by the nickel
complexes is apoptotic or necrotic in nature. This, along with the effect of the nickel
complexes on other human cancer cell lines and normal cell lines is important
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information that could be used to direct further investigations into the therapeutic
potential of this classes of metal complexes.
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Supplementary Figures

Figure S3.1: gCOSY NMR spectrum of (53), with H-H correlations highlighted.

Figure S3.2: HSQC NMR spectrum of (53), with selected C-H correlations
highlighted.
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Figure S3.3: HMBC NMR spectrum of (53), with selected C-H correlations
highlighted.

Figure S3.4: 1H NMR spectrum of (57).
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Figure S3.5:: 1H NMR spectrum of (58), with an expansion of some signals, for
clarity.

Figure S3.6: 1H NMR spectrum of (60), with an expansion of some signals, for
clarity.
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Figure S3.7: 1H NMR spectrum of (61), with an expansion of some signals, for
clarity.

Figure S3.8: gCOSY NMR spectrum of (61), with selected H-H correlations
highlighted.
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Figure S3.9: 1H NMR spectrum of (63).

Figure S3.10: 1H NMR spectrum of (64).
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Figure S3.11: 1H NMR spectrum of (66).

Figure S3.12: 1H NMR spectrum of (67).
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Figure S5.1: Results obtained from an FID assay involving addition of increasing
amounts of (60) to a solution containing thiazole orange and D2. The inset shows a
Stern-Volmer plot derived from the data, which was then used to determine the value
of DC50 for (60) with this DNA sequence.

Figure S5.2: Results obtained from an FID assay involving addition of increasing
amounts of (60) to a solution containing thiazole orange and parallel Q1. The inset
shows a Stern-Volmer plot derived from the data, which was then used to determine
the value of DC50 for (60) with this DNA sequence.
233

Figure S5.3: Results obtained from an FID assay involving addition of increasing
amounts of (60) to a solution containing thiazole orange and parallel Q4. The inset
shows a Stern-Volmer plot derived from the data, which was then used to determine
the value of DC50 for (60) with this DNA sequence.
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